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And it came to pass, when he was in a certain
city, behold a man full of leprosy: who seeing
Jesus fell on his face, and besought him, saying
Lord, if Thou wilt, Thou canst make me clean.
And he put forth his hand, and touched him,
saying, I will: be thou clean. And immediately
the leprosy departed from him.
Luke £, 12-13
Frontispiece "The nerve destruction with consequent
deformity, which is the most important
complication of leprosy usually occurs
during borderline leprosy reactions,"
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Leprosy is still one of the most important diseases
in the world today: it afflicts 15 million people and is
the most important cause of deformity in man. The causative
organism, Mycobacterium leprae (M. leprae) has an affinity
for skin and nerve and is remarkably non-toxic; therefore,
most of the clinical manifestations are due to the host
response. The nerve destruction with consequent deformity,
which is the most important complication of the disease
usually occurs during borderline leprosy reactions.
Surprisingly there has been little research into this
type of reaction, though it seems likely that they result
from an increase in cell-mediated immunological reactivity.
This thesis describes a prospective study of 83
patients who attended the Addis Ababa Leprosy Hospital
with borderline leprosy, the purpose of which was to
clarify the mechanisms involved in borderline leprosy
reactions. Seventeen of the 83 patients developed
reactions during the period of follow up (between one
and two years) and the clinical, histological and
immunological findings were compared in this group of
patients with those patients who did not develop reactions.
It was observed that in the reaction patients there
was a significant rise in lymphocyte transformation (LT)
responses to both 'whole* and 'sonicated' preparations of
H. leprae, confirming that these reactions are due to an
increase in cell-mediated immunity to mycobacterial
antigens. However it was found that in those patients
who presented with reactions involving the skin alone,
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there was a very marked rise in the responses to whole
V., leprae (and a smaller rise in response to sonicated
M. leprae) whereas those who had reactions involving
nerve alone had a rise in LT responses only to sonicated
M. leprae. Those with involvement of skin and nerve in
the reaction had a marked rise in responses to both
antigens. The reason for this remains obscure, but it
seems likely that bacillary membrane antigens are associated
with 'skin' reactions, and cytoplasmic antigens with
'nerve' reactions; it is possible that this results from
different exposure of antigens in skin and in nerve.
There were two other findings of considerable
importance related to the mechanisms which might be involved
in reactions. Firstly, bacilli were often found in dermal
and peripheral nerves without surrounding chronic
inflammatory infiltrate, though there was marked
granulomatous response in skin. It seems likely that this
is of importance as sudden 'i mune recognition' of bacilli
in nerve tissue might account for the increased cell-
mediated reactivity that occurs in this type of reaction.
Secondly, autologous plasma, which is normally suppressive
to LT responses to phytohaemagglutinin in leprosy,
developed an augmenting effect during reaction. It is
possible that plasma factors normally act as a form of
•brake' mechanism preventing delayed hypersensitivity
reactions but during reaction this effect is lost.
Probably the most important observation of the
study in the short term was the effect of dapsone on
reactions. It has always been taught that dapsone should
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be given initially at low dosage in an attempt to prevent
reactions: however, there have been no published reports
to su port this hypothesis. In a study of 68 patients it
was found that of those receiving dapsone 5 n*g daily, 11
patients developed reactions whereas only 3 of those
receiving 50 mg daily did so. This would suggest that
dapsone in higher dosage does not predispose to borderline
leprosy reactions, and indeed, may prevent them.
When those patients who did not develop reactions
were studied it was found that those with borderline
tuberculoid (BT) leprosy had significantly higher LT
responses to whole and sonicated M. leprae than those
with borderline lepromatous (BL) leprosy. However, there
was considerable variation in both groups. Those patients
with inflamed skin lesions had higher responses in both
BT and BL patients than those with non-inflamed lesions,
and indeed, those with BL leprosy and inflamed skin lesions
had higher responses than those with BT leprosy and non-
inflamed lesions. This would suggest that the LT test
in leprosy reflects the degree of delayed hypersensitivity
rather than that of protective immunity, and that as in
tuberculosis the two phenomena are not necessarily related.
Thus some of the mechanisms involved in borderline
leprosy reactions and the Immune response in leprosy have
been clarified, and it is hoped that as a result of this
study reactions in some patients will be prevented. It
is also hoped that the encouraging results of the stud:/
will stimulate further research into these reactions to
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i. GS ~RAL INTRODUCTION
Leprosy is still one of the most important diseases
in the world today. It is estimated to affect 15 million
people, and is the most important cause of deformity
throughout the world. However, it is now mainly confined
to the tropics, whereas a millennium ago it was worldwide.
It is still a major problem in Africa, but in many
countries there have been effective leprosy control
programmes which have ameliorated the situation. However
this has not been so in Ethiopia, where leprosy control
was not instituted till 14 years ago, Ethiopia, though it
probably has the oldest culture in "black" Africa, is one
of the poorest and most primitive countries in the continent.
This is partly due to its Christian-based culture, as the
people were driven into the mountains of the Ethiopian
plateau with the upsurge in Mohammedanism and they have
consequently remained isolated from the rest of the world,
in such inhospitable terrain that communications have been
extremely difficult. In addition, the country has never
been colonised (apart from the period 1955-41 following
the Italian invasion of Ethiopia from Eritrea) and so
the country has never benefited from outside influence,
as have the other East African countries.
Partly as a result of the lack of previous leprosy
control programmes, Ethiopia has become a centre of major
importance in research and instruction on the disease, the
leprosy hospital in Addis Ababa embracing the Armauer
Hansen Research Institute, a sophisticated immunology
laboratory financed by Scandinavia and the All Africa
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Rehabilitation and Training Centre (ALERT). I was sent
to the Addis Ababa Leprosy Hospital in January 1974 to
work as a member of the Medical Research Council Leprosy
Project for 2 years, on secondment from the Laboratory for
Leprosy and Mycobacterial Diseases, Rational Institute for
Medical Research, Mill Hill, London, and the main purpose
for my presence in Ethiopia was to carry out a study of
borderline leprosy reactions. (Borderline leprosy is the
commonest type of leprosy there, roughly 75% of patients
having that classification.) This was a collaborative
study comparing the clinical, the histological and
immunological features of this kind of reaction, and my
main collaboration was with Dr. G. Bjune, a basic
immunologist working in the Armauer Hansen Research
Institute.
ii. MYCOBfiCTSRIUM LEPRAE - PROPERTIES 0? THE BACILLUS
Mycobacterium leprae (M. leprae), the causative
organism of the disease was originally described by
Hansen (1874): it has a number of special characteristics.
1. It is an obligate intracellular organism, being found
in the skin predominantly in macrophages, and in
peripheral and dermal nerve in Schwann cells.
2. It has an affinity for skin and nerve: involvement
of peripheral nerve causes the deformity so notorious
in this disease.
3« It has a longer generation time than any other
bacterium, estimated as 12 • 13 days in the
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logarithmic phase of growth in mice (Shepard and
McRae, 1965).
4. It has not to date been cultured on an artificial
medium, despite several claims to the contrary. This
has considerably hampered leprosy research. Indeed
it was only as late as i960 that Shepard (1960)
achieved multiplication of the organism in the mouse
footpad. Following this, mouse models have been used
extensively to study various aspects of the disease,
including immunopathology, (Rees, 1971). Latterly
Kircheimer and Storrs (1971) have used the armadillo
as an animal model for lepromatous leprosy, and this
is now proving of great benefit as a source of very
large numbers of bacilli for experimental work.
5. It is an organism with a remarkable lack of toxicity
(Godal et al, 1974). Thus most manifestations of
leprosy are due to the host's immunological response.
Lepromatous leprosy patients may be seen in the clinic
without a single clinical manifestation, though they
1 3
may harbour 10 ^ bacilli within the body tissues.
This fact gives added importance to leprosy in the
field of research, as a model of disease due to the
host response.
6. It is an organism of high infectivity, contrary to
previous belief. G-odal and Hegassi (1973) in a
study of staff contacts in the Addis Ababa Leprosy
Hospital demonstrated that these contacts developed
high responses in the lymphocyte transformation (LT)
test using H. leprae aa antigen, thus suggesting that
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most develop subclinical infection, a situation
analagous to that in tuberculosis.
This being so, the method of spread previously
assumed to be skin-to-skin clearly lay open to doubt
in this non-ulcerative disease where the organism is
probably non-motile (c.f. primary yaws). A number of
studies have shown recently that the most likely spread
of the organism is from nose to nose (Shepard, 1962;
Goodwin, 1967? Pedley, 1973? Davey and Rees, 1974?
Rees and Meade, 1974.) It is interesting to note that
this confirmed work of almost a century ago by Leloir
(1886) and Schaffer (1898). The "nose blow" is now
used, as a method of importance in assessing the
i fecti ity of patients.
Congenital leprosy has never been described,
which is surprising in that mothers with leprosy may
13
have 10 v bacilli within the body tissues, with a
constant bacillaemia of up to 10 bacilli (Orutz et
al, 1972). Barnetson et al (1976) have shown that
this may be partly explained by the fact that where
the mother possesses immunity to the bacillus, the
foetus also develops this immunity possibly due to
transplacental passage of a sub-lymphocyte factor
akin to 'transfer factor*.
iii. TRBATMS3TT OF LEPROSY
Prior to 1941, there was no effective treatment for
leprosy: a number of preparations were used, including
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hydnocarrms oil, though with very limited success. In
1941, the treatment of the disease was revolutionised by
the introduction of the sulphones in leprosy. Dapsone
(diphenyl diamino-sulphone) proved to be the most effective
antileprosy drug (Lowe, 1950) and has retained its place
as the primary therapeutic agent till the present day,
though it may have to be replaced or given as a drug
combination in view of increasing drug resistance (Pearson
et al, 1975; Pearson et al, in press). It has the
advantages that it is inexpensive, an attribute of major
importance in tropical medicine, and in the dosages required
is relatively non-toxic. Pew alternative drugs are
available: they include elofazamine, and such anti-
tuberculous drugs as thiacetasone, streptomycin, ethionamide
and rifampicin.
Most authorities however have taught th t dapsone
plays an important part in precipitating hypersensitivity
reactions (Jopling, 1964; W.H.O., 1966; Leiker, 1971;
Bryceson and Pfalzgraff, 1975)* However there is little
evidence that this is true either for borderline leprosy
reactions or for erythema nodosum leprosum (SHL), Lowe
(1950) described how nerves became smaller and less tender
when the patient received treatment with dapsone and in none
was neuritis aggravated. Two further studies by Lewis et
al (1957) and Prasad (1971) which compared "high" and
"low" dosage regimes in borderline tuberculoid leprosy
patients showed no difference in the incidence of reactions
between the two groups. Similarly in ENL, Pearson and
Helray (1973) and Waters and Helmy (1974) could find no
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evidence that dapsone caused or seriously worsened the
reaction.
iv. SPECTRUM OF LEPROSY - CLINICAL AID HISTOLOGICAh ASPECTS
Leprosy is a classical example of a disease which
demonstrates a spectrum both clinically and histologically.
This does not depend on variability in the properties of
the bacillus, but rather on the host response.
Danielssen and Boeck (1847) originally described two
forms of leprosy "anaesthetic*, subsequently termed
"tuberculoid", and "nodular" subsequently termed "lepromatous".
Surprisingly the concept of "borderline" leprosy - an
intermediate form between these two extremes - took 100
years to formulate. Initially, Wade (1952) put forward
a suggested comprehensive system of classification which
included borderline leprosy and it was decided on a formal
basis that this should be adopted by the 6th International
Congress of Leprology in Madrid 1953. In 1966 Ridley and
Jopling (1966) introduced a five group classification,
splitting borderline leprosy into borderline tuberculoid
(BT), borderline (BB), and borderline lepromatous (BL)
leprosy. Only then was the classification crystallised:
previously many BT patients were classified as tuberculoid,
and BL as lepromatous. A later modification by Ridley and
Waters (1969) defined a group between BL and LL termed
lepromatous indefinite (Li). Thus the full spectrum of
leprosy was characterised clinically and histologically.
The spectrum also correlated to some degree with the
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patients' immune defences. Tuberculoid (TT) leprosy is
characterised clinically by localization of the disease,
patients present with an anaesthetic anhidrotic hypo-
pigmented area in the skin, with perhaps a related enlarged
nerve. Histologically the picture is that of epithelioid
cell granuloma in the skin, with areas of epithelioid cells
and giant cells surrounded by cuffs of lymphocytes. This
process usually arfects the full thickness of the dermis
with infiltration of the subepidermal zone, and erosion
of the epidermis. Bacilli are rarely found, though
occasionally they may be seen in dermal nerve or muscle}
thus the immune response seems to be comparatively efficient.
At the other end of the spectrum lies lepromatous (LL)
leprosy, and this is characterised by lack of immune
responsiveness. Thus the disease is generalised, and
clinically there may be diffuse hypopigmentation with
nodules in the skin and diffuse thickening of the peripheral
nerves (though this may be a minor feature), Nodules are
not only found in the skin, but also in the mouth, nose
and larynx. Histologically the picture is that of a
histiocytic infiltrate throughout the dermis, though not
infiltrating the epidermis: there is no evidence of
epithelioid cell formation and within the histiocytes,
which have a "foamy" appearance, there are numerous
bacilli, a proportion of which are intact (suggestive
of viability), though a majority appear granular and
fragmented.
In borderline leprosy a mixture of these two extremes
is seen both clinically and histologically. An important
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characteristic of borderline leprosy is its unstable
state, with a tendency to progress to one end of the
spectrum or the other. Those with untreated leprosy tend
to progress towards the lepromatous end of the spectrum,
and those receiving treatment progress towards the
tuberculoid end of the spectrum. Those in the middle of
the spectrum are the most unstable group of all.
In BT leprosy, the disease is more widespread than
in tuberculoid. The patient has numerous hypopigmented
areas which are anaesthetic, with diffuse nerve enlargement,
and commonly resultant deformity from nerve destruction.
Also characteristically in this type of leprosy the
hypopigmented areas may become swollen and erythematous,
with associated nerve swelling and tenderness. Histologically,
BT leprosy resembles TT leprosy with epithelioid-cell
granuloma formation, though the subepidermal zone tends
to be spared and giant cells are more numerous. Bacilli
are rarely found.
BL leprosy presents a more lepromatous picture
clinically, H popigmentation is very diffuse and the skin
lesions are not well demarcated as they are in BT leprosy.
There may be nodules particularly on the limbs and on the
face, within the hypopigmented areas. Nerve enlargement
is diffuse and deformity is 'gain common. Histologically,
the infiltrate within the dermis is histocytic with few
lymphocytes (generally), and bacilli are present within
the histiocytes, though less numerous than in lepromatous
leprosy.
Borderline leprosy (BB) is a highly unstable 3tage,
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with features clinically and histologically of both BT
and BL leprosy. Patients usually develop inflammation
of their hypopigmented lesions and this process is often
very active* A very characteristic sign of this type of
leprosy is the "ring lesion" where there is an area of
normal skin within the inflamed lesion. Histologically
there is epithelioid cell granuloma formation, with a
moderate number of bacilli present. Langhans giant cells
are absent and lymphocytes may be scanty.
One further group also deserves mention; these are
patients with "indeterminate leprosy". This group is
something of a "rag bag", including those with very early
leprosy who have not yet developed the characteristic
histology of the disease. However, some BT patients as
diagnosed clinically, have an indeterminate histology on
skin biopsy, though biopsy of a peripheral nerve may
demonstrate typical epithelioid cell granuloma.
v. THE IMMUNE RESPONSES IN IBPROSY AND THEIR RELATIONSHIP
TO TUB CLINICAL AND HISTOLOGICAL SPECTRUM
During the immunology "explosion" of the last decade,
many papers on the immunology of leprosy have been written,
and leprosy has thus become a model of the human host
response to chronic infection. The non-toxieity of the
bacillus makes immunological study of this disease doubly
Interesting, as most of the clinical manifestations of the
disease are due to the host's immune response.
It is well recognised that the human host immune
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responses may be split into two components; cell mediated
immunity and humoral immunity# In cell mediated immunity
the lymphocytes are dependent on a maturation stage in the
thymus, and they are thus known as T lymphocytes. However
humoral-immune responses are mediated by a different class
of lymphocytes; in chickens these have been shown to be
dependent for maturation on the Bursa of Pabricius and
they are thus known as B lymphocytes, although no equivalent
to this organ has been described in man. As might be
expected, there is considerable interplay between these
two immune systems, and it is becoming increasingly apparent
that humoral immunity is important in diseases which were
thought only to provoke a cell mediated response, and vice
versa#
(1 ) GBLI MEDIATED .T.I?" (O.H.X.)
It has long been known that immunity to intercellular
parasites such as the leprosy bacillus is mainly dependent
on cell mediated immune mechanisms rather than serum anti¬
bodies (Mackaness and Blanden, 1967), and thus on T
lymphocytes. However, the T lymphocytes are not usually
capable of destroying the parasites directly (Tripathy and
Mackaness, 1969, McGregor and "oster, 1971); their function
is to release lymphokines, including macrophage migration
inhibition factor, macrophage activation factor and
specific macrophage-arraing factor, -which inhibit macrophage
migration (David, 1966) and activate the surrounding
macrophages (Mackaness, 1967). This results in a number
of changes in properties of the macrophage including
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inci'eased pinocytosis, increased phagocytosis and enhanced
bacteriostasis, enabling more efficient destruction of the
bacillus.
Roar crises to Antigens
Assessment of the cell mediated immune response to
leprae may be carried out by in vivo or in vitro
tests.
a) In vivo: the lepromin test has been in use since
1919 (Mitsuda, 1919) but to date has proved of only very
limited use as a diagnostic test. The reagent is prepared
from infected human tissue and consists of autoclaved
leprosy bacilli contaminated with some tissue elements
(Rees, 1964). Injected intradermally the suspension may
elicit an early reaction (Fernandez) after 4-8-72 hours,
equivalent to the "Tuberculin test" and a late reaction
(Kitsuda) which reaches its maximum 4 weeks after injection
and is equivalent to the Kveim test.
It has proved of very limited diagnostic value, as
in studies of healthy controls in non-leprosy-endemic
areas, a proportion of those tested have had positive
results. This is almost certainly due to cross-reactivity
with other mycobacteria (Rees, 1964; Goihman-Yahr et al,
1968) coid this may be supplemented by the host skin
elements present in the lepromin (Rees, 1964). However,
it has recently been shown by Myrvang et al (1975) that
provided the test is standardised, the early reaction may
be of epidemiological value in detecting leprosy contacts
with evidence (obtained by in vitro tests) of subclinical
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infection.
The significance of the late reaction is still
unknown. De Souza and De Souza (1948) suggested that the
Fernandez reaction might demonstrate the "allergic
condition"of the patient, and the Mitsuda reaction his
"immune statiis". This hypothesis is still tenable (Myrvang
et al, 1973). It is interesting to note that even 30 years
ago hypersensitivity and protective immunity in leprosy
were considered by some as separate entities,
b) In vitro; recently a number of tests have been
established by which it is possible to monitor lymphocyte
function in vitro. They include (i) the lymphocyte
transformation (IT) test and (ii) the leucocyte migration
inhibition (LITI) test, both of which have been used in
leprosy. The Immunological bases for these tests are
as follows
(i) LT test (Ling, 1968), It is well established that
T lymphocytes carry receptors for antigen on their
surface. When exposed to an antigen which can
interact with the receptors, the lymphocytes will
enlarge and start to divide. This lymphocyte
"transformation" may be monitored in vitro by
counting the number of morphologically transformed
cells, or measuring the associated DMA synthesis
by uptake of radioactive thymidine.
(ii) LMI test (David et al, 1964) One of the results of
T cell stimulation is the liberation of lymphokines.
This production -aid release of 1 -mphokines can be
monitored in vitro by various tests, but the most
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useful test using this principle is the leucocyte
migration inhibition test. However this test has
lost some of its popularity as B lymphocytes may
also produce macrophage inhibition factor, and
results are often poorly reproducible.
Both these tests have been used to assess the cell-
mediated immune response of leprosy patients, using M. leprae
as the antigen. (Particular a tention has been paid to
correlating L? test results and the classification of the
disease, and to demonstrating changes associated with
reactions. They have also been used to detect subclinical
infection of leprosy and to characterise the defect of
O.M.I, in leproraatous leprosy.
DEFINITION 0^ I^IUI.'OIOGIC \L dPgCTBII/i If LNPNOJY
Myrvang et al (1973) studied the immune responsiveness
to M. lerrae and other mycobacterial antigens throughout
the clinical and histopathoio-. cal spectrum of leprosy
by using the lepromin test, the LT test and LMI test in
135 patients. By all these methods of investigation, a
continuous decrease was shown from strong responses in
the tuberculoid patients to virtually negative responses
in the LL group} and there was a good correlation between
the in vitro methods and the lepromin skin test. However,
there was considerable v riation in each group, and all
histologically indeterminate patients were exempted from
the study. These patients were the subject of a later
paper.
The immune response to .;/eobacteriun: tubercuiosis
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bovis. strain Bacille Calmette Guerin (BCG) and
"purified protein derivative" (PPD) in those patients
studied, decreased only slightly to ards the lepromatous
pole of the spectrum, confirming the high degree of
specificity of the defect in lepromatous leprosy.
Their findings have given strong support for the
concept of a host-determined, immunological disease
spectrum as su gested by the 'Ridley-Jopling spectrum*
(Ridley and Jopling, 1966).
They also studied a group of indeterminate patients,
based on histopathoiogical diagnosis (Myrvang et al, 1973).
(It is important to note here that the definition of
indeterminate leprosy varies quite markedly between the
clinical and the histopathological spectrutrv and this is
especially so in Ethiopia where many patients with wide¬
spread hypopigmentation suggestive of BT leprosy may give
an indeterminate histology when their skin is biopsied,
though nerve biopsy may show typical epithelioid cell
granuloma.) In their series, they studied 31 histologically
classified indeterminate leprosy patients, of whom 14 were
also clinically indeterminate, the others being classified
as IT or BT. Those who were indeterminate both histologically
and clinically had no response with in vivo or in vitro
tests: however, those with a clinical diagnosis of TI
or BT had a variable response, one or two giving quite
strongly positive results.
The reason for the apparent inability of lepromatous
patients to destroy the bacillus is not fully understood.
Most studies of macrophage function in these patients
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have not shown any defect (Godal and Rees, 1970; Druta
and Cline, 1970; Samuel et al, 1973; Drutz et al, 1974;
Convit et al, 1974). It is likely therefore that there
is a specific defect in lepromatous patients* T lymphocytes,
and this has been borne out by a number of studies. Godal
et al (1971, 1972) have shown that though LL patients
have negative responses with the LT test using fo. leprae
as antigen, they may have strongly positive responses to
3CG- and ?PD, thus underlining the specificity of the
defect. Furthermore, this defect seems to be lifelong,
as LL patients failed to respond to H. leprae even after
10 years of anti-leprosy treatment# (This might preclude
the possibility of the effect being due to T lymphocyte
trapping in lymph nodes due to overloading with persistent
antigen as suggested by Rook (1975).) They concluded that
in these patients there was immunological tolerance to the
bacillus, though the reason for this was unclear.
RECPOffiO TO KITQ&Zia
It is well recognised that small lymphocytes can be
transformed by non-specific substances termed mitogens.
These are plant lectins which interact with carbohydrate
receptors on lymphocytes. One example of a mitogen which
stimulates T lymphocytes to transform is phytohaemagglutinin
(PHA) which is extracted from the red kidney bean, Phaseolus
vulgaris and this can be used to some extent to measure
the immune c ipacity of the patient. However, the range
of responses in the normal population is so great that
cell-mediated deficiency has to be very marked before it
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can be detected by this method.
There have been a number of studies of lymphocyte
responses to PHA in leprosy patients, though results have
been contradictory. A majority of authors are however
agreed that PHA responses are sub-normal in lepromatous
patients (Rodriguez Paradisi et al, 1968; Dierks and Shepard,
1968; Bullock and Fasal, 1971} Han et al, 1971} Wong et
al, 1971} Mehra et al, 1972). A number of papers have
also suggested that PHA responses in tuberculoid patients
are also decreased, though less markedly (Dierks and
Shepard, 1968; Bullock and Pasal, 1971} Han et al, 1971}
Wong et al, 1971). Others have not been able to confirm
a decreased PHA response in leprosy patients (Sheagren et al,
1969; kelson et al, 1971; Rea et al, 1976).
There are a number of possible reasons for these
controversial findings. The methodology varied considerably
in these studios and in some the LT test was carried out
in the presence of autologous plasma or serum, which has
been shown to depress responses in some leprosy patients
(Nelson et al, 1971). (These authors also found considerable
racial differences in responses.) Another important
variable was the patients' therapy when tented: some
were receiving treatment with dapsone or other anti-
leprosy drugs, whilst others were tested before initiation
of treatment. Ilehra et al (1972) found that patients
with lepromatous leprosy had reduced responses prior to
treatment, but these returned to normal after dapsone
therapy. A further important factor which might modify
PHA responses is the reduction of circulating T cell3
which has been reported in lepromatous patients by Dwyer
et al (1973), and Mendes et al (1974)J this might also
account to some degree for the difference between lepromatou
and tuberculoid patients.
(2) HUMORAL IMMUNITY IN L-.PIOOY
Although the main defence against intra-cellular
organisms such as K. leprae is through cell-mediated
mechanisms, humoral antibodies are produced against the
organism. Their function in the pathogenesis of leprosy
is unknown, and the only consequence of their presence
demonstrated to date is the occurrence of erythema nodosum
leprosum associated with immune complex formation.
There have been several studies of serum
immunoglobulins (Ig) in leprosy. In stiidies of IgG, IgA
and IgM there have been varying results. Sirisinha et
al (1972) demonstrated that all these immunoglobulins
were significantly higher in leprosy patients, whether
tuberculoid or lepromatous, than in a normal control
population. Bullock et al (1970) however found that
only lepromatous leprosy patients had significantly
raised levels of these immunoglobulins, when compared
with normal controls, and Sheagren et al (1969)
demonstrated similar results in lepromatous patients
though the raised Ig levels were confined to IgG and
IgA. Of particular interest for the purpose of this
thesis is the study of Srivastava et al (1975), as it
was performed on leprosy patients in Ethiopia. They
found that compared with healthy controls Igflf, IgA and
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IgM were all elevated in lepromatous patients* whereas
only IgG and IgM were elevated in tuberculoid patients,
Malaviya et al (1972) on the other hand could not
demonstrate any difference between leprosy patients
(lepromatous or tuberculoid) and normal controls.
There have also been several studies of specific
anti-myeobactorial antibodies* which are found in the
IgG and IgM classes. They are much more common at the
lepromatous end of the spectrum, where they are found in
nearly 100% of patients, though they are also present in
a small proportion of patients with tuberculoid leprosy
(Navalkar et al, 1965; Ulrich et al, 1969; Myrvang et al,
1974; Kronvall et al, 1975), Similarly the number of
demonstrable antibodies is greater in patients towards the
lepromatous end of the spectrum.
The incidence of auto-antibodies has also been studied
in leprosy patients, Bonomo (1965), Matthews and Trautman
(1965), Malaviya et al (1972) and Petchclai et al (1973)
all found that leprosy patients had a higher incidence of
auto-antibodies (including anti-nuclear antibodies,
rheumatoid factor, antithyroglobulin antibody) than did
normal controls, and this was particularly true in
lepromatous patients. Kreisler et al (1975) also demonstrated
cold lymphocytoxins 50$ of leprosy patients, most of
whom were lepromatous. Finally Wright et al (1975)
demonstrated that 40$ of lepromatous and 20$ of tuberculoid
patients have circulating anti-neural antibodies. It had
previously been suggested that nerve damage in leprosy
might be caused by similar mechanisms to those causing
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experimental allergic neuritis (Waksman and Adams, 1955).
vi. REACTIONS IN LBFHQJY
It has been recognised that leprosy patients have acute
episodes of inflammation, which are now recognised as being
immunological reactions due to hypersensitivity to bacillary
antigens. Two types of reaction commonly present:
1. Borderline leprosy reaction ("reversal reaction")
2. Erythema nodosum leprosum*
As will be seen it is likely that the former i3 an
example of delayed-hypersensitivity reaction (Coombs and
Gell type IY hypersensitivity reaction), and the latter is
an example of reaction due to immune complex formation
(Coombs and Gell type III hypersensitivity reaction)(Coombs
and Gell, 1963).
1. Borderline leprosy reactions present characteristically
with swelling and erythema of previously hypopigmented skin
lesions and appearance of new lesions and on occasion with
severe oedema of the face and limbs. Usually a marked
feature of this type of reaction is neuritis with swelling
and tenderness of the peripheral nerves (on occasion reaction
may present with neuritis and no alteration of skin lesions).
If this neuritis is untreated, then permanent nerve damage
due to granuloma formation and consequent deformity is
likely to result: neuritis in borderline leprosy reactions
is the most important complication of the disease.
Histologically there is an increase in epithelioid cell
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granuloma, formation both in skin and nerve, and in skin there
is a tendency to develop more tuberculoid features. (Thus
the term "reversal reaction", as there is an apparent
reversal of the tendencjr of untreated borderline leprosy to
become more lepromatous).
2. Erythema nodosum leprooum (ENL) occurs only in patients
with lepromatous leprosy. They develop tender erythematous
swollen skin lesions which tend to be smaller than those
in borderline leprosy reactions, and more transient.
Common concomitant manifestations are fever, neuralgia and
arthralgia. Less commonly they may also have severe
continuous neuritis, arthritis, orchitis, irido-cycliti3
and features of glomerulonephritis, with a clinical picture
suggestive of serum sickness. The histology is typical of
lepromatous leprosy, with the addition of foci of poly¬
morphonuclear leucocytes, and evidence of vasculitis in
some cases.
a) PRllvI :I ' 'LXhlC .1 .--ND HISTOLOGIC-lb OBSERVATIONS
There are five accounts of importance and each reflects
the confusion that has existed as to the classification of
reactions.
(1) Hansen and Looft (1895)
Hansen and Looft (1895) described the occurrence
of "eruptions" in their treatise on leprosy, and from
their description both main types of reaction may have
been implicated. However it is clear that many of those
who had reactions had erythema nodosum leprosum, especially
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as they describe in these patients concomitant irido¬
cyclitis and orchitis.
They described a very varied duration and presentation
of these "eruptions". Some had fever and malaise, and those
with frequent reactions tended to have a poor prognosis.
In some the skin lesions ulcerated and nerves became scarred
with result?ant anaesthesia. In some the "leprous affections"
disappeared and the patient was healed from his leprosy
though "this was not frequent". Confirmation of this was
obtained at autopsy.
(2) Camoos and de Sow,a (1954)
Probably the neat important description of
reactions in leprosy was that by Campos and de Souza (1954),
(the first 50 years of the 20th century s em to be in
general a "leprological dark age"). Their paper highlighted
the state of confusion which existed at the time in regard
to reactional states. However it is clear th- t they
classified ENL in its own separate group, being apart from
all other relational states. The paper describes the
reactional states which occur in tuberculoid and borderline
leprosy, and it is probable that these would all come under
the definition of borderline leprosy reaction in present
day nomenclature.
They classified these reactions in 3 groups:
(i) Tuberculoid reactions. In the acute exacerbation
occurring in the circinate variety of tuberculoid leprosy,
pre-existing lesions became active, and somewhat increased
in size, and new lesions might appear. Involvement of
nerves was frequent though general disturbance was not caused.
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The patients were bacteriologically negative and their
lepromin test remained positive. Histologically there was
tuberculoid granuloma and oedema.
(ii) Reactional tuberculoid (RTh). An acute condition
characterised by the appearance of lesions of polymorphous
aspect. On occasion these were the initial manifestations
of the disease, though usually it constituted a development
from indeterminate leprosy to tuberculoid. Clinically the
lesions consisted of "tubercules", "nodular plaoues" or
"erytlirodermic ©xanthoses". This state might progress to
cure, or conversely towards the lepromatou3 end of the
scale. The lesions were erythematous or erythemato-
violaceous, and well demarcated from the surrounding skin.
Involvement of the face, palmar and plantar surfaces was
particularly characteristic. Smears were almost always
positive, progressing to negativity. The lepromin test
was usually negative initially, progressing to positivity.
Histologically this type of reactional state was characterised
by the presence of epithelioid cells, and intercellular
and intracellular oedema. Giant cell3 were present in a
variable number. Lymphocytes were usually present -
without the usual tendency to form cu'"fs around the
"epithelioid nodules".
(iii) Bord&rline aroun. Clinically this type of
reactional state resembled RTL but the lesions were a
slightly different colour - more yellowish, having a
rather "rusty" colour. There were large plaques and
nodules of varied sizes with borders sometimes well-
defined and sometimes indefinite. These might embrace
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(as a relapse eruption) an area where there was previously
a reactional lesion. The new lesion surrounded the site
of the old one and therefore its inside edge was well
defined. Smears were consistently positive, and the lepromin
test was negative. The histology of the lesions was
difficult to interpret, being an intermediate stage between
RTL and lepromatous leprosy. In general there was
epithelioid cell granuloma, but bacilli were numerous.
There might be some lymphocytes, but there were no giant
cells.
It is probable in retrospect that these authors were
describing the same immunological phenomenon as it presented
throughout the borderline spectrum. Their description
however of this picture is extremely accurate though the
involvement of nerves in these reactions is barely mentioned,
(5) Ta.liri (1955)
The other important account of that time was
that of Tajiri (1955) who recognised that reactions could
occur in both tuberculoid and lepromatous patients.
In discussing reactions in tuberculoid patients he
emphasised that he was not considering such things as
acute neuritic syndromes in neural cases but noted that 2
forms of reaction were recognised: reaction in established
T cases and RTL. These followed the definition of Campos
and de Souza (1954).
In lepromatous leprosy, reactions also occurred and
these he classified into 5 groups:
(i) Acute lepromatous infiltration or "reactivation"
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in which there was an active aggravation of infiltrations
on nodules caused by an increase in histiocytes bearing
bacilli. This was mainly a histopathological condition
and was probably equivalent to the "exacerbation nodules"
described by Ridley (1969)«
(ii) Er 'thema nodosum lenrosum. which he reported to
be more frequent with the introduction of sulphones.
These reactions were characterised by pain and other
clinical manifestations and did not appear to be related
to the course of the disease.
(iii) Acutq infiltration syndrom?. These occurred
abruptly in lepromatous cases, sometimes at an early stage
of the disease but more frequently after a prolonged period
of "regression and resorption" of the disease without
augmentation and aggravation of the pre-existing lepromatous
lesions.
They were characterised mainly by an erysipelas-like
eruption with hyperaemic lesions, with limited or extensive
oedema associated. The face might become swollen over¬
night and there might be cone mitant fever. Smears
demonstrate bacilli, but fewer than one would expect in a
lepromatous case. The lepromin test (Mitsuda) was converted
from negative to positive during the reaction, and remained
positive for some time subsequently. Histologically the
lesions demonstrated an infiltration of lymphocytes and
epithelioid cells, sometimes with giant cells and plasma
cells. Prognostically there was variation. They might
proceed to healing, or they might bocome lepromin negative
again with the re-appearance of lepromatous nodules. Some
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patients also suffered severe nerve damage.
It is probable from this account that the latter group
were borderline leprosy reactions occurring in BL patients.
Tajiri's account is thus similar to that of Campos and de
Sousa but they introduce the concept of "exacerbation
nodules" as an exti-a group.
(4) HWey (1,959)
Probably the most important descriptive paper on
reactions was that by Ridley (1969). However, it has been
outdated to some extent by recent immunological research.
Ridley recognised 4 types of leprosy reactionsi
(i) Downgrading reactions in borderline leprosy
(ii) Reversal reactions in borderline leprosy
(iii) Exacerbation nodules in lepromatous leprosy
(iv) Erythema nodosum leprosum in lepromatous leprosy
Reactions in borderline leprosy. Downgrading and
reversal reactions were considered under the same heading
and the author conceded that they had similar clinical
features with erythema, oedema of nerves and nerve
involvement, though the former resulted in loss of immunity,
and the latter in gain of immunity# Thus downgrading
reactions tended to occur in the near-tuberculoid and
borderline patients and in patients who were not receiving
treatment, and reversal reactions tended to occur in near-
lepromatous and borderline patients in patients on treatment.
However histologically there were differences when
the reaction process was followed through sequentially.
Both were characterised by intracellular and extracellular
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oedema, but in reversal reactions the granuloma tended to
increase in volume and become more typically epithelioid
cell granuloma whereas in downgrading reactions there was
a loss of focalisation of the granuloma with a subsequent
increase in the number of bacilli in each section.
Reactions in lenromatous leprosy. Erythema nodosum
leprosum differed from other reactions as ENL occurred not
in major skin lesions but in small clinically inapparent
lesions where there were few bacilli. However, the centre
of reaction always aopeared to coincide with the bacterial
focus. The presence of polymorphs was the essential and
predominant feature of the early stage of the reaction
lesions and there was much cellular degeneration. Later
there might be significant numbers of lymphocytes;
vasculitis was prominent in some.
He described exacerbation nodules as more of academic
interest than of practical importance. They occurred in
patients with very active LL, usually in relapse. One
lesion became exceptionally large and loaded with many times
more bacilli than most othe - lesions: microscopic
examination demonstrated heavy polymorph infiltration and
a picture very similar to that in EEL.
(5) Waters et al t, 1,271)
Finally, Waters et al (1971) described a study
of the histology of lymph nodes in 15 patients with border¬
line leprosy reactions. (The histological appearance of
the lymph nodes across the leprosy spectrum had previously
been described by Turk and Waters (1971) who found that in
lepromatous patients the paracortical areas were infiltrated
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by undifferentiated cells of the histiocyte-macrophage
series which failed to eliminate mycobacteria: as
resistance to infection increased across the leprosy
spectrum histiocytes became more differentiated eventually
appearing epithelioid, and this was paralleled by increasing
numbers of lymphocytes in the paracortical areas.) In
general the lymph nodes of patients in reaction did not
differ significantly from patients with the same classification
in the spectrum without reaction, but in 2 patients with
BL/LI leprosy partial repopulation of the paracortical
areas with lymphocytes was seen, suggestive of regeneration
of the cell-mediated immune response in these patients, the
features becoming more suggestive of tuberculoid leprosy:
this correlated with the bacteriological and histological
obse vations.
From these accounts it was possible to surmise that
there were two main types of reaction, borderline leprosy
reactions, and erythema nodosum leprosum, though their
pathogenesis remained unclear. However, this has been
clarified to a considerable extent by subsequent immunological
investigations.
b) ?Rb7I0U3 I: .KhTOlOGI 0AL RSGEAKCK
Borderline leprosy reactions
Prior to our study there was only one important
publication on the mechanisms of reactions in b rderline
tuberculoid lepx-osy, that of Godal et al (1973)# which they
described as a preliminary report. They studied 10 3T
patients with reactions, using the lymphocyte transformation
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test, the leucocyte migration inhibition test, and skin
testing with lepromin. Seven patients had no previous
treatment, and their reactions were the clinical presentation
of their disease, each having erythematous swollen skin
lesions which had appeared 2-7 months before they were
examined in hospital. The other 3 patients had -well
established leprosy, two of these being on low doses of
dapsone for about 1 year before the commencement of their
reactions (low dosage dapsone was at that time recommended
in an attempt to prevent reactions.) In addition, they
studied 3 other patients with clinical and bacteriological
evidence (increase in bacterial index) of movement from BT
to BL leprosy; these patients were considered to be "down¬
grading", though there were no clinical manifestations of
reaction.
Those patients with reaction, whether receiving treatment
or not, had a strongly positive LT test and Lbl test during
the reaction, whether they were on treatment or not. Those
who had evidence of "downgrading" hnd negative LT tests.
They therefore concluded that patients whether receiving
treatment or not, and whether 3T or BL, who presented
with signs of reaction were all having "reversal reaction"
with greatly increased LT and LMI responses to H. leorae.
They conceded that some patients if left untreated might
subsequently become lepromatous and thus appear to have
downgraded. They emphasised both that it would be
paradoxical for a decrease in immunity to provoke an
acute reaction, and also that the 3 patients who were
downgrading were not in reaction and showed very different
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immunological findings. Thay thus favoured the view that
all borderline reactions were "reversal reactions", though
the final outcome post-reaction might be "upgrading" or
"downgrading". The important contribution of this paper
is to separate the concept of "reaction" from that of
"upgrading"or "downgrading"•
Sr?/thema nodocum leprosurn
In contrast to borderline leprosy reactions, there has
been a considerable amount of immunological research in
ENL.
Wemambu et al (1969) first demonstrated deposits of
immunoglobulin complement and soluble mycobacterial antigens
in the skin lesions of ML and concluded from this that ML
was an example of the Arthus phenomenon, due to immune
complex formation.
Circulating immune complexes were also detected by
Moran et al (1972), Rojaa-Espinosa et al (1972), and Gelber
et al (1974) though they were found also in patients with
uncom licated lepromatous leprosy. Moran et al (1972) and
Gelber et al (1974) found that the levels of immune complexes
circulating were higher in those with EHL, and it was
suggested that the clinical manifestations of ENL were
probably due to immune complex deposition.
However a recent paper by Bjorvatn et al (1976) has
suggested that the skin manifestations of ENL may be due
to extravascular formation of immune complexes, as no
1 25
significant correlation between serum IClq oinding
activity and the Cjjd level in the serum was found, though
patients with ENL and uncomplicated lepromatous leprosy
all had evidence of circulating immune complexes.
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This is an interesting observation, because the histology
of E'HL is not always typical of vasculitis as there are
often dense sheets of polymorphs presenting a picture
similar to that seen in experimental animals when cohnf»l«xes"
ore inoculated directly into the skin (W.B. Parish, personal
communication). It is likely however that circulating
immune complexes are- deposited at times, and this could
account for some of the more unusual complications such
as nephritis, where immune complex deposition h~s been
shown to occur (Tin Schwe, 1972).
vii PmPQPED OBJECTIVE' OF T'TUDY
It was planned to perform a prospective study of about
100 patients with borderline leprosy (of whom about 25$
would be expected to develop reaction) in an attempt to
clarify the mechanisms involved in borderline leprosy
reactions. This was to be achieved by correlation of the
clinical and histological observations with the immunological
results.
It was considered impor ant to confirm the report
of Godal et al (1973) that patients in reaction had high
LT responses to whole K. leprae, which suggested an increase
in cell-mediated immune reactivity. It was also important
to establish that these high responses coincided with the
reaction, raid were not present previously in these patients.
By using "whole K. leprae" and "sonicated X. leprae" as
antigens in the IT test it was hoped to define to some
extent the nature of the mycobacterial antigens involved
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in reaction.
The triggering mechanism for borderline leprosy
reactions has not been elicited, but it was suggested
by Godal et al (1973) that infection with other mycobacteria
might be responsible. For this reason, LT tests to BCGr
and Mycobacterium duvalii should be performed also.
It was felt that it would be useful to study the LT
responses to PHA in relation to re- ction, and in particular
to compare the responses in a standard serum pool with
those in autologous plasma, as plasma factors might play
some part in the reaction.
There had been no research into the role of humoral
immunity, if any, in borderline leprosy rections. In
view of the numerous reports demonstrating T and B lymphocyte
co-operation in experimental animals, it was considered
important to estimate the levels of serum immunoglobulins
and to detect the presence of antiraycobacterial antibodies
in the patients who developed reaction.
It had been suggested that the nerve destruction which
follows these reactions might be due to auto-immune phenomena
in a manner analagous to experimental allergic neuritis
(Waksman and Mams, 1955) though there had been no research
to support this hypothesis. For this reason, a study of
auto-antibodies (anti-nuclear antibodies, anti-lymphocyte
antibodies and neural, auto-antibodies) should be included
in the trial.
Finally the role of treatment in these reactions had
to be elicited. It had always been taught that the dosage
of dapsone was an important factor in triggering reactions,
though there was no good evidence for this in the literature.
Patients were thus to be treated with two different regimes,
half on dapsone 50mg daily, and half on dapsone 5mg daily





b) Subsequent follow-up investigations.
c) Investigations during reactions.
d) Investigations subsequent to reaction.
TREATMENT
METHODS I fflJHOLOGICAL TEST,'
a) Lymphocyte transformation tests.
b) Serum immunoglobulin estimations.
c) Detection of iramunoglobulin G
heterogeneity by agarose gel
electrophoresis.




analysis of immunoglobulin G.
f) Detection of anti-nuclear antibodies.
g) Detection of anti-lymphocyte
antibodies.
h) Detection of neural auto-antibodies.
STATISTIC PL AN A.LYSI3
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PATIENTS
Eighty-three oatients attending the Addis Ababa
Leprosy Hospital were included in the study; 47 were male
and 35 female and their ages ranged from 12 to 61 years.
All had a clinical diagnosis of borderline leprosy,
and this was supported by histological examination of a skin
biopsy from an "active" lesion, though in some BT patients
the histology was that of "indeterminate" leprosy.
Each patient was interviewed by the Medico-Social
Unit of the Hospital, and the study included only those
deemed to be registerable for treatment in Addis Ababa.
I iVESTia•i-TIOL'n
a) Initial investigations on entry to the study.
JLIi IC ,1, . •) 111 m,QSICAL
1. History and Examination. A detailed history was
taken, and a ge eral medical examination was carried
out.
Clinical drawings of the extent and type of
skin lesions were made and the erythema and oedema
of lesions were graded on arbitrary scales (Table 1).
Photographs of he patients' skin lesions were
also taken.
A detailed neurological examination was performed,
and note was taken of the prese ce of enlarged and
tender peripheral nerves.
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TABLE 1 Scale for clinical grading of erythema and
« oedema of the skin lesions.




<+) Slight erythema Slightly raised edges









2. Yolu tary muscle tests (Goodwin, 1966) were carried
out in the physiotherapy department to test the
following nerves:
(a) Ulnar nerves by testing: abductor digiti minimi,
1st dorsal interosseus, and 3rd and 4th lumbrical
muscles.
(b) Median nerves by testing: abductor pollicis brevis,
opponens pollicis and 1st and 2d lumbrical muscles.
Hadial nerves by testing: extensor c rpi radialis
longus and brevis, extensor carpi ulnaris, extensor
digitorum communis, extensor in ices and extensor
digiti minimi muscles.
(<*) Facial xierves by testing: orbicularis oculi.
(e) L- te •• 1 popliteal nerves by testing: tibialis
anterior, extensor digitorum longus, extensor
hallucis longus and peroneus longus and brevis
muscles.
The power of these muscles was graded on a 6 point
(0-9) scale as follows:- 0 = no power, 1 = flicker
of movement, 2 = movement unopposed, 3 = movement against
gravit , 4 = slight weakness, 5 = full power#
3. erve conduction studies of the ulnar and median
nerves were performed in those patients who would
agree to the test (carried out by Dr. Haafs). It
was considered that motor nerve conduction was
abnormally slow below 55 m/sec. The methodology
was described by Naafs ot al (1976).
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4* Skin sme-rs for bacterial index (BI) and morphological
index (MI) from at least 4 sites.
5. Biopsy of active skin lesion for accurate classification,
and detailed histological ex;imination with Haematoxylin
and Eosin (.!. & E.) and Triff (a mixture of Trichrome
and Fite-Farraco stains which demonstrates both acid
fast material and cellular structure)(Wheeler et al,
1965) stains were carried out. Biopsy specimens were
halved, so that Dr. D.3. Ridley could give an
independent histological classification on each patient.
6. Biopsy of one radial cutaneous ne ve was carried out
in a majority of patients. Histological specimens were
3ta.ined with H. & E. and Triff stains.
7. Full blood counts, chest X-ray and urinalysis were
performed to exclude other significant disease. (If
these studies demonstrated the presence of other
significant disease, the patient was not included in
the trial).
IMMUNOLOGICAL
Blood was collected by venesection into 2 syringes
where possible. The first syringe (30ml) contained 10I.U,
of heparin (without preservative) per ml of blood, and
this was used for the lymphocyte studies. The second
syringe (20ml) contained no anticoagulant and was used
for serum studios. In some where it was impossible to
collect a second alLquot of blood, the plasma remaining
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from the lymphocyte studies was converted to serum by
incubation with 1% polybrene (heparin antagonist).
Studies on lymphocytes.
1. Lymphocyte transformation tests with M, leprae (whole
and sonicated), whole 3CG and sonicated Fx. duvalii
used as antigens.
2. Lymphocyte transformation tests with PHA in standard
serum, and autologous plasma.
Studies on scrum
1. Serum immunoglobulins G, A and M.
2. Anti-mycobacterial antibodies.
3. Anti-nuclear factor (IgG).
4. Anti-lymphocyte antibodies.
5. Neural auto-antibodies.
b) SUBSETUEI IT FOLLOW UP .NT) INVESTIGATIONS
CLI ICAL
Each patient was reviewed by myself monthly or two-
monthly. At review, a history of symptomatology was taken,
and a medical examination performed, taking account of
changes in skin lesions and enlargement and tenderness of
peripheral nerves. Voluntary muscle testing was carried
out each time in the physiotherapy department, by the same
tester. At six-monthly intervals skin smears for BI and
MI were repeated.
IMMUNOLOGICAL
Lymphocyte transformation tests and serum immunoglobulins
were repeated at intervals of between 1 and 6 months
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throughout the study. The frequency of testing varied
on 2 counts:
(a) Changing clinical picture in the patient, for example
those with erythematous lesions, or nerve tenderness
would be tested more '"re uently than those who were
relatively "inactive".
(b) The reliabilitjr and punctuality of the patient. LT
teats had to be performed on a s^t day, and relatively
early in the day.
c) investigation:; during reaction
Patients were informed of the symptoms of "borderline
leprosy reactions" and encouraged throughout the trial to
attend for review between appointments if they developed
relevant symptoms: increasing erythema and oedema of skin
lesions and/or severe pains and tenderness of the peripheral,
nerves.
On development of reaction, the patient was admi'ted
to the Hospital under my care.
The fo'lowing investigations were carried out:
Clinical and Histological
1. General medical examination, including drawings and
photographs. The erythema and oedema of skin
lesions were graded o arbitrary scales as
previously described. Me ve involvement in the
reaction was assessed by 3 criteria, at least 2
of which had to be satisfied for nerve involvement
to be considered to be marked -
(a) clinical assessment of nerve tenderness and
swelling, recorded as absent (0), slight (-), or
marked (+); (b) motor nerve conduction studies of
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the ulnar and median nerves (below 55m/sec was
regarded as abnormal); (c) voluntary muscle tests
(sustained fall in muscle power in two or more
muscles supplied by nerve indicated deterioration
(+•); lesser changes (0) were disregarded.
2. 3kin smears from at least 4 sites for BI and MI.
3. Biopsy of an active skin lesion, for diagnosis of
reaction, classification at the time, and detailed
histological examination. The stains used were
H. & S. and Triff, as before.
4» Biopsy of radial cutaneous nerve, usually the
contralateral to the nerve biopsied at the
inception of the study. Stains - H. & E. and
Triff.
Immunological
The immunological studies during reaction were
the same as those at the beginning of the trial. They
were repeated weekly whilst the patient was in hospital
during the reaction peiod.
d) INVBSTIO TlOf ". "UB3E .USM? TO REACTION
Patients were seen monthly after reaction, or more
frequently if their condition warranted it. Particular
note was made in the history of occurrence of limb pains,
weakness or changes in sensation, and on examination
tenderness and enlargement of peripheral nerves were
recorded. VMTS were carri d out as before. A post-
reaction skin biopsy was carried out 6 months to a year
after reaction.
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Lymphocyte studies were performed at intervals of
1 - 3 months after reaction, particularly when the
patients' steroid therapy was stopped. Blood for serum
studies was also taken at the cessation of steroid treatment,
TREATMENT
Antibacterial treatment
Following the initial investigations patients were
started on treatment with dapsone. The first 15 patients
on the trial were treated with dapsone 50mg daily orally.
The remaining 68 recei ed treatment with dapso e 5mg or
50mg daily orally on a random basiss 34 received 5mg and
34, 50mg daily. The tablets were issued monthly (or two
monthly) when the patient was reviewed.
On review, patients were asked when they last took
their tablets, and a specimen of urine was collected for
estim tion of the urine dapsone/creatinine ratio (Ellard
et al, 1974) to assess regularity of therapy.
Treatment of reaction
Patients who developed reaction were treated initially
with prednisolone 20-4Orng daily, and the dosage was
decreased as the clinical condition allowed. For symptomatic
relief of their symptoms they received paracetamol for




(a) LY' PHOCYTB TRU, 3FORMATION TESTS
The lymphocyte transformation test relies on the fact
that when T Ijrmphocytes are stimulated by mitogens, non-
specifically, or antigens to which they have been specifically
sensitized, they undergo mitosis. In doing so there is a
marked increase in DNA synthesis, and consequently in
thymidine incorporation. Thymidine may be labelled with
tritium, and the radioactive uptake by lymphocytes during
transformation may be measured in a scintillation counter.
LT testing was performed by a micro method in this
study according to the technicue described by Closs (1975)
with a few modifications. Venous blood (30ml) was drawn
into a disposable syringe containing 10I.U. of heparin per
ml of blood (heparin without preservative: Ulleval Apotek,
Oslo, Norway), The blood was mixed 2:1 with 0.9$ saline
and then layered onto Picoll/Isopacue, density 1.077 (10
parts of 33,9$ Isopaque [Nyegaard & Co A/S, Oslo, Norway]
plus 24 parts of 9/ Ficoll [Pharmacia AB, Uppsala, Sweden] )
in 10ml centrifuge tubes according to the method originally
described by Boyum (1968). The tubes were then ce;trifuged
at 400 g, and the plasma/saline layer removed. This was
kept at 0°C for use in those LT tests requiring atitologous
/■"I
plasma, or stored at -20 C for conversion to serum with 1$
polybrene in those patients where separate serum samples
were not obtained. The 1 mphocyte layer was then removed
from each tube and the lymphocytes washed twice with
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Hanks balanced salt solution (Hanks BSS, Plow Laboratories,
Irvine, Scotland). They were then re suspended in Hanks .BSS
at a concentration of 5 x 10° cells/ml.
The lymphocytes (25pl cell ;.uspension) were cultured
in triplicate in 20Dpi culture medium and 25pl antigen or
mitogen in plastic trays for tissue culture (IS-FB-96-TC,
Limbro Chemical Co., Hewhaven Connecticut, USA). The
culture medium consisted of TC 199 with Sarles salts
(Plow Laboratories, Irvine, cotland) containing 50I«U.
penicillin/ml and 50pg streptomycin/ml (BOH Chemicals Ltd.,
Poole, England) and 10$ human AB serum. (This serur. was a
pool from healthy controls from a leprosy-non-endemic
area). When LT responses to PHA were performed their
re nonses in 10$ human AB serum were compared v/ith those
in 10$ autologous plasma. The trays were incubated at
J7°C in an atmosphere containing 5$ COg and 100$ humidity.
Control cultures without antigen or mitogen were also
included in the trays. Mitogen stimulated cultures were
harvested on the fourth day, whereas antigen stimulated
cultures were harvested on the seventh day of culture.
(Pilot studies had shown that when an optimal concentration
of stimulant was used the peak response was obtained at
those times.)
The cells were labelled with 0.5pCi tritiated thymidine
(3H-TdR) (Specific activity 2Ci/mmol: Radiochemical Centre,
Amersham, England) 16 hours before termination of the
cultures.
The trays were either harvested immediately or frozen
and kept at -20( C for some days. By using a s ecially
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constructed harvesting device, the cultures were transferred
by suction, 6 at a time onto glass fibre filters (Gelraan
type A, G-elman Instrument Co., Ann Arbor, Michigan, USA).
Each well was then washed through with distilled water to
complete the transfer of cells to the filters. The filters
were transferred to counting vials and dried at 60°C for 1
hour.
5ml toluene based scintillator (5g 2,5-diphenyloxazole
and 0.15g 1,4 bis (2) - (5-phenyloxazolyl) benzene (Koch
Light Laboratories Ltd., Buckinghamshire, England) per
litre of toluene) was added to each counting vial before
estimation of 3H-TdR uptake in an Intertechnique SL31
scintillation counter (Intertechnique, Plaisire,France).
The recorded values for lymphocyte transformation by
antigens or PEA were calculated as the mean of stimulated
triplicate cultures, with the mean of unstimulated
triplicates (i.e. those wells on the tray with no antigen
or mitogen added) subtracted. The responses to antigens
recorded in the text were the peak responses in the dose-
resnorx e curve of antigen concentrations.
PREPARATION OF ANTIGENS ANO MITOGEN TOR LT TESTS
ANTIGENS
(i) M. leprae. The same antigen preparations were used
in all tests nd were derived from a large subcutaneous
histoid nodule (Wade, 1963) from a patient with
lepromatous leprosy. The nodule was cut finely with
scissors in a Petri dish, and ground in a glass
homogeniser in ice cold phosphate-buffered saline (PBS),
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pH 7.2, with 1% human serum albumin (HSA) (AB Kabi,
Stockholm, Sweden). The homogenate was centrifuged at
150g for 5 minutes. The supernatant was again centrifuged
at 2500g for 1 hour and the pellet washed twice in cold
PBS with HSA. After resuspension the volume was adjusted
to 1 x 109 acid fast bacilli (AFB) per ml in PBS-HSA.
The ba'ch was subdivided into small aliquots and stored at
-70°C until required. This preparation was termed "whole
washed" M. leprae.
Half of the batch was ultrasonicated in a Branson
Sonifier B-12 (Branson Sonic Power Co., Banbury,
Connecticut, USA) with 80watt output on tho medium-sized
tip for 1 hour, until no acid fast bacilli (AFB) remained.
This preparation was termed "sonicated" K. leprae and was
subdivided and frozen as described for "whole washed"
M. leprae.
In all tests both frl. leprae anti en preparations were
added at three concentrations standardised to the bacillary
content of the original homogenate: that is 10^, 1 r/" and
107 baoilli/ml.
(ii) Mycobacterium tuberculosis bovis. strain BCG (BCG).
LT responses to BCG in all patients were also
estimated. The whole antigen preparation was used because
it was felt that membrane antigens of BCG were more
important to assess previous aensitisation to M, tuberculosis
than cytoplasmic antigens which would be represented in the
sonicated preparation, (T. Godal, personal communication).
Dried BCG vaccine (Glaxo, Greenford, England) was
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resuspended in 0,9% saline to give a concentration of
10^ APB/ml and this suspension was kept at -20°C until
required. It was added to the lymphocyte cultures at
Q O rj
concentrations 10 , 10 and 10 bacilli/ml.
(iii) hycobaetorlum duvalii (FI. duvalii).
LT responses to duvalii were also assessed.
M. duvalii is a fast-growing scotochromogenic organism, of
which to date only 4 strains have been cultured, all
originating from cases of lepromatous leprosy. The
organisms have not been reported from studies of environmental
mycobacteria, suggesting that natural acquisition of
protection from leprosy is unlikely to be common. M. duvalii
is similar to K. leprae antigenically, and lepromatous
tissues may be particularly prone to colonisation with
FI. duvalli as a consequence of cross-protection provided
by the patients* specific inability to destroy M. leprae.
The LT test was carried out with the sonicated
preparation, which contained both membrane and cytoplasmic
antigens. The M. duvalii strain was obtained from Dr. J.
Stanford, Mi Idiesex Hospital, London, England and cultured
on Sauton mediipn solidified with 1,5% agar. The bacilli
/
were harvested/ in the log phase, washed three times in 0.9/"®
saline and resuspended at a concentration of 1CP bacilli/ml
£
in saline, 'fhis preparation was then subjected to
f
ultrasonicat.ion in the Bran, on Sonifier B12 for 1 hour
/!
after which .'time no AFB remained in the suspension. This
j
suspension was termed "sonicated" K. duvalii. and added to
jl q q









PHA (Reagent grade, Wellcome, Beckenham, England) was
stored at ~20°C until use. Lymphocytes were cultured with
—2
a final concentration of 10 from stock, which was found
to be optimal in previous experiments.
(b) SBRUF! IMMUNOGLOBULIN ESTIMATIONS
Serum IgG, IgA and IgM were quantified by the radial
immuno~diffusion method described by Mancini et al (1965).
In this test, antisera to the Igs are incorporated into a
thin layer of agarose, and the serum samples containing
the Igs, which act as antigens, are placed in wells cut
into the agarose. As the antigen diffuses radially, a ring
of precipitation forms around the well and moves outwards,
eventually becoming stationary at equivalence. At
equiv lence the diameter of the ring is related to the
antigen concentration in the well* Using standard antigen
concentrations run simultaneously a calibration curve
may be constructed to determine unknown concentrations
of the same antigen.
Serum specimens from patients were taken when patients
were first seen (baseline) and at intervals during the
trial. (In some Instances Ig determinations were carried
out using plasma from heparinised blood, diluted 2:1: in
saline as for lymphocyte separation. Appropriate correction
I
for dilution was made in these cases.) Those patients




reaction (at initiation of steroid therapy), and post-
reaction (on completion of their steroid therapy)). The
serum specimens were stored at -70°C until assayed. (One
baseline serum sample of a "reaction" patient was lost).
Serum I S, IgA and IgM levels were measured by addition
of 7jil diluted serum (dilutions: IgG, 1:50; IgA, 1:10; IgM,
1:5) to the wells in the agarose diffusion plates (2?
agarose in barbital buffer (sodium barbital 200gm, barbital
40gm, sodium aside 10gm, in distilled water, to a total
volume of 10 litres)) containing specific antieera to
these immunoglobulins (Dakopatts A/S, Copenhagen, Denmark)
and compared with antigen reference standards obtained
co raercially (Behring-werke Standard erum 974H (containing
1380mg/l00ml IgG, 250mg/lOOml IgA and 108mg/l00ml IgM),
Behring-werke A.G. Marburg/Lahn, Germany).
(c) DETECTION OF I- MUNOOLQBULIN G HETEROGENEITY BY GARQ3E
GEL ELECTROPHORESIS'
This test depends on the fact that protein molecules
bear different electrical charges. Thus subjected to an
electric field serum, proteins will separate in agarose
gels into albumin, {3 and ^ globulins. Most humoral
antibodies in leprosy belong to the IgG class: IgG forms
an electrophoretically heterogeneous group and gross
changes in the polyclonal Ig pattern may be detected by
this method (Laurel1, 1972). Serum from 6 reaction patients
was tested at baseline, during reaction and post-reaction
(on stopping steroid therapy).
Electrophoresis plates (size, 205 x 110 x 1.5mm) were
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filmed with t# agarose (Litex, Glostrup, Denmark) in
barbital buffer (pH 8,6) and slits were made in the gel
at one edge. Patients' serum was diluted 1:1 in 0.1^
broinophenol blue in barbitone buffer, and 7|a1 placed into
each slit with a micro-burette syringe (Hamilton, Micromesure,
B.V., Hague, Holland), Electrophoresis tvas performed in
elec-rophoresis apparatus as described by Laurell (1972)
with a potential difference of 3v/cm for a period of 3 hours.
After that time saturated picric acid solution was added
for 15 minutes, and then the excess of the solution removed
with 96/« ethanol; the gel was dried, and stained with Coomassie
brilliant blue in a dye tray.
(d) DETECTION OF ANTI-MYCQBACTBRIAL ANTIBODIES BY CROSSED
IHI 'illMO-ELECTR0PHOREd 10
In this method, first described by Laurell (1965) and
modified by Axelsen et al (1974), two steps .are involved:
first mycobacterial antigens (from sonicated E. leprae) are
sep.arated by means of agarose gel electrophoresis; the
second step is electrophoresis in a dimension at right
angles to the first dimension, forcing the separated
mycobacterial antigens into a bed of human serum. The
precipitin lines so formed in the agarose enable detection
and identification of the antibodies in the patients'
serum. The serum of all patients in the study was tested
initial y for antimycobacterial antibodies, and the serum
of those who developed reaction was tested also during
reaction and post-reaction, on completion of steroid
therapy.
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The first dimension plate was prepared by dissolving
agarose 1, in barbital buffer, pH 8,6, and pouring 20ml
onto an electrophoresis plate. Holes were punched at
intervals along one edge of the plate, and 8jil of antigen
(soluble preparation of M, leerae prepared by ultrasonication
in a Branson Sonifier B12, with insoluble residues removed
by centrifugation) was added to each hole with a micro-
burette syringe (Hamilton, Micromesure BV, Hague, Holland),
The plate was then placed in the electrophoresis apparatus
with the holes containing antigen adjacent to the cathode,
and electrophoresis carried out for 2 hours with a potential
difference of 5v/cm, After that time the agarose of the
first dimension plate was cut into 2cm strips in a direction
parallel to that of the electrophoresis and rdded to the
second dimension plate, which had been filmed with 20#
serum in 1agarose (from e ch patient separately) with
the first dimension strip adjacent to he cathode, the two
being separated by a s'rip containing 2ml barbital buffer
in 1/ agarose. Electrophoresis in the second dimension was
continued for 20 hours with potential difference of 3v/cm.
The plate was then immersed in PBS containing 0.02*# sodium
aaide (PB3A) for 24 hours, rinsed in distilled water, dried,
stained with Coomassie brilliant blue and then destained
in a methanol/acetic acid mixture.
(e) CROSSED IIllUEOSLEgTROPHOH'-.TIC Ah .If31 ■ OP I^IUITOOLOBULIH 0
A prerequisite for quantitative Immunoelectrophoresis
is that the antigen migrates at a pH at which the antibodies
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do not migrate. In agarose gel, native antibodies are
non-migrating at pH 8.6, as the tendency for anodal
migration at this pH is largely counterbalanced by the
endosmotic flow which is directed against the cathode. It
has been shown by Bjerrum et al (1973) that antibodies
which do not move electrophoretically at a pH between 8,6
and 4.5 may be prepared for immuno-electrophoresis by
carbamylation: in this process amino groups are converted
to carbamylamino groups by reaction with eyanate. These
groups are virtually non-basic and so the iso-electric
point of the antibodies will be lowered. Provided the
carbamylation is carried out under carefully selected
conditions, the antibody titre and the avidity are not
affected to any appreciable degree.
Thus using carbamylated rabbit anti-serum, qualitative
and quantitative analysis of IgG in human patients can be
carried out. Bjerrum et al (1973) showed that to make the
electrophoretically heterogenous serum IgG population
migrate in the same direction in agarose gel electrophoresis,
the pH must be lowered to 5.0. Consequently to quantitate
all classes of native IgG by immunoelectrophoresis an
antiglobulin with a migration rate of zero at pH 5.0 is
required, and as rabbit antibodies are non-migrating at
pH 8.6, the iso-electric point has to be drastically
lowered.
Most antimycobacterial antibodies in humans belong
to the class IgG, The above principle was used on the
serum of 6 reaction patients at baseline, during reaction
and post-reaction, to assess whether the rise in IgG during
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reaction was monoclonal, due to formation of new specific
antibody, or polyclonal, due to a non-s~ecific increase in
antibody formation.
10ml of rabbit anti-IgS antiserum was mixed with 10ml
saturated ammonium sulphate in PBSA. The precipitate was
recovered by centrifugation at 7700g and this was washed 4
times, and then dissolved in 6ml PBSA in dialysis tubes.
Dialysis was continued for 48 hours, with 2 changes of PBSA
during that period. Carbaraylation was carried out with
160mg potassium cyanate incubated at 45°0 for 4 hours, and
following this dialysis with PBSA was repeated for 48 hours,
'he contents of the dialysis tube were then ultracentrifuged
at 80,0G0g in a Beckman Spineo ultracentrifuge and the
supernatant collected and stored at ~20°C.
The first dimension of irnrnunoelectrophoretic analysis
of patients' serum was performed with a potential difference
of 5v/cm for 3 hours. The second dimension of electro¬
phoresis which caused the natients' serum to migrate into
the zone of carbamylated rabbit anti-human globulin was
carried out with a potential difference of 3v/cm, though
anode and cathode were reversed (as human IgG migrates
towards the cathode at pH 5.0). The gel was then pressed,
washed, dried, stained and destained as described previously.
DETECTION OF iNTI-NUCLEAR ANTIBODIES
Antibodies reacting with components of nuclei can be
most readily detected by indirect immunofluorescence, using
a variety of tissues. Anti-nuclear antibodies may be of the
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IgG, XgA and IgM classes though it is usually the IgG
antibodies which are clinically significant. In this test,
mouse liver was used as substrate and IgG anti-nuclear
antibodies were sought using the method originally described
by Holborow et al (1957). The serum of all patients was
tested initially for anti-nuclear antibodies, and in the
patients who developed reaction the test was repeated on
serum taken during reaction and post-reaction.
Frozen sections of mouse liver were dried in air on
slides. 25|il of patients' serum diluted 1:5 in PBSA, was
dropped onto each section and the preparation incubated in
a moist chamber for 45 minutes. After washing 3 times in
FBSA, 25ul of a 10% dilution of anti-human IgG (State
Bacteriological Laboratories, Stockholm, Sweden) labelled
with fluorescein isothiocyanate was dropped onto each
section, and the preparation was again washed with PBSA,
and dried in air. The sections were mounted in PBS-
glyeerine and the presence of anti-nuclear antibodies
assessed by fluorescent staining of the liver nuclei in
comparison with positive control serum using a Leitz
Orthoplan Fluorescence microscope. The positive control
serum was obtained co mercially (State Bacteriological
Laboratories, Stockholm, Sweden) and diluted 1:6 and 1:22
in PBSA.
(&) DETECTION OF A! :T I-LYMPHOCYTE ANTIBODIES
The presence of anti-lymphocyte antibodies can be
detected by a cytotoxicity test, using human lymphocytes
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in the presence of complement. The method used was a
micro-method, originally described by Teraaaki and McClelland
(1964) and modified by Axelsson (1975). Serum from 16 of
the reaction patients was tested at baseline, during
reaction and post-reaction, having been stored at -20°C.
Paraffin oil was dropped into rings of a micro tray
(Holler Coats A/S, Moss, Norway), and 1pi of serial doubling
dilutions of serum added to each ring with a micro-burette
syringe (Hamilton, Micromesure, Hague, Holland), To this
6
was added IjfL of human lymphocytes (concentration: 2 x 10"
cells/ml in Hanks BSS (Plow Laboratories, Irvine, Scotland))
and the tray incubated for 30 minutes at 20°C. Then 1pl
of guinea pig complement was added and the mixture incubated
for 10 minutes at 20°C. After this time 1|il BDTA (final
concentration: 0.4ug/ml) was added and the mixture
incubated at 20°C for 10 minutes. Finally 1|il 2i° Trypan
blue in saline was added and the trays incubated for 30
minutes at 20°C.
The degree of cytotoxicity of patients* serum was
assessed by counting 200 lymphocytes with an inverted
microscope and estimating the percentage of cells which
had absorbed Trypan blue. These were compared with positive
control serum (rabbit anti-lymphocyte antiserum), and
negative control serum from the healthy lymphocyte donor.
(h) DETECTION OF PEUP-'L VUTO-ABTIBQDIKS
This test was kindly carried out by Dr. D.J.M. Wright,
Charing Cross Hospital, London, on reaction patients*
serum at baseline, during nd post-reaction by the method
described by Wright et al (1975).
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STATISTICAL ANALYSIS
Non-parametric methods of statistical analysis were
used for all results of the study, except where otherwise
stated, (Where results are shown in scattergrams in the
text, medians are indicated.) Statistical significance
of differences between groups was estimated with the Wilcoxon
Matched-Pairs-Signed-Ranks test when observations were paired,
and by the Wilcoxon Rank-Sum test when observations were
not paired (v/ilcoxon, 1945). These tests were used
throughout, except where otherwise stated. Differences
were considered significant when the probability of their
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(a) CLINICIL FEATURES OF REACTION
(i) Clinical presentation
Of the 83 patients in the study 17 developed
reaction. However it was noted that there was
considerable variability in clinical presentation:
(1) Six developed reactions with skin involvement
only, with only slight tenderness of nerves
(if any) and no deterioration in VMTS or nerve
conduction velocities:- "SKIN REACTIONS".
(2) Five had erythema and oedema of skin lesions
together with marked swelling and tenderness of
nerves, with evidence of deterioration of VMTS
and nerve conduction velocities as previously
defined:- "MIXED REACTIONS".
(3) Six had no evidence of change in skin lesions,
but developed severe tenderness and swelling of
their nerves with deterioration of VMTS and nerve
conduction velocities:- "NERVE REACTIONS",
The clinical manifestations in these patients
are summarised in TABLE 2. Five of the patients with
skin reactions were BT, and one BB, Four of the
patients with mixed reactions were BT, and one BB.
Three of the patients with nerve reactions were BT,
and three BL, It was thus seen that BT patients
tended to develop skin and mixed reactions, and BL
patients to develop nerve reactions. A patient with
skin reaction is shown in Fig. 1, and with nerve
reaction in Fig, 2.
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classification Skin Nerve Reaction
C H M
1 BO? 2+ 0 im 0 Skin
2 BT 2+ 0 0 0 Skin
3 BT 2+ 0 0 0 Skin
4 BT 2+ 0 0 0 Skin
5 BT 2+
4-
mm 0 0 Skin
6 BB 2+ + 0 0 Skin
7 BT 2+ + 4* + Mixed
8 3T 2+ + HD + Mixed
9 BT + + ND + Mixed
10 BB 2+ + + 4* Mixed
11 3T 2+ -f + 0 Mixed
12 BT 0 + + + Nerve
13 BL 0 + + ■f Nerve
14 BT 0 *f + -f Nerve
15 BL 0 + ■f 4- Nerve
16 BT 0 + t* •f He > v@
17 BL 0 HD + Nerve
C « Clinical assessment
ND » Hot done
M m Voluntary muscle testing
H « Motor nerve conduction velocity studies
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OKI!' RSACTIOIIS: the ST patients who developed skin
reactions tended to do oo slowly, with a gradual increase
in the erythema and swelling of previously hypopigmented
lesions. This period varied between 1 month and 1 year.
In the BB patient progress from initial symptoms of the
disease to reaction occurred within a month. (The BB
patient with a mixed reaction also developed the reaction
quickly - within 2 months of initial clinical manifestations.)
HIXBD RlACTI-'Ilh: four of the patients who developed reaction
developed erythema and swelling of their skin lesions first,
followed by neuritis. In the remaining patient who
initially had BT leprosy clinically, with an indeterminate
histological picture, new erythematous lesions developed
towether with neuritis.
IBRVf RSACTi 13: all occurred in BT patients with indeterminate
histology, or in patients with BL leprosy. (One of the
latter had the histology of II leprosy.) The development
of reaction was relatively sudden in all patients, with a
crescendo of limb pains and deterioration of voluntary
muscle tests, partlculxvrly of the ulnar end median nerves,
accompanied by deterioration of nerve conduction velocities
of the ulnar and median nerves. In 1 patient, . ?ve
reaction followed an episode of EHL.
O-i) Q" .ppact^on after of tpoafoeftt y&ift
Of the 17 patients, 6 developed reaction during the
first month of treatment with dapsone, and a further 5
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during the second month of treatment. Pour developed reaction
in the period 2-6 months after commencement of treatment
and only 2 of the 17 patients developed reaction after that
time, at 7 months and 9 months (though the latter patient
had only had very Intermittent treatment due to irregular
re-attendance at the hospital.) There was no evidence that
skin reactions developed earlier than nerve reactions, or
vice versa.
(iii) Duration of reaction and duration of prednisolone
therapy — — ' *' -—
The period of reaction was very variable, though
nerve reactions tended to be more transient than skin
reactions. In mixed reactions neuritis tended to be
ameliorated with prednisolone therapy more quickly than
erythema and swelling of skin lesions.
Patients required treatment with prednisolone for
a period varying between 2 months and 15 months. They
required an initial dosage of between 20 and 40mg daily
to control the reaction. No patient developed permanent
deformity as a result of reaction whilst in the study,
provided they were treated with prednisolone immediately.
(Two patients who developed ulnar paralysis as a result cf
borderline leprosy reaction were away from Addis Ababa at
the time and thus could not be treated with prednisolone
immediately.)
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(b) o:..-sohb oovyr: ••••cibbncc or reaction in fikal 68 patients
Of those receiving dapsone 50mg daily, 26 had BT
leprosy and 8 BLs 18 were male and 16 female. Of those
receiving 5 mg daily, 24 had BT leprosy, 3 BB and 7 Bit 22
were male and 12 female. Borderline leprosy reactions
developed in 14 of the 68 patients, whose dosage of dapsone
had been randomised. Eleven of the patients were receiving
5sng of dapsone daily, and 3 were receiving 50mg (3ee Table 3).
There is a significant difference between the 2 groups
(p <"0.025) using the Chi-scunre test. Ten of the group
receiving 50mg daily dose had erythematous skin lesions
and reactions might have been expected to develop in these
patients: however reactions developed in only 2. Of the
group receiving dapsone 5mg daily, 9 had erythematous
skin lesions and reactions developed in 8.
table 3 Clinical data of 68 patients treated with dapsone
5mg or 50mg daily
Number of patients receiving
treatment with dapsone





at start of trial 8 1 2 8
Skin lesions "quiescent"
at start of trial 3 22 1 23
TOTAL 11 23 3 31
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2. ALL PATIENTS IN STUDY
(a) Importance of intermittent "limb pains" as a symptom
of disease activity
A majority of patients in this study presented themselves
for treatment because of "limb pains" probably associated
with neuritis. Only 5 patients tolerated these pains for
longer than a year, though many had observed hypopigmented
lesions on their skins for much longer (up to 14 years).
Following treatment the incidence of limb pains became
less as time progressed, only 7 patients having pains at
the end of 1 year, and 4 having pains by the end of the
trial (the period varied between 1 and 2 years). It was
noted that in the 68 patients who had the dosage of their
dapsone randomised, fewer patients on 50mg daily had pains
throughout the trial (see Fig. 3).
(b) Rcgul ritv of dvpsone intake by patients
Estimation of the dapsone/creatinine (D/C) ratio in
the •urine was carried out when each patient was reviewed.
From tho: e patients who were taking dapsone 50mg, it
was estimated that 36/ of observations were low (D/C ratio<30),
of which 8/ were very low (D/C ratio<10). (Tho e patients
taking dapoone 5mg daily all had much lower D/C ratios due
to the low drug dosage: it was therefore impossible to
assess regularity of drug ingestion in these patients.)
Hone of them however gave evidence of taking higher than
prescribed dosage.
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1 Patient with BT leprosy with a "skin reaction".
He had narked swelling and erythema of skin
lesions but no neuritis.
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Fig. 2 Patient with BT leprosy with a "nerve reaction".
She had severe generalised neuritis, with tenderness
and swelling of peripheral nerves, but no change in
her hypoplgmented skin lesions.
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Fir;. 3 Duration of limb pains due to neuritis following
commencement of treatment of dapsone 5mg or 50mg
in the 68 patients included in the study of the
comparison of dapsone dosage to the incidence of
reaction.
(E =s termination of study).
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HISTOLOGICAL OBSERVATIONS
(a) ' istology of akin and nerve in reaction -"it Ion to
Of those 17 patients who developed borderline reactions,
12 were BT clinically, 2 were BB and 3 BL. Histological
examination of initial skin biopsies confirmed the clinical
diagnosis in each case though one of the BL patients was
graded LI, and 4 of the BT patients had an indeterminate
histology.
When the patients developed reaction, those with
"skin" and "mixed" reactions all developed a more tuberculoid
picture in skin biopsies, with increase in volume of epithelioid
4.
cell granuloma, infiltration of the subepidermal sone and
erosion of the epidermis. Three of these "upgraded"
histologically, 2 from BT to TT and 1 from BB to BT. In
8 of these there were large dermal nerves deeper in the
dermis within inflammatory infiltrate, suggesting that
they were actively involved in the reaction process. In
those with nerve reactions, there was no change in the
histology of skin lesions (though one patient showed
evidence of the BNL which preceded his borderline leprosy
reaction), but biopsy of peripheral nerve showed dense
infiltration in each case, \%rith some epithelioid cell
granuloma formation usually related to perineurium.
Skin biopsies were repeated ' etween 6 months and 1
year after reaction, and in each case the histological
appearance had become more indeterminate.
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(b) V ..ri-tlon between initial clinic?.! rmd histological
When the 83 patients were classified clinically
59 were BT, 3 BB and 21 BL and this was confirmed
histologically on skin biopsy. The BT group was further
split according to histological findings into TT, BT and
Indeterminate (Idt) subgroups, and the BL group into BL and
LI subgroups. (See Table 4)
TABLE 4 Number of patients in the study which fall into
the different groups of the leprosy spectrum
when classified according to clinical and
histologic 1 criteria respectively.
Classification
Clinical Histopathological
BT 59 TT 10
BT 25
Idt. 24
BB 3 BB 3
BL 21 BL 9
LI 12
Twenty-four patients, though BT clinically, had
an Idt histology: 22 of them had nerve biopsies, 16 of
which showed typical BT histology with epithelioid cell
granuloma; 6 of them also contained demonstrable FBs.
It was therefore seen that both BT and BL groups
demonstrated a histological spectrum. This was particularly
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true of the BT patients: those with TT histology (see Fig. 4)
who clinically had erythematous skia lesions composing one
end of the spectrum* and those with Idt histology with
linear subepidermal infiltration (see Fig. 5)» and
featureless hypoplgmented akin lesions the other. It was
found that there was a significant difference in the
responses to whole and sonicate" K, leprae between these
two groups (see page 81). There was no significant
difference between those with 3L and LI histology in the
responses to these antigens.
(c) Disparity of bacilli ir. skin :nd nervp
In all BL patients, AFBs were seen in both dermal
infiltration, dermal nerves and peripheral nerve.
In the BT and BB patients there was often a marked
disparity between the presence of AFBs in skin infiltrate
and nerve tissue. Of 43 patients (BT and BB) who had
skin and nerve biopsies 3 had AFBs in the dermal infiltrate,
though 14 had bacilli in the dermal nerves and 13 in-
peripheral nerves.
The most prominent example of this bacillary disparity
between skin and nerve tissue is shown in Figs. 6 and 7.
In skin there is a dense round cell infiltrate with one
granular A.F3 within a histiocyte? however in nerve there




-t. . < .... • • .*
% - • • J* ^ \ • y # A I •
vh••• * ' - v> *.♦ . ;• .Vv
.'. * •--»*<"*/* \ % ' -til'' .
' c v - - • «J- <v . 'A^y t.>%v. • •>•..•
Fig. 4 BT case clinically with erythematous lesions. Dense
epithelioid cell granuloma in seen throughout the
dermis» with infiltration of the subepidermal region
and erosion of th© epidermis,
Haematoxylin and eosln x 200
?li?. 5 BT ease clinically with hypopigmented lesions..
Scanty linear subepidermal infiltrate, without
epithelioid cell granuloma formation.
Hasmatoxylin and eosln x 200*
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Fig. 6 BB patient. Skin biopsy demonstrating granuloma*
Fragmented AFB within a histiocyte.
Triff stain x 500.
Fig. 7 Same BB patient. Biopsy of radial cutaneous nerve,
with many AFBs within Schwann cells, and no
infiltrate.
Triff stain x 500,
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IMMUNOLOGICAL RESULTS
(a) LT Iii33PONSE5 T.Q ANTIGBHS
1. REACTION PA'JILNTS
(a) M. leprae (Whole and sonicated)
The LT responses to whole end sonicated K. leprae
in the 17 reaction patients during the pre-reaotion,
reaction and post-reaction (up to 12 months) periods
are shown in Figs. 0 & 9. (Bach LT response is
represented by a dot at the appropriate time in relation
to reaction.) It is seen that there is a marked increase
in the LT responses to both whole and sonicated M, leprae
during the period of reaction.
The LT responses to whole >n& sonicated M. leprae
at "baseline" (on initiation of patient's treatment
with dapsone), "during reaction" (on initiation of
treatment with prednisolone) and "post-reaction"
(on cessation of prednisolone therapy) in the 17
reaction patients are shown in Figs. 10 & 11.
Unfortunately 1 baseline blood specimen was lost.
With whole a. leprae there was a significant
rise for the group (p<0.055 in LT responses from
baseline (median: 67QCPM) to reaction values
(median: 1890CRO. There was also a significant
»
. t ' -r' -v •* . y •
fall (p<0.01) from reaction to $ost-reaction values
(median: 60CPM)
With sonicated I', leprae there was a significant
rise (p<0.01) the responses from baseline (median:
580CPM) to reaction values (medians 2090CPK). There
was also a significant fall (p<0.01 ) from reaction
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to post-reaction values (median: 70CPM).
Clinical presentation of reaction, -nd. I/.' responses to
whole and sonicated M. leprae "" '
Of the 17 patients, 6 had "skin" reactions, 6 had
"nerve" reactions and 5 had "mixed" reactions. It was seen
that in all 6 who had skin reactions there was a very marked
rise in the LT responses to whole K. lenrae during reaction
and in 5 of them there was a lesser rise in LT responses
to sonicated K. leorae which paralleled the rise with the
former antigen (see Fig, 12). In 5 of the 6 who had nerve
reactions there was a rise in LT responses to sonicated
lenrae but no concomitant rise to whole leprae
(see Fig. 13). In those with mixed reactions, 3 of the 5
had marked rise with both antigens (see Pig. 14). The LT
responses, correlated with the clinical presentation of
reaction are summarised in Table 5: the peak responses
(gross responses) during the clinical period of reaction
are shorn in each patient. (Gross responses were recorded
in this instance, to ensure that all results were greater
than aero, and thus ratios could be calculated.) The
ratio of LT responses to whole K. leprae to LT responses
to sonicated H. leprae are shown in Fig, 15. There is a
highly significant difference between the 3 groups of
atients (p<0,001) using the non-parametric test of
Kruskal and Wallis for independent samples (Kruskal, 1952).
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TABLE 5 Clinical manifestations related to peak LT
responses (gross responses) during reaction,














1 BT Skin 13,861 1 ,770 7.85
2 BT Skin 19,654 5,574 3.55
3 BT Skin 4,800 1,500 5.20
4 BT Skin 5,300 2,353 2.25
5 3T Skin 7,195 4,434 1.62
6 BB Skin 7,396 6,125 1.21
7 BT Mixed 12,089 10,051 1.21
8 BT Mixed 9,050 9,950 0.91
9 BT Mixed 1,515 2,001 0.76
10 BB Mixed 3,765 5,052 0.75
11 BT Mixed 1 ,086 1 ,494 0.75
12 BT Serve 359 357' 1.01
13 BL Nerve 5,187 6,669 0.78
14 BT Nerve 1,626 4,749 0.54
15 3L Nerve 2,156 6,073 0,51
16 BT Nerve 1,086 3,693 0.29
17 BL Nerve 261 1,136 0.25
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(b) 3CO- (Whole)
The LI responses to whole BOO in the 17 reaction
patients during the re-reaction, reaction end post-reaction
periods are shown in Fig. 16. There was a rise in LT
responses in 7 of the patients during reaction but there
was no significant difference between baseline values
(median: 4600PM) and reaction values (medians 5300PM)
for the group• There was also no significant difference
between reaction and post-reaction values (median: 2400PM).
The 3 very high LT responses during the post-reaction
period belonged to the same patient (No, 42).
(c) K. duvalii (Sonicated)
The LT responses to sonicated H. duvalii in the 17
reaction patients during the pre—reaction, reaction and
post-reaction periods are shown in Fig. 17. There was a
rise in LT responses in 9 patients during the reaction
period (median: 940CPT:) when compared with baseline (median:
350CPK) but there was no significant rise for the group.
However there was a significant fall (p<0.05) to T-ost--reaction
values (median: 180CPK)♦
2. INITIAL LT RiiSrO212..:; TO 1.. LdPRAH IN ALL PATI3HTS
Correlation pf LT resoles to K. leprae with c^in^cal
diagnosis
The initial LT responses to whole I-l. leprae in 76
of the patients are shown in Fig, 18. (Seven were lost
due to technical failures of the test.) Fifty-two of
these were clinically BT, 3 BB and 21 BL, It was seen
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that though the responses in BT patients (median! 550CPM)
were significantly higher (p<£>,05) than those in BL
patients, (median: 220 CPI4) there was considerable variation
of responses in each group. Though there were only 3 BB
patients, the responses of each were higher than the median
BT responses.
The initial LT responses to sonicated H, leprae in the
same 76 patients are shorn in Fig, 19. It was seen that
the responses in BT patients (median! 590CFH) were again
significantly higher (p<0,01) than the BL patients (medians
110CPM); as with whole M, leprae there was considerable
variation in LT responses in the two groups.
Correlation of LT responses to M, leprae with histological
diagqosj,s
When the initial LT responses to whole nd sonicated
K. leprae were correlated with the histological
classification, it was found that those who were clinically
BT, but had histology of TT leprosy had significantly
higher responses with both antigens (medians: 1630 and
1040CPM) than those with BT (medians: 500 and 490CPM)
or Idt (medians: 440 and 330CPM) leprosy histologically.
(p<0.01 for both)(See Fig, 20)
There was no difference in LT responses between
patients with BL leprosy histologically, and those who
were LI,
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3. HON REACTK N PATI3HTS
1. M. leprae (Whole raid sonicated)
The LT responses to whole M. leprae in the 66 patients
who did not develop reaction ire shown in Fig, 21. As with
the initial LT responses, there was considerable variation
in LT responses, related to the presence of inflammation
in skin lesions. Those with inflamed skin lesions (BT,
BB and BL) had higher responses than those with non inflamed
(silent) skin lesions (see below). However there were
4 exceptions to this. Four patients with "silent" skin
lesions had very high responses: the responses in those
patients are those joined by lines.
The LT responses to sonic ted H. leprae in these 66
patients are shown in Fig, 22, Again, there was considerable
variation in LT responses, those with inflamed skin lesions
having higher responses than those with silent lesions.
However 3 of the 4 patients with silent lesions who had
very high responses to whole II, leprae also had very high
responses to sonicated M, leprae: again the responses in
th se patients are those joined by lines.
Correlation of LT responses to clinical inflammation of
skin Regions
The LT responses to whole K, leprae comparing those
with inflamed skin lesions and those with silent skin
lesions in the BT and BL patients are shown in Fig. 23.
(The responses 3hown are those throughout the period of the
study: when a patient's inflamed skin lesions became silent,
they are included amongst the "silent" group.) In both
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BT and BL patients there was a significant difference
between those with inflamed lesions (medians: 650 and
650CPM respectively) ana those with silent lesions (medians:
270 and 130CPM respectively). (p<0.01 for BT patients,
p<jD.01 for BL patients.) Also those with BL leprosy with
inflamed lesions (median: 650CPM) had higher IT responses
than the BT patients with silent lesions (median: 270CPI ),
though the difference did not reach significance.
The LT responses to sonicated M. leprae comparing
patients with inflamed skin lesions and those with silent
lesions in BT and BL groups are shown in Pig. 24. In both
BT and BL patients there was a significant difference
between those with inflamed lesions (medians: 430 and
280CPK respectively) and those with silent lesions (medians:
180 and 30CFM), (p<JD,01 for both BT and BL patients).
Also the LT responses in the BL patients with inflamed
lesions were higher than those BT patients with silent
lesions, though the difference was not significant.
2. BGG (Whole)
25/- patients in the study had consistently high
responses to BCG, suggesting previous infection with
tuberculosis. There was however quite marked variation
in responses from time to time: LT responses to BCG were
often increased when responses to M. leprae antigens were
increased, (such as in reaction patients) suggesting cross
reactivity.
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3. ii. Duvalii (Sonicated)
The LT responses to M. duvalii were also very variable,
and usually paralleled high LT responses with the K. leprae
and BCG antigens, suggesting cro s reactivity.
(b) LT REoPOIvGBS TO MITOGEN (PH,)
1, HON RL'.-.CTI " PATIHMT'J
Though LT responses to PHA in standard serum were
performed on all patients at baseline and throughout the
trial, LT responses to PHA in autologous plasma were not
carried out routinely till 5 months after the trial had
commenced. Thus PHA responses in autologous plasma were
only performed at baseline in the last 33 patients in the
study.
The baseline responses to PHA in standard serum and
autologous plasma in 23 of these patients (the reaction
p .tients and those with methodological failures were
excluded) are shown in Fig. 25. The responses in autologous
plasma (median: 18,700) wore lower than those in standard
serum (median: 23,900), though this difference is not
significant. There was no difference in PHA responses
between BT and BL patients.
The LT responses to PHA in standard serum at baseline
were compared with those after the patients had received 6
months treatment with dapsone 5mg daily and dapsone 50mg
daily respectively (see Fig. 26). There was a significant
difference (p^O.OI for both) between the post-treatment
responses and the baseline responses (median: 24,200)
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for both that group taking 5mg dapsone daily (median:
46,700CFM) and that taking 50mg dapsone daily (median:
64,70QCPM). Though the responses to HIA were higher in
those taking dapsone 50mg daily than in those taking 5mg
daily, the difference between the 2 groups was not
significant•
The LT responses to PHA in autologous plasma at
baseline were also compared with those after 6 months
treatment with dapsone 5mg and 50mg daily (see Fig. 27).
There was a significant difference (p<0.05) between the
post-treatment responses and the baseline responses (median:
18,500) for those patients taking dapsone 50mg daily (median:
42,000CPM): there was also a difference in PHA responses
in those patients taking dapsone 5mg daily, but it did
not reach significance. Again the responses to PHA were
higher in those taking dapsone 5Gmg daily than those
taking 5mg daily but the difference between the two groups
was not significant.
2. REACTION PATIENTS
Plasma from the 17 patients who developed reactions
together with 7 patients (4 BT, 1 BB, 2 BL) not included
in the prospective study produced a similar degree of
suppression of PHA responses both before and after reaction,
while by contrast for the period related to the reaction
they augmented the responses. The uration of the
augmenting effect of plasma and its degree showed great
individual variation, as did the intensity and duration
of the clinical reaction. In 10 of the patients we were
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able to perform several tests before, during and after the
reaction (Pig, 28), When the Effect of autologous plasma
from BT patients on the lymphocyte responses to PHA
(recorded as a percentage of the responses in standard serum)
was compared before, during and after reaction, a significant
difference appeared (Fig. 29). The median value before
reaction was 527>, during reaction 12Syo and after reaction
577- (p<C,01 for both rise and fall).
The augmenting effect of plasma from BL patients
appeared later than that from BT patients. Post-reactional
values recorded up to 2 months after the clinical reaction
had subsided, were higher (median: 90^) than the reactlonal
values (median: , though this did not reach significance•
The changes in the effect of plasma on PHA responses
during the course of reversal reactions were not a direct
effect of steroid treatment. Reactional BT patients on
steroid treatment had a median response of 126f° and post-
reactional ones 52,5^# which were not significsntly
different from patients in the same groups without such
treatment (125;- and 57/ respectively).
The effect of plasma in each case from reactional
patients, taken before, during and after reaction, was
tested simultaneoxxsly on autologous lymphocyte responses
and lytaphoc tes from an unrelated individual. The
relationship of the effect of reactional patients' plasma
on autologous and homologous 1 mphocytes is shown in Fig. 30.
Prom this it is seen that the plasma had the same effect on
both types of test cells. Correlation coefficient,
r = 0,81 (pCO.001).
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The FHA responses of the reaction patients were
compared with those of 19 other patients in the study who
had non-inflamed skin lesions end no neuritis, nd thus
their leprosy was relatively "in ctive" and in these there
was a significant difference (p<0.01 ) when their lymphocytes
were cultured in standard serum (medians 40,200CPK)
compared with culture in autologous plasma (medians 34,700CPM).
The degree of inhibition by autologous plasma remained
fairly constant in the 9 clinically stable males, while
the 10 stable females showed considerable variation from
test to test (Pig. 31)•
(c) 3ERT.1I I ■; "1'TOO-LOBlThIITG
1. REACTION ?aTI£<T3
Serum I :0
The serum IgG levels at baseline, during reaction and
post-reaction (post steroids) are shown in Pig. 32.
There was a significant rise (p<0.01) in IgG levels
from baseline (medians 2,216 mg, ) to reaction values
(medians 2,615 mg$) md there was a significant fall
(p<0.01 ) to post-reaction levels (medians 2,099 mg;').
Serum IgA
The serum IgA levels at baseline, during reaction and
post-reaction are shown in Pig. 33.
There was a significant rise (p<0.01) in IgA levels
from baseline (medians 206 mg£) to reaction values
(medians 253 mg;"-) and there was a significant fall (p<C0.01 )
to post-reaction levels (medians 218 rag£).
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Serum IgH
The serum IgK levels at baseline, during reaction and
post-reaction are shown in Fig. 34.
There was a significant rise (psO.01) in IgK levels
from baseline (medians 98 to reaction values (median:
127 mg/O, but the fall to post-reaction levels (median:
114 mg/O was not significant.
2. NOH ABACTION PATIONTS
All patients in the study had blood for serum studies
taken initially, and at intervals during the trial. Most
patients had between 2 and 3 samples tented for serum Igs
each, over the period of the trial.
The initial serum levels of IgG, IgA and IgK all
demonstrated a considerable variation. The ranges and
medians for each Ig in the non-reaction patients were as
follows:
(a) IgG: range 1065 - 4925 mg^} median 2,662 mg°/>
(b) IgA: range 39 - 596 mg/'; median 252 mgr>
(c) IgM: range 42 - 477 mg;£; median 150 mg/'
There was also considerable variation in the serum
Igs in the post-treatment serum serapies in each patient,
but no evidence that treatment for the duration of the
study (1-2 years) had any effect in raising or lowering
the patients' immunoglobulins.
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(a) AN?I-KYCOB ACTSRIAL ANTIBODIES
1, REACTION PATIENTS
The following investigations were carried out at
baseline, during reaction and post-reaction on 6 of the
17 reaction patients.
(a) Agarose gel electrophoresis for detection of
IgG heterogeneity,
(b) Crossed inmunoelectrophoretic analysis of
patients* IgG carried out at pi! 5.0 using
carbarsaylated ammonium sulphate fractionated
gamma globulin from rabbit anti-human IgG anti¬
serum,
(c) Crossed imarunoelectrophoretic analysis of
antimycobacterial antibodies us in;; sonicated
K. leurae as antigen.
Agarose gel electrophoresis, and crossed immunoelectro¬
phoresis of these sera showed a polyclonal increase in gamma
globulins and IgG respectively. No monoclonal components
were detected, (/in example of the crossed Immunoelectrophoresis
in 1 of these patients is shown in Pig. 55.) Crossed
iromunoeleetrophoretic analysis of antimycobacterial anti¬
bodies also showed no change between baseline, reaction
and post-reaction sera in each case. In particular there
was no rise in titres of existing antimycobacterial anti¬
bodies and no evidence of formation of new antibodies
during reaction (changes of 30/* can be detected using
this technique semiquantitatively (Kronvall et al, 1975).
Of the reaction patients, 9 had antim; cobacterial antibodies
demonstrated (5 of the 12 BT patients [average: 0,67
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antibodies/patient] , 1 of the 2 BB patients [average;
0.5 antibodies/patient^ and all 3 BL patients [average;
2 antibodies/patient] )#
2. HON REACTION PATIENT3
Crossed immunoelectrophoretic analysis was performed
on the initial serum samples of 50 patients. Six of 34
BT patients (including those with Idt histology) had
antimycobacterial antibodies demonstrated (average: 0.26
antibodies/patient), the 1 BB patient had 2 antimycobacterial
antibodies and 14 of 15 BL patients had antimycobacterial
antibodies (average; 2.27 antibodies/patient).
(e) ANTI-NUCLfiPR ANTIBODIES
No anti-nuclear (IgG) antibodies were found in any of
the reaction patients at baseline, during reaction or post-
reaction, Two non reaction patients had antibodies present
on initial testing of serum.
(f) ANTI-LYMPIIOCYTB APTIBODISS
No anti-lymphocyte antibodies were found in any of
the reaction patients at baseline, during reaction or
post-reaction.
(a) HBURAL AUT0-AI-TTIB0DIB3
Three of the patients who developed reaction had neural
auto-antibodies demonstrated. There was no evidence of
formation of fresh neural auto-antibodies during reaction in
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Fig* 8 LT responses to whole li. leprae in the 17
reaction patients in tne pre-reaction
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Fift* 9 LT responses to sonicated K, leprae in the
17 reaction patients, in the prs-reaetion
































Baseline Reaction Post Reaction
Fig. 10 Li' responses to whole M. leprae in the


































Baseline Reaction Post Reaction
Fig. 11 LT responses to sonicated M. leprae, in
the 17 reaction patients, at baseline,
during reaction and post-reaction.
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Time In Months
Fir:, 12 IT responses to whole K, leprae and
sonicated I-i. leprae in patients v?ith
'skin * reactions.




BLa. 15 LT responses to whole M. leprae and sonicated
M» leprae in patients with 'nerve' re ctiono.
The apparent second peak in LT responses to
sonicated n. leprae at 7 months in one patient
was probably due to concomitant very high LT
responses with BCG (ho. 42)
(R = time of reaction)
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Time In Months
Fi,1:, 14 LT responses to whole M. leprae.and sonicated
K» leprae in patients with 1mixed1 reactions,
















































cc: "skin" mixed nerve
Fig* 15 Ratios LT responses to whole M. leprae/
LT responses to sonicated K. leprae in
the 17 patients presenting with "skin*,
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Fix* 16 LT reo onses to whole BCG in the
17 reaction patients,
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Fig. 17 Id? responses to sonicated K. invalid
in the 17 reaction patients.
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Borderline Borderline Borderline
Tuberculoid Lepromatous
Fi/c. 18 Initial LT responses to whole K. leprae
in all patients (7 were methodological













































Fire. 19 Initial VZ responses to sonicated
?■!» iourae in all patients (7 were
netnodolo^ieal failures, and thus
































































Idt TT BT Idt
Fta. 20 Correlation of initial LT responses to
whole II. leprae and sonicated M. lenrae
to the histological dia/pnosis in those
patients who were clinically "borderline
tuberculoid.
(TT = tube -culoid, BT = borderline tuberculoid,
Idt = indeterminate leprosy)
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Time In Months
Pig« 21 LT responses to tvhole H. leprae in those
oatients who did not develop reaction.
(Dots joined by lines re 4 patients with




Fi&« 22 LT responses to sonicated M. leprae in
those patients who did not develop reaction.
(Dots joined by lines are 3 of the 4 patients
in Pig. v?ho also had unexpectedly high LT




Fi;;. 25 LT responses to whole M. leprae in
those patients who did not develop
reaction (all LT responses); patients
were classified on the basis of
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Fig. 24 LT responses to sonicated K. leprae in those
patients who did not develop reaction (all
LT responses); patients were classified on the


















































Fig. 25 LT responses to PHA in 23 "non reaction" '
patients comparing the initial responses in













































Fig. 26 LT responses to PHA in standard serum
in 23 patients who did not develop
reaction, before commencing treatment
and after 6 months treatment with
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Fife. 27 LT responses to PHA in autologous plasma
in 23 patients who did not develop reaction,
before commencing treatment and after 6 months
treatment with dapsone 5mg or 50mg daily.
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prednisolone
?i,«y. 26 Effect of autologous plasma on LT responses
to PEA, recorded as a percentage of the
parallel responses in standard serum, in
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Fig. 29 Effect of autologous plasma on LT responses
to PHA recorded as a percentage of the parallel
response3 before reaction (B)t during reaction (R)
and post-reaction (P). Comparison of LT responses
in 16 BT patients and 5 BL patients who developed
reaction {Some patients had their PHA responses
measured on 2 or more occasions during the reaction
and post-reaction periods).
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•/. INFLUENCE OF PATIENTS' PLASMAS
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HOMOLOGOUS LYMPHOCYTES
Fi30 Effect of reactional patients' plasma
on LT responses to PHA, recorded as a
percentage of the parallel responses in
standard serum: correlation between the
effect on autologous lymphocytes and
lymphocytes from unrelated individuals.
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31 Effect of autologous plasma on the
responses to FHA, recorded as a percentage
of parallel responses in standard serum,
in 10 clinically stable females (p) and










Baseline Reaction Post Reaction
?ig» Serum levels of immunoglobulin 0 at baseline,












Baseline Reaction Post Reaction
Fig* 35 Serum levels of immunoglobulin A at
baseline, during reaction and post-












Baseline Reaction Post Reaction
Fig. 34 Serum levels of immunoglobulin M at
baseline, during reaction and post-
reaction in the 17 reaction patients.
o o o
Before reaction During reaction Control serum
35 Crossed inmunoelectrophoretic analysis of
IgG in one patient who developed reaction
carried out at pH 5«0, using ammonium-
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(a) CELL MODI USD IK-OJNE RE :PONS S3
i. LT responses to antigens
ii. LT responses to phytohaemagglutinin
(b) HUMORAL I7MUNE RESPONSES
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120
KBQTlANI.'WS 0? BOR.PURLIN5 L7PRQ '7 RUCTIONS
(Oorrelation of ~linical and histological observations,
and immunological results.)
C5LL-MEDI AT .3D I/'MUNK RB3?OK35S
i. LT responses to antigens
(a) M, leprae
The prospective study of the 17 patients who
developed borderline leprosy reactions showed an
appreciable rise in LT responses to antigens of
M. leprae during the reaction and confirmed the
observations of Godal et al (1973)» that the mechanism
of these reactions is an increase in cell-mediated
immunological reactivity. (Of the 3 patients in whom
there was no increase in LT responses during reaction,
the lack of response in 2 was probably due to technical
failure of the test, and in the other was due to the
fact that the reaction peak was missed when she was
away from Addis Ababa.)
The problems of discerning histologically between
"downgrading" and "reversal" reactions except by
serial biopsies have been em hasised by Ridley (1969):
and in this series all reactions were classified as
'Reversal1; although a number occurred in patients who
had hardly started treatment, and might therefore have
been e-peeted to be "downgrading". It must be concluded
that in borderline leprosy there is only one type of
reaction, immunologically characterised by increased
LT responses to M, leprae, and histologically by
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evidence of delayed hypersensitivity reaction, whether
in skin or nerve. This is not to say that "downgrading"
as a process is non-existent: indeed it is well documented.
But the reaction that can accompany downgrading should be
regarded as a transient pause in the process, or as an
immunologically irrelevant episode, rather than as
aetiologically concerned with the process. The same may
be true for upgrading: it is yet to be proved that reversal
reactions permanently affect the immunological status of
the patient, Probably the only way the question could be
tested would be to compare relapse rates of matched
patients who did or did not develop reversal reactions.
It is surprising that in a chronic infection which
provokes a cell-mediated immune response that a sudden
increase in delayed hypersensitivity should occur at all.
It would be expected that the host-parasite relationship
would be in balance, unless new antigens were introduced.
We have confirmed the observations of Muir and Chatterji
(1936), and Weddell and Pearson (1975) that many leprosy
bacilli are often found in Schwann cells of nerve in BT
and BB patients, whereas they are not found in the 3kin.
The same phenomenon has been noted in BL patients after
several months of treatment. It seems likely that
borderline leprosy reactions result from "lmune recognition"
of antigen lying in the nerve tissue, which would be
equivalent to intro uction of new antigen.
If bacilli lie "concealed" within Schwann cells, it is
likel that only soluble (probably cytoplasmic) antigens
are able to escape to the surface of the Schwann cell or
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out of it and so be "recognised"• In the early phases of
a reaction, therefore, responses to cytoplasmic (sonicated)
M. leprae might be expected to increase. There is some
indication that this is so. When LT tests in patients
with erythematous skin lesions (in the pre-reaction phase)
are compared with those with hypopigmented macules, the
difference is shown more markedly with sonicated
preparations of M. leprae.
The same argument may be applied to nerve reaction,
in which the LT responses are only directed at sonicated
M. leorae. In these cases the reaction process was always
aborted by steroid treatment at an early stage. It is
likely therefore that in nerve reaction the majority of
the bacillary-loaded Schwann cells remained intact, at
least sufficiently so that the soluble cytoplasmic antigens
provided the antigenic stimulus for the reaction. The
failure under these conditions for reaction to develop in
the skin may be quantitative; too little antigen escaped
from the dermal nerves to stimulate reaction. In patients
developing nerve reaction the "trigger" mechanism is
uncertain. But it has been shown by Pearson (1975) that,
in patients under treatment, bacillary material is
redistributed within nerves so as to be concentrated
around intraneural blood vessels and in the subperineurial
zone: in this way higher concentrations of antigen might
accumulate in those parts of the nerve where it would be
more readily recognised.
In skin reactions the increase in LT responses was
much greater, and also more prolonged. This may be
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accounted for by the bulk of tissue involved, which is
greater.even in mild skin reaction than in severe nerve
reaction. However, the major immunological difference
was that in skin reactions the responses directed at whole
K. leprae (i.e. membrane antigens) increased, as well as
those to sonicated M. leprae. This difference can most
readily be explained by intraneural granuloma formation:
this was commonly seen in dermal nerves in skin reaction.
The Schwann cell destruction associated with granuloma
formation would be likely to expose surface antigens of
M. lenrae. and so increase LT responses to whole M. leprae.
(This contrasts with the situation in nerve reactions
where patients failed to develop permanent nerve damage
indicating that there was no significant intraneural
granuloma formation in these cases.) In addition the increase
in bacillary exposure and de truction would further increase
responses to sonicated M, leprae: this was demonstrated
in some patients who only developed skin reactions.
In mixed reactions, there was a marked rise in LT
responses to both whole and sonicated K. leprae, as might
be suggested "by the findings in skin and nerve reactions.
The nerves were often affected some weeks after skin
reaction had begun to develop, and this might imply that
cytoplasmic antigens released during the "skin phase"
resulted in immune recognition of bacilli lying in the
Schwann cells of peripheral nerve, due to an increase in
circulating T lymphocytes sensitised to these antigens.
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<b) BCG and K. Duvalli
Godal et al (1973) suggested that borderline
leprosy reactions might be triggered by contact with
other mycobacterial disease, such as tuberculosis or
infection with anonymous mycobacteria. We therefore
studied the LT responses to BCG and H. duvalii in
our patients. There was no evidence of increased
LT responses to these antigens prior to reaction,
though there was a rise in the LT responses in some
patients to both antigens during reaction. It is
probable that this was due to some degree of cross-
reactivity. One patient (no. 42) developed very
high responses to BCG after reaction, though he had
no evidence of clinical tuberculosis at that time.
His LT responses to M. leprae were also higher
concomitantly.
li. LT responses to nhytohaemagglutin.in
The observation that LT responses to PHA during or
after reaction are augmented by autologous plasma instead
of the usual suppression by these factors may be of
great importance. The reason for the emergence of
hypersensitivity from a state of comparative non-
reactivity is still unclear. One possibility, however,
is that reaction occurs when there is a breakdown of
control mechanisms which normally regulate CHI responses
and prevent them from becoming overactive and harmful.
A factor in plasma might play an integral part in that
control mechanism.
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Factors in the blood inhibiting lymphocyte responses
to FHA have been demonstrated in a number of conditions
where there is prolonged stimulation of the immune systems
e.g. in leprosy by Kelson et a! (1971)» in recurrent
infections in childhood by Fitzgerald and Hosking (1976),
in various neoplasms by Sucio-Foca et al (1975) and in
pregnancy by Gatti (1971).
Patients with borderline leprosy often show surprisingly
little inflammatory response, despite the presence of
bacilli in the tissues for many years. Plasma from such
patients caused inhibition of lymphocyte responses to PHA
compared with the responses in standard serum. In those
patients with BT leprosy who developed a reaction this
inhibitory effect disappeared during the reaction and was
replaced by an augmenting effect of plasma on lymphocyte
response. However in those with BL leprosy the augmenting
effect of plasma appeared later than those with BT leprosy,
though within 5 months after the reaction.
That both the augmentation and inhibition of lymphocyte
responses were due to factors in the plasma and not to a
change in lymphocyte receptors, is supported by the observation
that the plasma had the same effect on both homologous and
autologous lymphocytes. Control experiments with different
concentrations of PHA gave no indication of a changed
sensitivity of lymphocytes during reaction nor was there
any significant change in the actual height of the PHA
responses in standard serum in relation to reaction. So
the augmentation of responses by autologous plasma during
reaction was not due to a change in the lymphocytes'
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responsiveness to PHA,
Although male patients with stable leprosy had a
constant degree of inhibition during the period of
observation, the effect of plasma from stable female
patients on PHA responses showed great variation from
test to test. Further studies on normal individuals
(G. Bjune, personal communication) have shown that
females have pronounced variations of plasma effect on
the PHA response related to the menstrual cycle. The
magnitude of these variations considerably surpasses
the basic level of suppression due to the leprosy
infection.
The finding in 3L patients that the period of
augmentation by autologous plasma was delayed in relation
to the onset of clinical reaction, could indicate that
the plasma factor(s) were secondary to the reaction.
However, it is probable that the plasma factor(s)
described here will initially occupy lymphocyte receptors
and exert their effect there, before they appear free
in the blood. Therefore the delayed appearance in the
blood of the augmentary effect does not necessarily
negate their primary importance in transforming the OKI
response from a well controlled fight against bacillary
multiplication to an overactive and self-destructive
hypersensitivity reaction.
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i. Serum immunoglobulins and ant i-myabacterial
antibodies
The finding of significant alterations in
Immunoglobulins during borderline leprosy reactions
raises the question of whether they themselves are
the c use of the reaction, or associated with the
cause directly, or whether they are merely secondary
incidental findings caused by the reaction.
The results indicate that there is a non-specific,
polyclonal rise in Ig levels rather than specific
increases in anti-mycobacterial antibodies or
formation of auto-antibodies or tissue destruction
during the reaction. Such changes are likely to be
secondary. They would not be expected to influence
T-cell activation by K, leprae antigens or to be
caused by their exposure.
That the increases in Ig levels are apparently
not due to if, leprae antigen stimulation calls for
an alternative explanation. Several studies have
demonstrated that proliferating, non-secreting B
cells can be converted into antibody producers by a
factor or factors produced by activated T cells,
(Button et al, 1971? Schimpl and v.'ecker, 1972; Watson,
1973; Amerding and Katz, 1974; Davie and Paul, 1974.)
In borderline leprosy reactions there is a marked
increase in the number of circulating T lymphocytes
sensitised to antigens of the leprosy bacillus. These
lymphocytes, when activated in the widespread lesions,
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might stimulate the production of serum Igs by non
specific action on proliferating B lymphocytes. This is
supported by the finding that the rise in IgM during
reaction was proportionately much less than that in IgG
or IgA, and there was no significant fall after reaction.
This is in agreement with the findings of Davie and Paul
(1974), who noted a relative T-cell independence of IgM
antibodies in experimental animals. The rise in Igs in
this study would thus be an effect rather than a cause of
the reaction.
ii. Anti-nuclear antibodies, anti-lymphocyte antibodies
and neural auto-antibodies
It has been suggested that peripheral nerve injury
during borderline leprosy reactions might be due to auto¬
immune phenomena in a manner analagous to experimental
allergic neuritis (Waksman and Adams, 1955). The reaction
patients in our study were tested for ANAs,AIAs and neural
auto-antibodies before, during and after reaction but
without positive findings. There was thus no suggestion
from these tests that auto-immunity played any part in
these reactions. Moreover the histopathological changes
seen in nerve biopsies were quite unlike those in auto¬
immune neuritis.
2. RELATIONSHIP OF DAP30NS DOSaGE TO INCIDENCE OF
BORDERLINE LEPROSY REACTIONS
Of 34 patients taking 5mg dapsone daily, 11 developed
borderline leprosy reactions whereas only 3 taking 5Qmg
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dapsone dally developed reaction. These results indicate
that patients (particularly those with erythematous swollen
skin lesions) receiving low dosage of dapsone (5mg daily)
are more likely to develop borderline leprosy reaction
than those 50mg daily from the start of treatment. This
finding contradicts current teaching, and is probably the
most important observation of the study, in the short term.
In the 2 previous studies by Lewis et al (1957) and Prasad
(1971) which compared "high" and "low" dosage regimens and
found no difference in the incidence of reaction between
the two groups. The "low" dosage was, except for the
initial 2-3 weeks equivalent to 50mg daily or more.
In this series, as is usual, reaction developed in
most patients (11 of 17) within the first 2 months of
being started on dapsone treatment. The reason for this
is obscure, as dapsone is a bacteriostatic drug and the
multiplication time of the bacillus about 14 days; thus,
any direct effect of the drug on the bacillus with
exposure of new antigens seems unlikely. It is possible
though that many patients initially attended hospital
for treatment because of the r-rodromal symptoms of
reaction. If this is so, dapsone 5mg daily may be
regarded as not affecting the natural history of the
reaction whereas 50mg resulted in suppression. The
influence of dapsone on the immune system is unknown. It
appears to have some immunological activity e.g. it
suppressed the Arthus reaction in guinea pigs (Thompson
and Souhami, 1975)> and this may account for its therapeutic
success in dei-matological conditions such as dermatitis
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herpetiformis and leucocytoclastic vasculitis. Beiguelman
and Pisani (1974) suggested that dapsone may also suppress
cell mediated immunity.
The results of this study are inconsistent with these
suggestions, for the LT responses to PHA were higher in
patients receiving treatment than before treatment. This
rise, however, developed slowly: probably too slowly to
affect reactions in the first month or two of treatment.
Also it was somewhat greater in patients receiving dapsone
50mg daily; whereas those on 5mg daily were more liable to
develop reaction. Since the minimal inhibitory dose of
dapsone is about 1mg daily (Waters et al, 1968) prevention
of reactions is unlikely to be the result of variation in
anti-bacterial activity. The mechanism by which dapsone
in higher dosage seems to suppress reactions remains obscure.
The finding, however, is of considerable practical
importance. Current drug regimens are unduly complicated
for field workers and patients. Their design was based on
the misconception that low dosage of dapsone would prevent
or mitigate reactions. It has previously been shown by
Pearson and Helmy (1973) that even stopping dapsone
completely does not significantly ameliorate EEL, and this
study indicates that dapsone in higher dosage may be
beneficial in borderline leprosy reactions. We believe
therefore that all patients with leprosy should be treated
with dapsone 1 - 2mg per Kg daily from the start of
therapy, and that treatment should be continued uninterrupted
during reactions. If this policy is implemented many
reactions will be prevented, and effective treatment for
reactions that do develop will not be delayed by
ineffectual manipulation of dapsone dosage.
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3. TH3 SP.-jCTRUM OF LEPR03Y. HYPBR33N3ITIVITV KD PROTECTIVE
IKMvNITY IN L3PR03Y
It has been shown that the histopathological changes
in reversal reaction are diagnostic of Coombs and Cell
Type IV reaction, and the immunological tests described
indicate that, when skin is involved in the reaction, the
membrane antigens of M. leprae are mainly associated with
the reaction. Loss of a humoral inhibiting factor could also
play an important role in the pathogenesis of the reaction.
The relationship between LT responses and the spectrum of
leprosy, however, is much less precise, and the average
responses shown by Myrvang et al (1973) conceal a very
great range of results for each type of leprosy. The
results of this study confirm this (Figs. 18, 19) in the
borderline ran e of leprosy. Clearly the LT test, as used
in this study, is a poor assessment of host resistance
during the disease.
How, then, is host resistance to be defined. In
practice, 2 methods can be employed. One is the ability
of the patient under effective treatment to dispose of
disintegrating bacillary material. A rough indication
of this can be attained by following the fall of the
Bacterial Index during treatment. However, this process
is markedly hastened when patients develop reversal reactions
that is to say, it i3 influenced by hypersensitivity phenomena.
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The other indication of hoot resistance is the ability
of the patient to limit his baeillary load. Thus resistance
is defined in terms of the spectrum of leprosy, and can be
investigated by studying the hist©pathology of the untreated
disease. When this is done, the disparity between LT tests
and resistance is clearly shorn.
In the 3T patients, LT responses to M. lenrae were
lower when the histopathologioal features consisted of
non-specific round cell infiltration in the df?rmis. High
LT responses correlated with the numbers of epithelioid and
giant cells (i.e. with hypersensitivity) which in turn
was commonly associated with erythematous raised lesions.
But the average duration of the disease in the "indeterminate"
histology group (3«8 years) was greater than in the
histologically determinate (BT or TT) cases (2.2 years).
This indicated that the disease had been "contained" for
longer, and therefore the host resistance was higher, in the
low LT toot group.
Also in "indeterminate leprosy" (diagnosed both
clinically and histologically) many lesions are self healing?
host resistance should therefore usually be high. But LT tests
are almost always low (Kyrvang et al, 1973) and there is no
histological evidence of hypersensitivity.
There is therefore clear evidence that LT test
results using K. lenrao (as prepared in this study) as
antigen are related to hypersensitivity phenomena rather
than to host resistance. The marked though transient
increases seen during reactions, which are known to be
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hypersensitivity phenomena, confirm this conclusion.
There are a number of possible explanations of this
apparent paradox (that high resistance tends to be
associated with low LT responses). They include
(a) Tec nical failures of the test. Thi seems
unlikely here. Bach patient in this study was tested
with 3 different concentrations of 2 different
preparations of M, leprae. Differences in the dose
eliciting a peak response should therefore not affect
the percentage of responders. Good responses to PHA,
as well as to antigens like BCG and X. duvlii prove
the ability of the cells to respond in the actual
experiment. Most patients were also tested more than
once, and if clinically stable during the period of
observation, the LT responses were also stable.
(b) The wrong antigens were used. CXI in leprosy
could have specificity for different antigens of
M« leprae. In a given preparation of bacilli not all
antigens are necessarily equally well exposed. Thus
lymphocytes which perforin well in vivo might show no
LT response in vitro.
(c) The wrong lymphocytes were used. The number of
specifically sensitized lymphocytes in the peripheral
blood represents a bal nee between their production
and their trapping in the lesions (Thestrup-Pedersen,
1974); small numbers in the circulation need not imply
inefficient formation. j1he potential of the patient's
immunity is difficult to estimate when no standard
stimulus exists in vivo.
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Elucidation of this situation is clearly still
required. But it is clear that the dissociation between
resistance and hypersensitivity which has long been
reeo nised in the field of tuberculosis (Rich and KcCordock,
1929) must now be accepted as also important in leprosy.
There are a number of theoretical explanations
(i) The antigens stimulating high LT responses are
irrelevant for resistance, possibly because they are
exposed only by dead bacilli (Youmans, 1975).
(ii) Differences in the presentation of antigen,
especially between presentation in Schwann cells
and macrophages, could explain why bacilli can stay
undetected in one tissue, while giving rise to
vigorous reactions in another. The findings in
reversal reactions indicate that antigens are
presented differently in the two cell types.
(iii) Even in untreated patients most ftl. leprae
are non-viable. It is possible that only antigens
produced by living bacilli and which can escape from
the host cell are responsible for immune resistance
to the infection.
The results of this study offer some clues as to the
nature of the antigen(s) involved in infection immunity:
in previously untreated patients the difference in response
between BT and BL cases was greater with sonicated than
whole washed M. leprae (Pigs. 18, 19), suggesting that
a cytoplasmic antigen is involved. However, it must be
emphasised that the difference was not marked. At present,
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it appears, the LT test is of limited value in the
assessment of host resistance during the disease.
4. OTHER OBoKRV TIONS
1• Incidence of "limb" pains
Pain is an important symptom of leprosy as an
indication of disease activity. This may seem a facile
observation, but it is not given emphasis in textbooks on
leprosy. A number of patients had hypopigmented lesions
for many years (up to 14 years) but presented soon after
they developed "limb pains" due to neuritis. Only 5 of
the patients who had had pains prior to clinical presentation,
had them for longer than 1 year.
After commencement of treatment, these pains disappeared
in a vast majority within the first year of treatment. Three
of the 4 patients who were having pains at the end of the
study had had "nerve reactions" and thus might be expected
to have more prolonged neuritis than those who had not
had reactions.
A recent study at the Addis Ababa Leprosy Hospital
(B, Naafs, personal communication) showed that those
patients who had been "released from control" having had
what was felt to be adequate therapy for their leprosy,
(the duration of treatment depending on the type of
leprosy) and relapsed, tended to present with limb pains.
It is likely that any patient who continues to have
pains for longer than 1 year after commencement of
treatment may not be taking his therapy. Three of the
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patients who were having pains at the end of the trial
(including the 1 non-reaction patient who had consistently
low D/C ratios) were tiking dapsone 5mg daily.
2. Regularity of dapsone intake
Patients' urine was tested for the dapsone/creatinine
ratio at each review*. It was found that overall 36% of
observations were low, of those taking dapsone 50mg daily.
In only 8% of observations was the D/C ratio less than 10,
implying that dapsone had not been ingested for a number
of days. Very often, low observations fitted with the
patient's story of their tablets having become crushed
or destroyed by the rain. The patients in the study took
their dapsone more consistently than those reported by
Low and Pearson (1974) and thi3 might be expected, as they
were receiving more attention than the normaL patients;
in particular they were being reviewed by a doctor monthly
(or two-monthly) rather than 6 monthly.
5. erum immunoglobulin levels in all patients
in the study
Though there was considerable variation in serum
levels of IgG, IgA and IgM, there was no significant
difference in those patients with BT leprosy and those
patients with BL leprosy. This variation in Ig levels has
been noted in other developing countries (McParlane, 1966;
Hobbs, 1971) and presumably reflects the greater
immunological challenge provided by the environment.
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5. CONCLUSIONS AND WORK FOl TTt'-v FUTURE
Borderline leprosy reactions are the most important
complication of leprosy infection. Our study has clarified
some of the mechanisms involved but it is important that
the work is continued in certain directions:
1. We have confirmed that borderline leprosy reactions
are a type of delayed hypersensitivity reaction. It
seems likely that different presentations of the
reaction when they affect skin or nerve are associated
with the release of different antigens. The mechanism
of this requires further study.
2. It is possible that these reactions are related
to the presence of "plasma factors" which though
normally suppressive to the cell-mediated responses,
during reaction develop augmentary properties. It is
important that the nature of these plasma factors is
ascertained, and that a primary role in the reaction
is confirmed.
3. It seems likely that the intrinsic mechanism of
borderline leprosy reactions is immune recognition
of bacilli lying sequestered in Schwann cells of
peripheral and dermal nerves. This is a fascinating
phenomenon which deserves further study.
4. Serum immunoglobulins G, A and M all rise during
reaction. We have shown that this is likely to be
a secondary phenomenon due to T-lymphocyte sensitization
of B lymphocytes. It is pleasing that on occasion
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work demonstrated in experimental animals can be
confirmed in human disease.
5. We have shown that contrary to previous teaching,
dapsone given in higher dosage does not predispose
patients to borderline leprosy reactions. Our results
suggest in fact that higher dosages of dapsone prevent
reactions, and it is important that this be confirmed
by an independent group, and the mechanisms of
prevention fully investigated.
6. A great majority of patients develop reactions
during the first 6 months treatment. It may be
beneficial to give borderline leprosy patients a
low dose of steroid prophylaetically during the first
6 months of review in an attempt to further prevent
reactions. A trial designed to test this hypothesis
has been instituted in the Addis Ababa Leprosy Hospital.
7. The triggering mechanism for borderline leprosy
reactions has not yet been elicited. Four of our
patients had unexpectedly high responses to antigens
M. leprae and high responses are often seen in
contacts of leprosy patients. It is possible that
further contact with lepromatous patients may induce
an increase in circulating T-lymphocytes sensitised
^0 leprae, even in patients who already have the
disease and this could trigger reactions. This
possibility should be examined further.
8« The LT test in leprosy measures parameters of
hypersensitivity rather than immune protection
against the bacillus* It may be that different
bacterial antigens are involved in the 2 phenomena
and this will clearly need further investigation.
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Antigenic heterogeneity in patients with reactions in
borderline leprosy
STC BARNETSON, G BJUNE, J M H PEARSON, G KRONVALL
immary
fteen patients with borderline leprosy who developed
■eversal" reactions were studied from the inception of
eatment. Thirteen showed an appreciable increase in
mphocyte transformation (LT) when preparations of
ycobacterium leprae were used as antigen. The LT
sponses to either "whole" or "sonicated" preparations
'
the bacillus in these 15 patients and in nine others also
reaction correlated with the clinical presentation,
bose with skin disease predominating in the reaction
lowed an appreciable increase in LT when whole
leprae was used as antigen. Those with nerve disease
•edominating showed an increase with sonicated M
prae. In those with both skin and nerve disease there
as an increase with both antigen preparations. The
itios of the LT test results (whole to sonicated M leprae)
towed highly significant differences between the three
•oups.
Production
'ycobacterium leprae, the causative organism of leprosy, is an
iligate intracellular parasite with an affinity for skin and nerve,
is remarkably non-toxic—patients may have 1012-10ls bacilli
the body without systemic illness—and most of the clinical
anifestations of the disease result from the host response. The
ost important cause of deformity in leprosy is nerve damage
le to hypersensitivity to bacilli lying in the nerves. Such damage
ay result from two different mechanisms, both termed
eaction."
"Reversal" reactions, which occur in borderline leprosy, are
obably due to a delayed hypersensitivity reaction (Coombs and
ell type IV hypersensitivity reaction), as there is usually a
:nse lymphocytic infiltration in histological specimens of skin
id nerve and an appreciable increase in lymphocyte transfor¬
ation (LT) when "whole" M leprae is used as antigen.1
"Erythema nodosum leprosum," which occurs in lepromatous
orosy and is associated with immune complex formation,2 is
i example of a Coombs and Gell type III hypersensitivity
action. Nerve damage rarely results from this type of reaction
iless it recurs frequently.
Patients with reversal reactions may vary considerably in their
inical presentation and may be divided into three groups—(1)
ose with skin hypersensitivity predominating, in which there
erythema and oedema of the skin lesions without obvious
sease of the nerves; (2) those with nerve hypersensitivity
predominating, in which there is swelling and tenderness of the
nerves but no change in the hypopigmented skin lesions; and
(3) those with both skin and nerve hypersensitivity.
We describe here 24 patients who developed reversal reactions.
Patients and methods
Fifteen patients were included in a prospective study of the
immunology of borderline leprosy; pretreatment assessments
(including LT responses) were available. Nine further patients were
first seen at the start of their reactions. All were classified clinically
and histologically according to the Ridley-Jopling scale3; 16 were
borderline tuberculoid, two borderline, and six borderline lepro¬
matous. Ten of the patients were male and 14 female, and their ages
ranged from 12 to 41 years.
All of the patients were on dapsone, which was continued in
unaltered dosage throughout the study. Reactions were treated with
prednisolone. The initial dosage was 30-40 mg daily, which was
gradually reduced over one to nine months depending on the duration
and severity of the reaction.
ASSESSMENTS DURING REACTION
The following assessments were made repeatedly during the
reactions and in the post-reaction periods, which varied from one to
nine months.
Skin disease was rated arbitrarily as 0 to 3+ according to the degree of
erythema and oedema of skin lesions.
Nerve disease was assessed by three criteria, at least two of which had to be
satisfied for nerve involvement to be considered to be marked—(a) clinical
assessment of nerve tenderness and swelling, recorded as absent (0), slight
(±), or marked ( + ); (i>) motor nerve conduction studies of the ulnar and
median nerves (below 55 m/s was regarded as abnormal); (c) voluntary muscle
tests1 (sustained fall in muscle power in two or more muscle groups supplied
by nerve indicated deterioration (+ ); lesser changes (0) were disregarded).
LT tests were performed at least twice during the reactions, whole and
"sonicated" preparations of M leprae being used as antigens, and phyto-
haemagglutinin being used to show cell viability.
Whenever the LT tests were performed dose-response curves were
drawn for each antigen and the maximum values for the two prepara¬
tions ofM leprae added together. The concentrations with the highest
total, representing the peak of the reaction, are those reported here.
Similarly, assessments of skin and nerve disease are the maximum
figures recorded.
PREPARATION OF ANTIGENS
The same antigen preparations were used in all tests and were
derived from a large subcutaneous nodule excised from a patient with
lepromatous leprosy. The nodule was homogenised and the bacilli
were washed in phosphate-buffered saline at pH 7-2. The suspension
was stored at — 20°C. This preparation is referred to as whole M
leprae. The bacilli in part of the same suspension were exposed to
sonic vibration until no acid-fast bacilli remained. This preparation
is referred to as sonicated, and was also stored at — 20°C.
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TECHNIQUE OF LT TEST
In all tests both M leprae antigen preparations were used at three
concentrations standardised to the bacillary content of the original
homogenate—that is, 106, 10',' and 108 bacilli/ml. A micromethod
was used. Peripheral blood lymphocytes were separated on Ficoll
Isopaque, washed three times, and cultured in tissue culture medium
199 (Gibco) at a concentration of 106/ml. Triplicate cultures were
BMJ/399 / 7 5 COPYRIGHT © 1975. All rights of reproduction of this reprint are reserved in all countries of the world
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incubated with the appropriate antigen preparation in 5% CO, in air
for seven days at 37°C and 100% humidity. Contrdl cultures without
antigen added were also included in the tray. Sixteen hours before
harvesting, 0-5 u.Ci tritiated thymidine (aH-TdR; specific activity
2 Ci/mmol) was added to each well. The contents of the wells were
harvested on to glass-fibre filters and the 3H-TdR uptake was recorded
as counts/min using a liquid scintillation counter.
Results
The LT responses (with control values subtracted) in the 15
patients studied from the inception of antileprosy treatment at base¬
line (before treatment), during a reaction, and in the post-reaction
period are shown in the fig. Thirteen of the patients showed an
appreciable increase in response with the two antigen preparations
during a reaction, with a comparable fall in the post-reaction period.
Both the rise and fall were highly significant (P< 0-005; Student's
t test).
The rise in LT response was due, in different patients, to increased
responses to whole or sonicated preparations of M leprae or both.
When the total LT responses in these patients when in reaction, and in
the nine further patients who were also in reaction though they had not
been followed from the inception of treatment, were studied the
clinical presentation was found to correlate with the rise in LT with
the two different antigen preparations. In the 10 patients judged to
have a skin reaction clinically there was an appreciable increase in
LT when whole M leprae was used but a smaller or negligible increase
when sonicated M leprae was used. In those judged to have a nerve
reaction the reverse was true. Those with mixed reactions showed a
high LT response with both antigen preparations. The table gives a
summaryofthese results, together with theLT values expressed as a ratio
ofwhole to sonicated M leprae (total responses). Themean ratios forthe
patients with skin, mixed, and nerve reactions were 2-91, 0-94, and
0-50 respectively. Statistical significance was estimated with the non-
parametric test of Kruskal and Wallis5 for independent samples, the
differences between the three groups being highly significant
(P<0-001).
Discussion
The prospective study on the 15 borderline leprosy patients
showed an appreciable increase in LT responses to antigens of
Af leprae during reversal reactions, and confirmed that the
mechanism of these reactions is an increase in cell-mediated
immunological reactivity. The results of LT tests in all 24
patients in reaction showed that nerve involvement and skin







































LT responses in 15 patients before (baseline), during, and after reactii
Responses to whole and sonicated M leprae are added, with control vah
subtracted.
failure of whole washed bacilli to elicit a high response in ner
reactions suggests that cytoplasmic antigens play an imports
part in this condition. In skin reactions the increased response
chiefly directed at whole washed bacilli, indicating that surfa
antigens are more important. The smaller response to sonicat
preparations (in which surface antigens are present) may be
dilution affect.
The mechanism ofnerve reactions may therefore be as follov
In some borderline tuberculoid leprosy patients immunologica
competent enough to recognise and destroy the leprosy bacill
many bacilli may be present in the nerve but few if any may













M lepraec N M
1 BT 2 + 0 ND 0 Skin 13 861 1770 7 83
2 BT 2 + 0 0 0 Skin 11 799 2353 5 01
3 BT 3 + ± 0 0 Skin 4306 950 4 53
4 BT 2 + ± 0 0 Skin 2665 1029 2 59
5 BB 3 + 0 0 ND Skin 6493 3462 1 88
6 BT 2 + 0 0 0 Skin 7022 3751 1-87
7 BT 2 + ± 0 0 Skin 7195 4434 1 62
8 BL 2 + 0 0 0 Skin 4196 3014 1 39
9 BB 2 + + 0 0 Skin 7396 6123 1 21
10 BL 2 + ± 0 0 Skin 2925 2484 1 18
11 BT 2 + + + + Mixed 12 089 10 031 1 21
12 BT 2 + ± + + Mixed 3450 3174 1 09
13 BT + + + + Mixed 1550 1658 0 93
14 BT 2 + + ND + Mixed 9050 9950 0 91
15 BT 2 + + + + Mixed 3763 5032 0 75
16 BT 2 + + + 0 Mixed 1086 1494 0 73
17 BT 0 + + + Nerve 359 357 1 01
18 BL 0 + + + Nerve 5187 6669 0-78
19 BT 0 + ND + Nerve 1232 1967 0 63
20 BL 0 + ND + Nerve 827 1831 045
21 BT 0 + + + Nerve 1626 4749 0 34
22 BL 0 + + + Nerve 2156 6873 0 31
23 BT 0 + + + Nerve 1086 3693 0 29
24 BL 0 -f- ND + Nerve 261 1136 0-23
•Ridley-Jopling scale.1 BT = Borderline tuberculoid. BB - Borderline. BL * Borderline lepromatous.
tC - Clinical assessment. N = Motor nerve conduction velocity studies. M — Voluntary muscle testing. ND = Not done.
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;nt in the skin." The same phenomenon has been noted in
erline lepromatous patients, particularly afer one or two
i of treatment. This is presumably because Schwann
, in which most of the bacilli are contained, are relatively
-lived. In this situation probably the surface antigens of the
lus are rarely exposed; soluble cytoplasmic antigens are
: likely to be exposed but they are probably released slowly,
at few lymphocytes are sensitised. In reactions there appears
e a sudden increase in the release of these cytoplasmic
;ens, though the trigger mechanism is unknown. Subsequent
uction of the Schwann cells may then lead to increased
sure of bacillary surface antigens, and it was noted that in
)f the eight patients with nerve reactions there was a rise in
-esponses when whole M leprae was used as antigen in the
s after the reaction began.
skin reactions the LT results indicate that there may be an
ased exposure of bacillary surface antigens. In borderline
rculoid leprosy few bacilli are present in the skin and they
iredominantly found in the dermal nerves. It appears that
^mphocytes and macrophages in the skin suddenly recognise
acilli in the dermal nerves, with destruction of the Schwann
and consequent exposure of surface antigens. This
bility is borne out by the observation that in eight out of 10
tr patients with skin or mixed reactions who had skin
;ies during reaction large nerves were present containing
aerate bacilli within granuloma.
mixed reactions hypersensitivity reaction in nerves often
: weeks after the reaction in skin. This may be because some
ilasmic antigens are released during the "skin phase" with
ased lymphocyte sensitisation to these antigens, leading to
ased recognition of such antigens elsewhere—particularly
in nerves.
Although the trigger mechanism for these reactions remains
unknown, it has been suggested that coincidental exposure to
other mycobacteria1 may be a cause. There is no good evidence
for this, however, and in those of our patients on whom LT
tests were performed using BCG and M duvalii as antigens
during reactions there was no consistent concomitant rise in
responses.
Reversal reactions are of great importance as they may lead to
nerve destruction almost overnight. Unfortunately this usually
occurs when the patient is receiving antileprosy treatment, the
more so if he has been diagnosed at an early stage of the disease,
before nerve damage has occurred. It is important to elucidate
the precipitating factors that cause these reactions, and when this
is achieved it may be possible to prevent them.
We thank Monica Lovgren and Kesete Negassi for technical help,
Dr B Naafs for nerve conduction studies, and Dr D S Ridley for
independent histological classification of the patients. We also thank
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sensitisation could be detected at twelve months. How¬
ever, when a group of patients were re-patch tested four
or more months after sensitisation and one d.n.c.b.
patch test, full migration inhibition was restored (fig. 3).
Discussion
This simple technique enables sensitivity to d.n.c.b. to
be monitored in-vitro. Since it can be quantitated, it
could prove useful in monitoring the small changes of
c.m.i. which occur in immunosuppression, in augmen¬
tation of the immune response in immunotherapy, or in
study of the immunological response to surgery, radio¬
therapy, or chemotherapy. Monitoring of drug dosage in
immunosuppression for transplantation might be made
more rational. The lymphocyte transformation method2
for detection of d.n.c.b. sensitisation takes five days to
complete, whereas the migration test can be read at 24
hours. If the migration inhibition test described reflects
the overall state of the patients' c.m.i. then it will be use¬
ful as a rapid monitor of c.m.i.
• Inhibition of migration by the conjugate waned withme but could be restored by pat h testing. To prevent
the decline in inhibition by the d.n.c.b./r.b.c. conjugate,
skin tests for sensitivity should be repeated every three
months.
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EVIDENCE FOR PREVENTION OF
BORDERLINE LEPROSY REACTIONS BY
DAPSONE
R. StC. Barnetson J. M. H. Pearson
R. J. W. Rees
Medical Research Council Leprosy Project, Box 1005, Addis
Ababa, Ethiopia, andNational Institute for Medical Research,
Mill Hill, London NW7 1AA
ISummary 68 patients were included in a prospec-b tive study of the treatment of borderline
leprosy. 34 were treated with dapsone 5 mg daily, and
34 .with 50 mg daily. Reversal reactions developed in 11
of those on 5 mg daily and in 3 of those on 50 mg daily.
The statistically significant difference between the two
treatment groups indicates that, contrary to previous
teaching, dapsone given in higher dosage does not
predispose patients to reversal reactions and indeed may
prevent them.
Introduction
Deformity in leprosy usually results from nerve
damage caused by delayed hypersensitivity reactions
termed "reversal reactions" which occur in borderline
leprosy. During these reactions there is an apparent
reversal of the tendency of untreated borderline leprosy
to become more lepromatous, and the histological fea¬
tures become more tuberculoid. When this occurs there
is a pronounced increase in the erythema of skin lesions
and swelling and tenderness of the peripheral nerves. In
severe cases there may be fever, malaise, and generalised
oedema. During the weeks preceding a reaction there are
often prodromal symptoms, including vague aches and
pains and paresthesia:. Lymphocyte transformation
tests, in which whole Mycobacterium leprte is used as
antigen are strongly positive during reversal reactions1 2
suggesting an increase in cell-mediated immunity to the
bacillus, possibly triggered by recognition of "hidden"
antigen in Schwann cells.2
Reversal reactions can cause such sudden and severe
nerve damage that their prevention would be a major
advance in the management of leprosy. The risk of
reversal reactions is thought to be reduced when dap¬
sone treatment is initiated at a low dosage rather than
at a high dosage.3-6 There are, however, no published
reports to support (or refute) this hypothesis; and in par¬
ticular the incidence of reactions in patients treated with
dapsone in "orthodox" dosage (1-2 mg per kg) or the
very low dosage which is now often advised has not been
studied. We describe a prospective study of the effect of
very low dapsone dosage on the incidence of reversal
reactions in borderline leprosy.
Patients and Methods
68 patients with borderline leprosy who attended the Addis
Ababa Leprosy Hospital, Ethiopia, were studied for 6 months
to 2 years after dapsone treatment started. 52 patients were
borderline tuberculoid cases, 3 were borderline cases, and 13
were borderline lepromatous cases as judged by the Ridley
Jopling clinical and histological scale.7 There were 38 males
and 30 females aged from thirteen to sixty-one. In each case
clinical examination, chest X-ray, full blood-count, and urin¬
alysis were performed to exclude the presence of other impor¬
tant disease.
Therapy was given on an outpatient basis, and patients were
randomly allocated to treatment with 5 mg or 50 mg of dap¬
sone daily. There were 34 patients in each group. Treatment
was continued at an unaltered dosage throughout the study,
and urine specimens were tested monthly for dapsone8 to assess
regularity of intake. In those in whom reactions developed, the
diagnosis was made on clinical grounds and confirmed in each
case by a pronounced increase in the strength of response to
whole and sonicated preparations of M. leprce in lymphocyte
transformation tests.2
Results
Reversal reactions developed in 14 of the 68 patients
1-9 months after dapsone treatment started. 11 of these
patients were receiving 5 mg of dapsone daily and 3
were receiving 50 mg (see accompanying table)
(p<0-025). 10 of the group on the 50 mg daily dose had
erythematous skin lesions and reactions might have been
expected to develop in these patients; however, reactions
developed in only two. Of the group on dapsone 5 mg
CLINICAL DATA OF 68 PATIENTS TREATED WITH 5 mg OR 50 mg
OF DAPSONE DAILY
No. of patients receiving treatment
with dapsone
Clinical data 5 mg daily 50 mg daily
No No
Reaction reaction Reaction leaction
Skin lesions active at
start of trial 8 1 2 8
Skin lesions quiescent at
start of trial 3 22 1 23
Total 11 ' 23 3 31
J
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daily, 9 had erythematous skin lesions, and reactions de¬
veloped in 8.
Discussion
These results indicate that patients (particularly those
with erythematous swollen skin lesions) receiving low
dosage of dapsone (5 mg daily) are more likely to de¬
velop reversal reactions than those on 50 mg daily from
the start of treatment. This finding contradicts current
teaching. Two previous studies9 10 have compared
"high" and "low" dosage regimens, but in both of them
the "low" dosage was, except for the initial 2—3 weeks,
equivalent to 50 mg daily or more. This probably
accounts for the failure of both studies to demonstrate
any difference in the incidence of reactions and neuritis
with different dosages of dapsone.
In this series, as is usual, a reaction developed in most
patients within the first 3 months of being started on
dapsone treatment. It seems likely, however, that many
patients initially attended hospital for treatment because
of the prodromal symptoms of reaction. If this is so, dap¬
sone 5 mg daily may be regarded as not affecting the
natural history of the reaction, whereas 50 mg daily
resulted in suppression.
The mechanism by which dapsone prevents reactions
remains uncertain. Since the minimal inhibitory dose of
dapsone is about 1 mg daily,11 prevention of reactions is
unlikely to be the result of variation in antibacterial
activity. Dapsone appears to have some immunological
activity—e.g., it suppressed the Arthus reaction in
guineapigs12—and this may account for its therapeutic
success in dermatological conditions such as dermatitis
herpetiformis and leucocytoclastic vasculitis. Beiguel-
man and Pisani13 suggested that dapsone may also sup¬
press cell-mediated immunity, but in our patients there
was no significant difference in lymphocyte transform¬
ation responses to phytohaemagglutinin in those receiv¬
ing 5 mg dapsone daily and those receiving 50 mg.
Current drug regimens are unduly complicated for
field workers and patients. Their design was based on
the misconception that low dosage of dapsone would
prevent or mitigate reactions. It has previously been
shown14 that even stopping dapsone completely does not
ameliorate erythema nodusum leprosum (the other type
of leprosy reaction, which occurs in lepromatous
leprosy); and our results indicate that dapsone in higher
dosage may be beneficial in reversal reactions. We
believe that all patients with leprosy should be treated
with dapsone 1-2 mg kg daily from the start of therapy,
and that treatment should be continued uninterrupted
during reactions. If this policy is implemented, many
reactions will be prevented, and effective treatment for
reactions that do develop will not be delayed by
ineffectual manipulation of dapsone dosage.
We thank Dr D. S. Ridley for independent histological classification
of the patients, and the staff of the AH Africa Leprosy and Rehabili¬
tation Training Centre for referral of patients and provision of clinical
facilities.
Requests for reprints should be addressed to R. J. W. R., National
Institute for Medical Research, Mill Hill, London NW7 1AA.
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Preliminary Communication
TREATMENT OF LAMELLAR ICHTHYOSIS
AND OTHER KERATINISING DERMATOSES
WITH AN ORAL SYNTHETIC RETINOID
Gary L. Peck Frank W. Yoder
Dermatology Branch, National Institutes ofHealth, Bethesda,
Maryland 20014, U.Sj1.
Summary Thirteen patients with keratinising der¬
matoses were treated for 2—17 weeks
with oral 13-ct's retinoic acid. There was near complete
clearing of the skin lesions beginning within 2 weeks of
starting treatment in all five patients with lamellar ich¬
thyosis (including two cases of non-bullous congenital
ichthyosiform erythroderma), in two of the three pa¬
tients with Darier's disease, and in one patient with
pityriasis rubra pilaris. The patients with psoriasis andflB
nsevus comedonicus did not improve. The main form o;
toxicity was cheilitis. These results indicate that 13-ct's
retinoic acid may be more effective and is less toxic than
naturally occurring retinoic acid (a\\-trans vitamin A
acid), and that the synthetic retinoids may represent a
potent new class of drugs in the treatment of cutaneous
disease.
introduction
Vitamin A, and more recently retinoic acid (a\\-trans
vitamin A acid), has been used either systemically or
topically to treat keratinising disorders of the skin.1
Therapeutic responses have been inconsistent and
limited by either systemic toxicity or local irritation
when applied topically. Retinoic acid has proved to be
more potent than vitamin A in the treatment of these
conditions. However, the hypervitaminosis-A syndrome
induced by systemic retinoic acid has prompted the
search for synthetic derivatives with similar or greater
therapeutic activity which are less toxic. Preliminary
data in animals and man have indicated that 13-czs
retinoic acid may be as potent and less toxic than the
naturally occurring a\\-trans retinoic acid.2 *
materials and methods
Drugs.—13-ds retinoic acid (Ro-43780, Hoffmann-La
Roche, Nutley, New Jersey) was administered as 10 mg and 20
mg capsules.
Patients.—Thirteen patients with chronic, treatment-resis¬
tant, keratinising dermatoses were studied (see accompanying
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Does Nonspecific T-Lymphocyte Stimulation of
B Lymphocytes Occur During Reversal Reaction
in Borderline Leprosy?
R. StC. BARNETSON, A. BARNETSON, J. M. H. PEARSON & G. KRONVALL
Medical Research Council Leprosy Project and Armauer Hansen Research
Institute (AHRI), Addis Ababa, Ethiopia
Barnetson, R. StC., Barnetson, A., Pearson, J. M. H. & Kronvall, G. Does Non¬
specific T-Lymphocyte Stimulation of B Lymphocytes Occur During Reversal
Reaction in Borderline Leprosy? Scand. ]. Immunol. 5, 287—291, 1976.
Serum immunoglobulins G, A, and M were estimated in 14 patients with border¬
line cases of leprosy at commencement of treatment and subsequently when they
developed 'reversal reaction'. There was a significant increase in all immuno¬
globulin levels during the reaction, with a subsequent fall; the postreaction
values for IgG and IgA were below the base-line figures. Additional investiga¬
tions in six patients indicated that the rise was a nonspecific one, not brought
about by an increase in antimycobacterial antibodies. It seems likely that the rise
in immunoglobulins during reaction is due to nonspecific T-lymphocyte stimula¬
tion of B lymphocytes.
R. StG. Barnetson, Department of Dermatology, Royal Infirmary, Lauriston Place,
Edinburgh, Scotland
Infection immunity to intracellular parasites
such as Mycobacterium leprae (M. leprae) is
dependent on cell-mediated immune mecha¬
nisms rather than circulating antibodies (7,
10, 12, 22, 24). However, humoral antibodies
are also produced in leprosy, particularly at
the lepromatous end of the spectrum (1, 3,
15, 21, 23, 30). Their function is unknown,
and the only clinical consequence of their
presence demonstrated to date is 'erythema
nodosum leprosum' associated with circulating
(20) and tissue deposition of immune com¬
plexes (11, 28, 33).
M. leprae has many unique features. In par¬
ticular, it has an affinity for skin and nerve,
and it is remarkably nontoxic, so that most
of the clinical manifestations are due to the
host responses. In patients with borderline
cases of leprosy it is this cell-mediated response
that causes nerve damage and consequent de¬
formity. The process can occur as part of the
natural history of the disease, but more sudden
and severe nerve damage occurs during the
course of 'reversal reactions'. During these re¬
actions there is an apparent reversal of the
tendency of untreated borderline leprosy to
become more lepromatous, and the histological
features become more tuberculoid. When this
occurs, there is a very marked increase in the
oedema and erythema of skin lesions, with
concomitant swelling and tenderness of the
peripheral nerves. In severe cases there may
be fever, malaise, and generalized oedema.
Lymphocyte transformation tests using whole
M. leprae as antigen are strongly positive dur¬
ing reaction (5, 13), suggesting an increase










IgM Fig. 1. Serum levels
of immunoglobulins G,
A, and M at base line
(B), during reaction (R),
and after reaction (P).
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in cell-mediated immunity to the bacillus, pos¬
sibly triggered by recognition of 'hidden' an¬
tigen in Schwann's cells (5).
There have been several studies of serum
immunoglobulins in leprosy (6, 18, 27, 29,
31). Sirisinha et al. (29) demonstrated that
IgG, IgA, and IgM levels were significantly
higher in leprosy patients, whether tuberculoid
or lepromatous, than in a normal control pop¬
ulation. Bullock et al. (6), however, found
that only lepromatous leprosy patients had
significantly raised levels of these Igs when
compared with normal controls. There has to
date been no study published of serum Ig levels
in patients who developed reversal reactions.
This paper describes a prospective study of
14 patients who developed reversal reactions
and who were followed from the commence¬
ment of treatment.
MATERIALS AND METHODS
Fourteen adult Ethiopians with borderline cases
of leprosy who developed reversal reactions
were studied. Twelve were borderline tuber¬
culoid (BT) and two borderline lepromatous
(BL), as classified histologically according to
the Ridley-Jopling scale (25). Six were men
and eight women, with ages ranging between
20 and 55 years.
Each patient was examined and investigated
to ensure that there was no other significant
disease present. To this end, a full blood count,
chest X ray, and urinalysis were carried out
both initially and later when the patient de¬
veloped a reaction.
Blood specimens for immunoglobulin deter¬
minations were taken at the following times:
(a) base line, at commencement of treatment,
(b) during reaction, and (c) after reaction—
a period that varied from 1 to 9 months after
reaction. Two of the base-line serum samples
were lost before analysis.
Blood specimens were refrigerated immedi¬
ately after collection. Sera were separated and
frozen within 24 hr and kept frozen at —20 °C
until assayed. Quantification of IgG, IgA, and
IgM was performed by means of agar diffusion
plates containing specific antisera (Dakopatts
A/S, Denmark), as described by Mancini et al.
(19), and compared with antigen reference
standards that were obtained commercially
(Behringwerke, Standard Serum 974H). In
some instances immunoglobulin determinations
were carried out using plasma from heparinized
blood, diluted 2:1 in saline as for lymphocyte
separation. Appropriate correction for dilution
was made in these cases.
The following investigations were also car¬
ried out on base-line and reaction serum sam¬
ples from 6 of the 14 patients who developed
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Fig. 2. Crossed
immunoelectrophoretic
analysis of IgG in one
patient who developed
reaction. Carried out at
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reversal reaction: (a) agarose gel electropho¬
resis (17) for analysis of serum proteins; (b)
crossed immunoelectrophoretic analysis of hu¬
man IgG (16) carried out at pH 5.0 using
carbamylated ammonium-sulphate-fractionated
gamma globulin from rabbit anti-human IgG
antiserum (4); and (c) crossed Immunoelec¬
trophoresis for analysis of antimycobacterial
antibodies, using 'sonicated' M. leprae as an¬
tigen (14, 15).
RESULTS
Serum immunoglobulin levels in the 14 re¬
action patients at base line and during and
after reaction are shown in Fig. 1. There were
significant rises in the mean values of each
class of immunoglobulin during reaction (IgG,
P < 0.005; IgA, P < 0.005; IgM, P
< 0.025), using the Student's t test for sta¬
tistical analysis. After the reaction, however,
there was a significant fall in IgG and IgA
only (IgG, P <0.001; IgA, P <0.001).
Agarose gel electrophoresis and crossed im-
munoelectrophoresis of sera from 6 of the 14
patients who developed reversal reactions
showed a polyclonal increase in gamma glob¬
ulins and IgG, respectively; no monoclonal
components were detected. (An example of
the crossed Immunoelectrophoresis in one of
these patients is shown in Fig. 2.) Crossed
immunoelectrophoretic analysis of antimyco¬
bacterial antibodies also showed no change be¬
tween base-line and reaction sera in each case.
In particular, there was no rise in titres of
existing antimycobacterial antibodies and no
evidence of formation of new antibodies dur¬
ing reaction in patients with no antibodies
detected in base-line serum samples. (Titre
changes of 30% can be detected using this
technique semiquantitatively (15).)
DISCUSSION
The finding of significant alterations in im¬
munoglobulins during reversal reactions raises
the question of whether they themselves are
the cause of the reaction or associated with the
cause directly, or whether they are merely sec¬
ondary, incidental findings, caused by the
reaction.
Reversal reactions are characterized histo-
pathologically as delayed-type hypersensitivity
reactions and in lymphocyte transformation
tests in vitro by very high responses to whole
washed M. leprae as the antigen. Extensive
T-cell proliferation and activation clearly un¬
derline the inflammation of reversal reaction;
the primary cause, however, is unclear, although
exposure of previously 'hidden' mycobacterial
antigen is the most likely explanation.
The findings of this study, however, make it
unlikely that this is the cause of the immuno¬
globulin changes. The results indicate that there
is a nonspecific, polyclonal rise in immuno¬
globulin levels rather than specific increases in
antimycobacterial antibodies or formation of
antitissue antibodies on tissue destruction dur¬
ing the reaction. Such changes are likely to be
secondary; they would not be expected to in¬
fluence T-cell activation by M. leprae antigens
or to be caused by their exposure.
8
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That the increases in immunoglobulin levels
are apparently not due to M. leprae antigen
stimulation calls for an alternative explanation.
Several studies have demonstrated that prolif¬
erating, nonsecreting B cells can be converted
into antibody producers by a factor or factors
produced by activated T cells (2, 8, 9, 26,
32). In reversal reactions there is a marked
increase in the number of circulating T lym¬
phocytes sensitized to antigens of the leprosy
bacillus. These lymphocytes, when activated in
the widespread lesions, might stimulate the
production of serum immunoglobulins by non¬
specific action on proliferating B lymphocytes.
This is supported by the finding that, although
there was a highly significant rise in IgG and
IgA during reaction, the rise in IgM was much
less significant and there was no significant
fall after reaction. This is in agreement with
the findings of Davie & Paul (8), who noted
a relative T-cell independence of IgM anti¬
bodies in experimental animals.
The rise in immunoglobulins in this study
would be an effect rather than a cause of the
reversal reaction.
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Lymphocyte transformation test in leprosy; correlation
of the response with inflammation of lesions
G. BJUNE, R. StC. BARNETSON, D. S. RIDLEY & G. KRONVALL Armauer Hansen Research Institute,
Addis Ababa, Medical Research Council Leprosy Project, Addis Ababa, and Hospital for Tropical Diseases, London
(Received 19 November 1975)
SUMMARY
Lymphocyte transformation tests (LTT) using 'whole washed' and 'sonicated' preparations of
Mycobacterium leprae (M. leprae) as antigen were studied in eighty-one patients with borderline
leprosy. The results were correlated with the histological and the clinical pictures.
There was a good correlation with the histological spectrum, LTT responses generally being
higher in the borderline tuberculoid leprosy patients and lower in the borderline lepromatous.
However, considerable variation was noted in each group of the borderline leprosy spectrum,
and it was found that this was due in part to the degree of inflammation in the skin. Thus those
with 'inflamed' skin lesions had higher responses than those with 'silent' lesions, and even
those with borderline lepromatous leprosy with inflamed lesions had higher responses than
those with borderline tuberculoid leprosy whose lesions were silent. Those who had reversal
reactions, where inflammation is very marked, had very high LTT responses which fell with
treatment of the reaction with steroids.
It thus appears that the LTT in leprosy is influenced by the occurrence of hypersensitivity
reactions as well as by the patient's ability to resist bacillary multiplication.
INTRODUCTION
Leprosy is probably the best example of a disease which has a clinical spectrum due to the host response
(Ridley & Jopling, 1966). The high resistant form, tuberculoid leprosy (TT), presents with a few well-
defined skin lesions that histologically resemble delayed-type hypersensitivity granulomata. Bacilli are
.rarely found. In the low resistant form, lepromatous leprosy (LL), the lesions are multiple and diffuse,
"and consist histologically of histiocytes containing large numbers of leprosy bacilli (M. leprae). Between
these two extremes (polar forms) a continuous clinical and histopathological range, termed borderline
leprosy, is seen; patients in this range can be classified as mid-range (BB) or near the lepromatous (BL)
or tuberculoid (BT) poles.
The skin lesions of patients with borderline leprosy can vary in appearance from time to time, both in
treated and untreated cases: they may be hypopigmented macules, or they may be erythematous and
oedematous nodules and plaques. Sometimes inflammation is severe and acute, and this phenomenon
is termed a 'reversal reaction' (Fernandez et al., 1962; Ridley, 1969). The histological counterpart of this
is a development of more tuberculoid features, and a relatively rapid elimination of bacilli.
The lymphocyte transformation test, using peripheral blood lymphocytes from leprosy patients, and
whole washed M. leprae as antigen, gives a spectrum of responses corresponding to the clinical and
histopathological spectrum of leprosy, though considerable variation in each group has been noted
(Myrvang et al., 1972). Because of this correspondence, the LTT has been assumed to measure the host
cell-mediated immunity (CMI) responsible for resistance to the infection. However, a more detailed
Correspondence: Dr G. Bjune, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia.
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histological study of the cases reported by Myrvang et al. revealed that the LTT was correlated with the
proliferative and destructive aspects of inflammation but not with the number of lymphocytes in skin
lesions, though the presence of many lymphocytes enhances the prognosis in some respects and is a
factor in classification (Ridley, 1974).
In tuberculosis (both experimental and human) it has been shown that delayed hypersensitivity
responses to intradermal challenge with purified protein derivative (PPD) do not parallel immunity to the
infection (Reggiardo & Middlebrook, 1974; Knight Shapiro, Harding & Smith, 1974; Medical Research
Council, 1963). It seems likely that this is also the case in leprosy, where similar hypersensitivity pheno¬
mena could account for the variations in LTT responses noted by Myrvang et al. (1972), and also for the
high responses found in reversal reactions (Godal et al., 1973; Barnetson et al., 1975).
This paper describes a study of LTTs in correlation with the clinical and histopathological features in
eighty-one patients with borderline leprosy.
PATIENTS AND METHODS
The study includes eighty-one previously untreated leprosy patients who attended the routine diagnostic clinic of the Alb
Africa Leprosy and Rehabilitation Training Centre (ALERT) in Addis Ababa. There were thirty-six females and forty-five
males; their ages ranged from 13 to 61 years. In all cases clinical examination, chest X-rays, blood counts and urine analysis
were performed to exclude the presence of other significant disease.
Assessment of leprosy. The following assessments were undertaken.
Skin involvement. Clinical drawings on body charts recorded the sites and extent of the skin lesions. The erythema and
oedema of lesions were graded on arbitrary scales (Table 1). Drawings were supplemented by photographs of individual
lesions.
Table 1. Scale for clinical grading of erythema and















oedema also of the
surrounding skin
Nerve involvement. Enlargement and/or tenderness ofperipheral nerves at specific sites was recorded. In addition, motor
nerve function was assessed by voluntary muscle testing (Goodwin, 1968) and by electromyography.
Skin smears for acid-fast bacilli. Skin smears were taken from six sites, stained with Ziehl-Neelsen's stain (Baker, 1967),
and the bacteriological and morphological indices recorded (Ridley, 1964).
Skin histology. Biopsy of a representative skin lesion was performed for independent histological classification according
to the modified Ridley-Jopling scale (Ridley&Jopling, 1966; Ridley &Waters, 1969). Inmanycases (and in all patients whose
histological classification was reported as Indeterminate) biopsy of the radial cutaneous nerve was also undertaken.
In addition to the routine classification, each biopsy was given an arbitrary rating of a number of histological features
(Table 2). The presence of other findings (such as polymorphs and plasma cells) was also recorded.
Lymphocyte transformation test (LTT). LTTs were performed before treatment was initiated (see below).
Clinical management and serial tests. After initial assessments all patients received treatment with dapsone, which was
continued in unaltered dosage throughout the study. Clinical assessments, voluntary muscle testing and electromyography
were repeated periodically, including all occasions when LTTs were performed. Skin smears were repeated 6-monthly.
When patients developed reactions, biopsies and other tests were repeated, and treatment initiated with prednisolone 30-40
mg daily; this dcse was gradually reduced over a period of 1-9 months according to the duration and severity of the reaction.
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^ Lymphocyte transformation test. Lymphocyte cultivation. LTT was performed according to the technique of Closs (1975),
"with a few modifications.
Lymphocytes separated from peripheral blood by centrifugation on a layer of Ficoll-Isopaque (Boyum, 1968) were culti¬
vated in Linbro tissue culture trays (IS-FB-96-TC, Linbro Chemical Company, New Haven, Connecticut) for 7 days in the
presence of antigen. Lymphocytes were cultured in triplicate with a minimum of four concentrations of each antigen and two
or more triplicates were left without antigen (control). Tritium labelled thymidine was added 16 hr before harvest of the
cultures. Cells were harvested on glass fibre filters, washed in distilled water and counted in a liquid scintillation counter
(SL-31, Intertechnique, Plaisire, France).
The reagents employed were: Ficoll (Pharmacia, Uppsala, Sweden); Isopaque (Nyegaard & Company, Oslo, Norway);
Hanks's balanced salt solution (Flow Laboratories, Irvine, Scotland); medium TC 199 with Earles salts (Flow Laboratories);
penicillin-streptomycin for TC (BDH Chemicals Ltd, Poole, England); glass fibre filters, type A (Gelman Instrument
Company, Ann Arbor, Michigan, U.S.A.); toluene, PA grade (March, Dharmstad, West Germany); 2,5-Diphenyloxazole
(Koch-Light Laboratories Ltd, Bucks., England); l,4-Bis(2)-(5-phenyloxazolyl) benzene (Koch-Light Laboratories).
Preparation ofantigens. Leprosy bacilli prepared from a single subcutaneous nodule of a non-treated lepromatous leprosy
patient were used as stimulants for the cultures. The nodule was immediately cut finely with scissors in a Petri dish. It was
then ground in a glass homogenizer in ice cold phosphate-buffered saline (PBS), pH 7-2, with 1% of human serum albumin
(HSA) (AB Kabi, Stockholm, Sweden). Homogenates were centrifuged at 150 g for 5 min. The supernatants were again
centrifuged at 2500 g for 1 hr and the pellets washed twice in cold PBS with l°/0 HSA. After resuspension the volume was
adjusted to 1 x 109 acid-fast bacilli (AFB) per millilitre in PBS-HSA. The batch was subdivided into small aliquots and
stored at — 70°C until use. This preparation is termed 'whole washed' M. leprae.
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Half of the batch was ultrasonicated in a Branson B-12 (Branson Sonic Power Company, Danbury, Connecticut) with 80
Watt output on the medium-sized tip for 1 hr, until no AFB remained. This preparation is termed 'sonicated' At. leprae
and was subdivided and frozen as described for 'whole washed' M. leprae.
All patients were simultaneously tested with whole BCG bacilli (Dried B.C.G. vaccine, Glaxo Lab. Ltd, Greenford,
England) and/or purified protein derivative, PDD (Statens Seruminstitut, Copenhagen, Denmark).
PHA stimulation. Cultures for stimulation with phytohaemagglutinin (PHA, Reagent grade, Wellcome Research
Laboratories, Beckenham, Kent, England) were carried out in all patients in parallel with the antigen stimulation, to check
culture conditions and cell viability. Experiments without stimulation by PHA were rejected.
Statistical analysis. The values recorded were the peak responses in the dose-response curve of antigen concentrations,
with the control values (cultures without antigen) subtracted. Lymphocyte transformation results for groups of patients are
given as medians with the variation expressed as the interquartile range covering the middle 50% of the observations. For
comparison of groups of patients the Kolmogorov-Smirnov Two-Sample-Test is used (Siegel, 1956). This non-parametric
test is applicable to populations of unequal size where the distribution of observations within the population is not known to
be normal.
RESULTS
LTTS: correlation to histology
(a) Initial LTTs and the histological classification. The histological classification of the patients is shown
in Table 3; the distribution is characteristic for Ethiopian patients with borderline leprosy. It will b^
Table 3. Number of patients in the study
which fall into the different groups of the
leprosy spectrum when classified according
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Fig. 1. Median LTT responses in patients in the different groups of the leprosy spectrum, (a) Responses
throughout the borderline range; (b) responses throughout the range of BT leprosy alone.
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noted that patients having clinical characteristics of BT leprosy could be subdivided (according to skin
biopsies) into three groups: (1) twenty-four patients showed an indeterminate histology (but tuberculoid
features were usually present in their nerve biopsies); (2) twenty-five patients had a classical BT histo¬
logy; (3) nine patients had a histology of TT. Since all the 'indeterminate' cases in this study were
clinically BT they are grouped as tuberculoid.
The correlation between the initial LTTs and the histological classification is shown in Fig. 1. Both
'whole washed' and 'sonicated' preparations of M. leprae showed significantly higher responses at the
tuberculoid (BT, TT and Indeterminate) than at the lepromatous (BL, LI) end of the borderline range
(P< 0-001 for both). The difference between TT and BT patients was also significant (P< 0-005 for both
preparations), as was the difference between the histologically Indeterminate and 'determinate' (BT and
TT) patients (P< 0-001 for both).
Table 4. Scoring of histological features correlated to LTT responses to 'whole washed' M. leprae
in untreated tuberculoid and lepromatous patients. (For lepromatous patients none of the recorded
parameters gave significant differences.)
»













No. of lymphocytes 0 0 — P>0-1 2 475
+ 6 650 9 120
39 1100 8 100
23 1000 6 550
No. of epithelioid cells 0 2 425 P< 0-05 21 300
+ 13 650 2 -425
+ 29 1000 2 1000
++ 24 1400 0 -
No. of giant cells 0 34 650 P< 0-005 24 200
+ 2 1400 0 —
15 1600 1 1900
_L _L 17 1400 0 —
Infiltration of the 0 8 725 P< 0-001 21 125
subepidermal zone + 25 500 0 —
4~ 35 1825 3 700
Erosion of the 0 48 650 P< 0-01 24 275
epidermis ± 9 1350 0 —
+ 11 4300 0 —
Enlarged dermal 0 38 850 P< 0-05 22 200
nerves -f. 18 1350 1 1900
Histological activity 0 13 650 P< 0-05 7 0
+ 19 650 1 300
+ 24 1350 3 150
_1_ _l_ 8 1000 11 200
Oedema 0 19 650 P< 0-1 16 175
+ 27 850 5 -75
+ 20 1500 2 750
Dermal reaction 0 26 600 P< 0-01 17 275
+ 26 1150 6 -500
+ 13 2125 0 —
++ 1 3000 0 —
Obs.= observations. ct/min= Counts per minute. P= probability.
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At the lepromatous end of the range LI patients showed slightly stronger LTT responses than BL
patients (P<0-1).
(b) Correlation of LTT responses to histological features. Particular study was made of the patients
classified histologically as TT, BT and Indeterminate. Various features of the pre-treatment biopsy
were graded (Table 4) and compared with the LTT response using 'whole washed' M. leprae as antigen.
In this group of patients LTT responses were correlated with most of the histological characteristics of
tuberculoid leprosy, including the presence and maturation of epithelioid cells (P<0-05), infiltration of
the subepidermal zone (P< 0-001), and erosion of the epidermis (PcO-Ol). In addition, 'histological
activity', signs of spreading of the granuloma, showed higher responses (/><0-05).
A further finding was that certain of the histological features of reaction (including interstitial oedema









Fig. 2. Serial LTT responses during the time of observation correlated to the stability of clinical signs of
inflammation in skin and/or nerves. Responses shown here are summed responses to 'whole washed' and
'sonicated' M. leprae, (a) Stable, non-reactional patients, (b) Labile, non-reactional patients, (c) Reactional
patients.
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reaction. Their presence, however, was associated with increased LTT responses (for oedema, 0-1;
for dermal reaction, TcO-Ol).
The presence of enlarged nerves in the biopsy (diameter more than 50% larger than the normal
maximum of 125 pm) was strongly associated with high LTT responses (P< 0-05); responses below
400 ct/min were never recorded in these patients.
A negative finding was the absence of correlation between the number of lymphocytes in tuberculoid
cases and LTT responses. However, when all patients were taken together, higher concentrations
(+ and + +) of lymphocytes were associated with increased LTT responses (/><0-05).
LTTS: correlation to clinical picture
(a) LTTs and the stability ofthe clinicalpicture during treatment. LTTs were performed more than once
in forty-six cases, and the patients grouped according to the appearance of their skin lesions and status
of their nerves. In fourteen cases both the clinical picture and the LTT results were stable (Fig. 2);
in this figure LTT results are the summed values of responses to 'whole washed' and 'sonicated' pre¬
parations. In fifteen patients both showed considerable variations; often (but not invariably) high LTTs
coincided with increased inflammation in skin and/or nerves. Seventeen patients with clinical and biopsy
•evidence of reversal reactions usually showed greatly increased LTTs during reaction (the peak ofclinical reaction being defined as the time of initiating prednisolone treatment). In all cases the LTT







Fig. 3. LTT responses to 'whole washed' M. leprae according to the clinical appearance of the skin lesions.
I= inflamed; S= silent.
(b) LTTs and the amount of inflammation in the skin lesions. Patients were grouped as 'Tuberculoid'
(histologically BT, TT and Indeterminate) and 'Lepromatous' (BL and LI) and subdivided according to
Fthe appearance of their skin lesions at the time of each test. Patients in reaction were excluded. The
average responses were much lower in the patients with 'silent' skin lesions (those receiving 0 gradings for
both erythema and oedema) of both groups (Fig. 3). The differences were significant for both groups
using 'whole washed' bacilli as antigen (P< 0-001 for tuberculoid and /><0-05 for lepromatous patients).
It was particularly remarkable that the 'inflamed' lepromatous group showed consistently higher readings
than the 'silent' tuberculoid group (PcO-l); the reverse of what should be expected according to their
place in the histopathological spectrum. This is in keeping with the finding that the rise in LTT due to a
reaction often outweighs a difference due to position in the spectrum.
DISCUSSION
The term 'resistance' in leprosy has never been accurately defined. However, in normal usage it is taken to
mean:
(a) The ability of the host to limit the bacillary load of the body. Thus resistance is defined in terms of
the spectrum of leprosy; tuberculoid patients having high resistance, lepromatous low. This definition is
ultimately histopathological.
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(b) The ability of the patient under effective treatment to dispose of disintegrating bacillary material. A
rough indication of this can be attained by following the fall of the bacteriological index during treatment,
and by this criterion a clear distinction is made between polar (LL), subpolar (LI) and borderline
lepromatous (BL) cases. It is of little value, however, towards the tuberculoid end of the spectrum
where bacilli are absent or scanty; and in this area histopathological classification is less precise than in
lepromatous leprosy.
The development of the LTT and its application to leprosy led to the hope that this test might be a
definitive assessment of host resistance. This study fully confirms the results of the previous study as
regards the general correlation of some histological features with a high LTT result, and the lack of
correlation between a high density of lymphocytes in the lesions and the LTT. This confirmation is of
some interest because the present study has made use of a different (and more sensitive) method for the
LTT, as well as different methods of preparation of M. leprae antigens. However, the present study
has also emphasized the limitations rather than the value of the test.
(1) The rise in the LTT during reactions in borderline leprosy patients far outweighs the LTT re¬
sponse associated with uncomplicated tuberculoid leprosy. This applies to BB as well as BT cases, and
there is a smaller though relatively high rise in patients who prior to the reaction are BL or LI. (It is true
that in the present series all the reactions were of the reversal or upgrading type, which occur either ini
borderline patients on treatment or possibly in some earlv untreated BT patients. However, Godal et al.
(1973) found a rise in the LTT even when the reacting patient was immunologically static or perhaps
downgrading).
(2) Following the termination of the reaction, with steroid treatment, there was a fall in the LTT
responses to baseline levels.
(3) There is some evidence that a high density of lymphocytes in lesions is associated with resistance to
downgrading and perhaps a predisposition to upgrading by the patient, but not with the ability to dispose
ofM. leprae (Ridley, 1974). Lymphocytes in lesions do not correlate with the LTT. Thus BL patients,
characterized by a high density of lymphocytes, give a lower LTT response than LI patients who show
few lymphocytes, though BL patients have a better prognosis and are placed higher up the spectrum than
LI. This suggests that the LTT does not simply reflect immune resistance.
(4) Patients with infiltrating granulomas (i.e. histological evidence of failure to contain the infection)
tend to have higher LTTs than those with less active spread. The low LTT values of the clinically BT
histologically indeterminate patients might be due either to the small size of the lesions (histologically),
and their quiescence, or to the large number of lymphocytes and absence of granuloma. Similarly the
high LTT responses given by patients with erythematous swollen lesions can probably be explained
either by the state of activity of the infection, or by the patient being in the early stage of a reaction.
The issues raised by these findings can be resolved into two questions.
I
1. Why do so many BT patients have low LTT responses?
(a) Methodological failures. This seems unlikely here. Each patient in this study was tested with four
different concentrations of two different preparations of M. leprae antigens. Differences in the dose
eliciting a peak response should therefore not affect the percentage of responders. Good responses to
PHA as well as to antigens like PPD and BCG prove the ability of the cells to respond in the actual
experiment. Most patients were also tested more than once, and if clinically stable during the period of
observation, they were also stable in LTT responses (Fig. 2).
(b) The wrong antigens were used. CMI in leprosy could have specificity for different antigens of M.
leprae. In a given preparation of bacilli not all antigens might be equally well exposed. Thus lympho¬
cytes which perform well in vivo might show no transformation response in vitro.
(c) The wrong lymphocytes were used. The number of specifically sensitized lymphocytes in the peri¬
pheral blood represents a balance between their production and their trapping in the lesions (Thestrup-
Pedersen, 1974); small numbers in the circulation need not imply inefficient formation. The potential of
the patient's immunity is difficult to estimate when no standard stimulus exists in vivo.
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2. What factors are responsible for high LTT responses ?
There appears to be a clear answer to this question, namely that LTT results are influenced by
hypersensitivity phenomena.
(a) In untreated patients clinically classified as BT, those with higher LTTs are those which have
histological features of delayed-type hypersensitivity.
(b) In both BT and BL patients (as clinically grouped) those in each group with erythematous swollen
lesions tend to have higher LTT responses than those with silent looking lesions.
(c) In reversal reactions, which show both clinical and histological features of delayed-type hyper¬
sensitivity responses, there is a marked rise in LTT responses.
All these observations indicate that LTTs as performed in this study are affected more by hyper¬
sensitivity to bacillary antigens than by resistance to the infection.
A dissociation between hypersensitivity and resistance has long been recognized in the field of tuber¬
culosis, and must now be accepted as also important in leprosy. There are a number of theoretical
explanations:
(a) The antigens stimulating high LTT responses are irrelevant for resistance, possibly because they
are exposed only by dead bacilli (Youmans, 1975).
»(b) Differences in the presentation of antigen, and specially between presentation in Schwann cells andmacrophages, could explain why bacilli can stay undetected in one tissue, while giving rise to vigorous
reactions in another. The findings in reversal reactions indicate that antigens are presented differently
in the two cell types. This heterogeneity of responses in reversal reaction is described fully elsewhere
(Barnetson et a I., 1975).
(c) Even in untreated patients most M. leprae are non-viable. It is possible that only antigens produced
by living bacilli and which can escape from the host cell are responsible for immune resistance to the
infection.
The LTT has been used to characterize the defect in lepromatous leprosy (Godal et a/., 1971), to
define the immunological spectrum (Myrvang et al., 1972), and has been suggested as a tool to evaluate
immune prophylaxis and immunotherapy in leprosy (Godal et al., 1974). It is clear, however, that the
interpretation ofLTT results is by no means straightforward. Until the implications of the heterogeneity
of the CMI response have been more thoroughly evaluated, the value of LTT to assess 'resistance' in
leprosy will remain doubtful: nevertheless it has proved to be of service in identifying the histological
features which are most precisely linked with hypersensitivity in leprosy.
We are grateful to Monica Lofgren and Wollelaw Ejigu for skilled technical assistance, to Arvid Nygaard for drawing the
illustrations, and to Otto Closs, Morten Harboe, Bjorn Myrvang, John Pearson and Dick Rees for fruitful criticism of the
manuscript. Armauer Hansen Research Institute is run by the Swedish and Norwegian Save the Children organizations and is
affiliated with the All Africa Leprosy and Rehabilitation Training Centre (ALERT), Addis Ababa, Ethiopia, and the Uni¬
versity of Bergen, Norway.
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Plasma factors in delayed-type hypersensitivity
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SUMMARY
The phytohaemagglutinin-induced responses of lymphocytes were found to be inhibited by
plasma from patients with leprosy when compared with their responses in pooled serum from
healthy donors. When patients developed reversal reactions, the initial inhibitory effect of their
plasma was replaced by an augmentary effect on the responses to phytohaemagglutinin. The
period of augmentation coincided with that of the reversal reaction in patients with borderline
tuberculoid leprosy, but was delayed in patients with borderline lepromatous leprosy. The plasma
from each leprosy patient was also observed to have the same effect on lymphocytes from unrelated
individuals, showing that the inhibition and augmentation were due to factors in the plasma
and not to a change in lymphocyte receptors.
It is possible that the normal stable state of leprosy results from the presence of factors in
plasma which act as a control mechanism, and that delayed hypersensitivity reactions may be caus¬
ed by a breakdown of this control.
INTRODUCTION
Cell-mediated immune (CMI) responses are essential for resistance to various intracellular organisms
and to neoplastic change in the tissues. Under certain circumstances, however, the CMI responses are
not beneficial to the host, and they are then termed 'delayed hypersensitivity reactions' (Coombs and
Gell type IV hypersensitivity reactions).
Possibly the most clear-cut clinical example of delayed-type hypersensitivity is the reversal reaction
in borderline leprosy which often leads to permanent deformity due to granuloma formation in nerves.
Ridley (1969) found the histology of these reactions typical of delayed-type hypersensitivity, and Godal
et al. (1973), Barnetson et al. (1975), and Bjune et al. (1976), found a marked rise in in vitro lymphocyte
transformation responses to antigens from Mycobacterium leprae during reaction.
The reason for the emergence of hypersensitivity from a state of comparative non-reactivity is still
unclear. One possibility, however, is that reaction occurs when there is a breakdown of control mech¬
anisms which normally regulate CMI responses and prevent them from becoming overactive and
harmful.
Humoral factors influencing CMI responses can be studied in vitro using the lymphocyte trans¬
formation (LT) test. Phytohaemagglutinin (PHA) stimulates T lymphocytes predominantly and
comparison of responses in autologous plasma and in standard serum may demonstrate any modifying
effect of the patient's own plasma. In this investigation we have utilized such a system to demonstrate
the effect ofplasma factors on T-cell responses in patients with borderline leprosy who developed reversal
reaction.
Correspondence: Dr G. Bjune, Institute for Experimental Medical Research, Ullevaal Hospital, Oslo 1, Norway.
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PATIENTS AND METHODS
Twenty-four patients with borderline leprosy who developed reversal reaction during their 1st year of treatment were
studied. All patients were classified clinically and histologically according to the Ridley-Jopling scale (Ridley & Jopling,
1966). Sixteen were borderline tuberculoid (BT), four, borderline (BB) and four, borderline lepromatous (BL). Twelve of
the patients were male, and twelve female; their ages ranged from 13-56 years. All patients received treatment with dapsone,
which was continued in unaltered dosage throughout the study. When they developed reaction they were treated with predni¬
solone at an initial dosage of 30-40 mg daily, and this was gradually reduced over a period of 1-9 months depending on the
duration and severity of the reaction. Clinical assessments and LT tests were carried out at intervals before, during and
after the reaction. The degree of inflammation in skin lesions and nerves was carefully recorded and graded on an arbitrary
scale as described earlier (Bjune et al., 1976). When erythema and oedema involved normal skin around the lesions, and/or
nerves were markedly tender and enlarged with electrophysiological and functional evidence of substantial acute involvement,
the inflammation was considered a fully developed reaction. The diagnosis of reaction was confirmed by biopsy of a skin
lesion and the radial cutaneous nerve.
Nineteen patients w ith borderline leprosy (BT: 14, BL: 5) matched for age, sex and duration of treatment who had quies¬
cent hypopigmented skin lesions and no evidence of neuritis for at least 6 months, were used as controls. All tests and clinical
assessments were carried out in the same way as for the reactional patients.
In forty-seven of the LT tests in reactional patients before, during and after the reaction, the effect of the patients' plasma
was tested on lymphocytes from another individual (healthy or leprosy patient) in parallel with the autologous lymphocytes.
The foreign lymphocytes and the patients' own cells were cultured identically on the same tray.
Lymphocyte transformation tests were carried out by a micro method as described by Closs (1975). Peripheral blood
lymphocytes were separated by centrifugation on Ficoll-Isopaque (Nyegaard, Oslo, Norway) as described by Bdyum (1968)
and cultured in a concentration of 0-5 x 106/ml. Stimulation with PHA (Reagent Grade, Wellcome, Beckenham) was carried
out at a dilution of 10"2 from stock, found to be optimal in previous experiments. The standard serum was collected from
twenty healthy donors from countries where leprosy was not endemic. It was filtered through a 0-45 n Millipore filter and
stored in small aliquots at — 70°C. The patients' plasma was recovered from the blood sample after the separation of cells,
and was kept for not longer than 4 hr before being mixed with the cells for culture. Lymphocyte cultures were carried out in
triplicate in medium TC 199 (Gibco, Glasgow) with 10% of either standard serum or patient's plasma on the same micro
tray (Linbro, IS-FB-96-TC, New Haven, Connetticut). Control cultures without PHA added were also included in the tray.
Lymphocyte cultures were incubated at 37°C, 100% humidity and 5% C02 for 96 hr. The cells were labelled with 0-5 /tCi
of tritiated thymidine (specific activity, 2 Ci/mM; Radiochemical Centre, Amersham) 16 hr before they were harvested onto
glass-fibre filters (Gelman, Ann Arbor, Michigan), washed with distilled water, dried and the thymidine uptake recorded
as ct/min in a liquid scintillation counter (Inter-technique SL 31, Plaisire, France).
The recorded values for stimulation by PHA were calculated as the mean of stimulated triplicate cultures, with the mean of
unstimulated triplicates subtracted. Statistical significance of differences between groups was estimated with the Wilcoxon
matched-paired-signed-rank-test (W), or the Kolmogorov Smirnov two-sample-test (KS) when observations were not
paired. Estimates of linear regression with statistical calculations for paired data were done on a Canon Canola F-20P
computer.
RESULTS
The PHA-induced responses of lymphocytes from the nineteen control patients who had stable border¬
line leprosy gave a median value of 34,700 ct/min when cultured in 10% autologous plasma. This value
was much lower than when the cells were cultured in 10% standard serum i.e. median; 48,200 ct/min
(/-1 <0-001 (W)). The degree of inhibition by autologous plasma remained fairly constant in the nine
clinically stable males, while the ten stable females showed considerable variation from test to test
(Fig. 1).
Plasma from the twenty-four patients who developed reactions produced a similar degree of suppres¬
sion of PHA responses both before and after reaction, while by contrast for the period related to the
reaction they augmented the responses. The duration of the augmenting effect of plasma and its degree
showed great individual variation, as did the intensity and duration of the clinical reaction. In ten of
the patients we were able to perform several tests before, during and after the reaction (Fig. 2). When the
effect of autologous plasma from BT patients on the lymphocyte responses to PHA (recorded as a
percentage of the responses in standard serum) was compared before, during and after reaction, a highly
significant difference appeared (Pfig. 3). The median value before reaction was 52%, during reaction
128% and after reaction 57% (P< 0-001 (KS) for both rise and fall).
The augmenting effect of plasma from BL patients appeared later than that from BT patients. Post-
reactional values recorded up to 2 months after the clinical reaction had subsided, were significantly
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Months
Fig. 1. Effect of autologous plasma on lymphocyte responses to PHA, recorded as a percentage of the parallel
responses in standard serum. Variation with time in ten clinically stable females (a) and nine stable males (b).
higher (median: 90%) than the reactional values (median: 36%), (P = 0-005 (KS)). The degree of
inhibition observed in stable BL patients (median: 61%) was not significantly different from the
inhibition by plasma from BL patients in reaction.
The changes in the effect of plasma on PHA responses during the course of reversal reactions were
not a direct effect of steroid treatment. Reactional BT patients on steroid treatment had a median
response of 126% and postreactional ones 52-5%, which were not significantly different from patients
in the same groups without such treatment (125% and 57% respectively).
The effect of plasma in each case from reactional patients, taken before, during and after reaction,
was tested simultaneously on autologous lymphocyte responses and lymphocytes from an unrelated
Prednisolone
Months
Fig. 2. Effect of autologous plasma on lymphocyte responses to PHA, recorded as a percentage of the parallel
responses in standard serum. Variation with time in ten patients going through a reversal reaction. 0 = height
of reaction clinically, when steroid treatment was initiated.














Fig. 3. Effect of autologous plasma on lymphocyte responses to PHA, recorded as a percentage of the parallel
responses in standard serum. Comparison of responses before reaction (B), during reaction (R) and post
reaction (P), in sixteen borderline tuberculoid and five borderline patients, (o) patients on steroid treatment;














Fig. 4. Effect of reactional patients' plasma on lymphocyte responses to PHA, recorded as a percentage of the
parallel responses in standard serum: correlation between the effect on autologous lymphocytes and lympho¬
cytes from unrelated individuals (homologous). Correlation coefficient, r — 0-81 (P< 0-001).
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individual. The relationship of the effect of reactional patients' plasma on autologous and homologous
lymphocytes is shown in Fig. 4. From this it is seen that the plasma had the same effect on both types of
test cells.
DISCUSSION
Factors in the blood inhibiting lymphocyte responses to PHA have been demonstrated in leprosy by
Nelson et a!. (1971), in recurrent infections in childhood by Fitzgerald & Hosking (1976), various
neoplasms by Sucio-Foca et al. (1973), in pregnancy by Gatti (1971), and also in several other conditions.
Common to many of these conditions is a prolonged stimulation of the immune system.
BT patients often show surprisingly little inflammatory response despite the presence of bacilli
in the tissues for many years. Plasma from such patients caused inhibition of lymphocyte responses
to PHA compared with the responses in standard serum (Fig. 1). In those patients with BT leprosy
who developed a reversal reaction, this inhibitory effect disappeared during the reaction and was
replaced by an augmenting effect of plasma on lymphocyte responses (Figs 2 and 3).
That both the augmentation and inhibition of lymphocyte responses were due to factors in the
plasma and not to a change in lymphocyte receptors, is supported by the observation that the plasma
had the same effect on both homologous and autologous lymphocytes (Fig. 4). Control experiments with
different concentrations of PHA gave no indication of a changed sensitivity of lymphocytes during
reaction nor was there any significant change in the actual height of the PHA responses in standard
serum in relation to the reaction. So the augmentation of responses by autologous plasma during reaction
was not due to a change in the lymphocytes' responsiveness to PHA.
Although clinically stable male patients had a constant degree of inhibition during the period of
observation, the effect of plasma from stable female patients on PHA responses showed a great variation
from test to test (Fig. 1). Further studies on normal individuals (Bjune, unpublished data) have shown
that females have pronounced variations of plasma effect on the PHA response related to the menstrual
cycle. The magnitude of these variations considerably surpass the basic level of suppression due to the
leprosy infection.
It has been observed by Weddell & Pearson (1975) that bacilli can lie unrecognized in Schwann cells
of dermal and peripheral nerves, while they are completely cleared from skin by macrophages. A reversal
reaction could therefore be caused by a sudden detection of formerly hidden antigen as well as by a
breakdown of control mechanisms possibly reflected by the plasma factor(s) described here.
The finding in BL patients that the period of augmenting effect of autologous plasma was delayed in
relation to the onset of clinical reaction, could indicate that the plasma factor(s) are secondary to the
reaction. Flowever, it is probable that the plasma factor(s) described here will initially occupy lymphocyte
receptors and exert their effect there, before they can appear free in the blood. Therefore the delayed
appearance in the blood of the augmentary effect does not necessarily negate their primary importance
in transforming the CMI response from a well controlled fight against bacillary multiplication to an
overactive and self-destructive hypersensitivity reaction.
We would like to thank Lena Lundin and Wollelaw Ejigu for skilled technical assistance, Dr Dennis Ridley for the histo¬
logical classification, Dr Ben Naafs for nerve conduction studies and Drs John Pearson, Peter Friedmann and Goran Kronvall
for help in preparing the manuscript. Armauer Hansen Research Institute is run by the Swedish and Norwegian Save the
Children organizations and is affiliated with the All Africa Leprosy and Rehabilitation Training Centre (ALERT), Addis
Ababa, Ethiopia, and the University of Bergen, Norway.
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Evidence for a soluble lymphocyte
factor in the transplacental
transmission of T-lymphocyte
responses to Mycobacterium leprae
Antigens introduced to the human foetus have been
considered as "self" and thus not to provoke an immune





















tested ten randomly selected normal mothers and their
babies at parturition for evidence of sensitisation to antigens
of Mycobacterium leprae. We found that when the mothers
showed sensitisation their bahies did too: the children of
unsensitised mothers were not sensitised. We consider the
likeliest explanation for our findings is the transplacental
passage of a soluble lymphocyte factor.
Lymphocyte transformation tests (LTT) were carried out
by a micromethod6 on both maternal and neonatal cord
blood: whole washed M. leprae were used as antigen, and in
each case the responses to BCG and PPD were also deter¬
mined. Of the ten mothers tested, five showed a positive
LTT response with M. leprae as antigen and five did not
(Fig. 1). It was considered that a positive response existed
when the LTT response with the antigen was more than
Table 1 Median responses to antigens
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Mother Baby Mother Baby
Fig. 1 LTT responses to whole M. leprae in mothers and neonates,
comparing the five mothers with positive responses and the
five mothers with negative responses (unstimulated control
values are subtracted). 3H-TdR, Tritiated thymidine uptake.
isms seem to coincide with birth, and the development of
adult immune responses is gradual. Moreover, in sheep,
antigens can give rise to more or less mature immune res¬
ponses in the foetus1,3, dependent on the stage of gestation.
The nature of transmission of these immune responses from
mother to foetus remains unclear. Brody et aldemon¬
strated in humans that T-lymphocyte sensitisation could
be transmitted from mother to foetus and considered this
was due to transplacental passage of antigen. Field and
Caspary1 showed that cell-mediated responses can be
induced in the foetus, but thought that either maternal
lymphocytes or some subcellular lymphocyte factor crossed
the placenta to sensitise the foetal lymphocytes. We have
Figures are c.p.m.
Median responses to antigens in the two maternal and the two
neonatal groups. P, Probability of distribution between the two
groups occurring by chance, calculated by Mann-Whitney U test.
twice the value of unstimulated control cultures. The values
for these control cultures were much higher in the neonates
(median : 13,171) than in the mothers (median : 532). In
the five mothers with positive lymphocyte blastogenic res¬
ponses, the response of the neonate reflected the maternal
response, though the former were much greater. In the five
unresponsive mothers, the neonatal response was much
lower than in the neonates born of responders. The differ¬
ence between the two neonatal groups is highly significant
(P<0.005), using the Mann-Whitney U test for statistical
analysis. There was also a statistically significant difference
in responses to PPD (but not BCG) between the maternal
responders and non-responders to M. leprae (Table 1), pos¬
sibly due to some cross reactivity. There was, however, no
significant difference of responses to PPD and BCG between
the two neonatal groups.
Five out of ten may seem a high proportion of mothers to
show evidence of sensitisation to M. leprae; but it is in
accord with our experience that up to 90% of contacts
with known cases of leprosy show evidence of previous sub¬
clinical infection7. Moreover, in Sao Paulo, Brazil, where
the leprosy endemicity is similar to that of Addis Ababa,
more than 50% of the normal population show positive
lepromin (Fernandez) skin tests8.
This study provides evidence that when mothers are
sensitised to M. leprae this sensitisation is transmitted to the
foetus. The sensitisation seems to be specific, as there was
no significant difference between the responses of the two
neonatal groups when BCG or PPD were used as antigens.
For transmission of this sensitisation, there are three
main possibilities. The first is transplacental passage of anti¬
gen. In our study, this seems unlikely as the mothers showed
no signs of leprosy, or other mycobacterial disease. The
second possibility is transplacental passage of maternal
lymphocytes. It is still debatable whether maternal lym¬
phocytes enter the foetal circulation9-12, so if they do cross
the placenta it must be in very small numbers. In view of
the high neonatal LTT responses, recruitment of neonatal
lymphocytes by maternal lymphocytes would again seem
improbable. Third, there could be transplacental passage of
a soluble lymphocyte factor. It seems most likely that such
a factor was responsible for the foetal lymphocyte sensitisa¬
tion we have demonstrated.
The nature of this lymphocyte factor remains unclear.
Some immunoglobulins are known to cross the placenta,
but none has been shown to raise antigen-specific T-
lymphocyte responses in unsensitised individuals. Several
soluble factors for specific T-cell stimulation however,
have now been described. One possibility in this context is
transfer factor13 which can transfer delayed type hyper¬
sensitivity and, having a molecular weight of less than
10,000, could cross the placenta passively. The nature of the
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Immune complexes and complement hypercatabolism
in patients with leprosy*
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SUMMARY
The occurrence of immune complexes in the serum and the level of the C3 breakdown product
C3d in the plasma from patients with leprosy were studied by quantitative methods and the results
were compared in various forms of the disease. These studies were performed on sixty-two
samples from twenty-six patients. The serum 125I-Clq binding activity was found to be increased
by more than 2 s.d., as compared to the normal values, in most of the sera from patients with
erythema nodosum leprosum (ENL) (80%) and uncomplicated lepromatous leprosy (82%), but
also in the sera from patients with tuberculoid leprosy (58%). In vitro studies suggested that
immune complexes involving mycobacterial antigens were present in leprosy sera. An increased
C3d level (> 2 s.d.) was also found in most of the plasma from patients with ENL (70%), but rarely
in the plasma from patients with uncomplicated lepromatous leprosy (18%) and never in tubercu¬
loid leprosy patients' plasma. The absence of a significant correlation between the 125I-Clq
binding activity and the C3d level in leprosy patients may suggest that extravascular immune
complexes are involved in the complement activation occurring in ENL. The quantitation ofC3d
in plasma may be of some practical interest in the early diagnosis ofENL complications of leprosy.
INTRODUCTION
The various forms of leprosy represent a wide, continuous spectrum of clinical manifestations (Ridley &
Jopling, 1966). Recent studies indicated that cellular and humoral immune reactions against Myco¬
bacterium leprae may be involved in the development of some of the pathological manifestations (Godal,
1974). The formation of immune complexes may be expected in lepromatous leprosy from the con¬
comitant occurrence of large amounts of mycobacteria and of corresponding antibodies. Indeed, there is
some evidence of an involvement of immune complexes in the pathogenesis of erythema nodosum
leprosum (ENL), mainly based on clinical and tissue studies. Certain disease manifestations of ENL,
such as albuminuria or skin lesions, are similar to those encountered in serum sickness, or in the experi¬
mental Arthus reaction (Waters & Ridley, 1963). Deposits of immunoglobulins and C3, and sometimes
mycobacterial antigens have been demonstrated by immunofluorescence in such ENL lesions (Wemambu
et al., 1969). The presence of immune complexes in circulating blood has also been suspected and sero¬
logical studies have revealed the frequent occurrence in leprosy sera of substances which precipitate with
Clq in agarose (Moran et al., 1972; Rojas-Espinosa, Mendez-Navarrete & Estrada-Parra, 1972; Gelber
et al., 1974). However, the complement level has been consistently found to be normal or elevated (Saitz,
Dierks & Shepard, 1968; Wemambu et al., 1969; Malaviya et al., 1972; Petchclai et al., 1973; Gelber
et al., 1974).
* Supported by the Swiss National Foundation (grant no. 3.260-0.74), the World Health Organization (Immlep pro¬
gramme) and the Medical Research Council Leprosy Project, Addis Ababa.
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The purpose of the present work was to apply to the study of leprosy quantitative methods for the
detection of immune complexes in serum and for the demonstration of complement activation products
in plasma. The serological results were compared in the various forms of the disease and the correlation
with the clinical activity of the disease in ENL was investigated. A radioimmunological method, the
[125I]Clq binding test, was used for the quantitation of immune complexes (Nydegger et al., 1974;
Zubler et al., 1976a). Complement activation was studied by measuring the C3d levels with an immuno¬
chemical method (Perrin, Lambert & Miescher, 1975). It is known that activation of C3 results in a
fragmentation of the native molecule (mol. wt 200,000) into C3b (mol. wt 190,000) and C3a (mol. wt
10,000). C3b is then cleaved by the C3b inactivator into C3c (mol. wt 150,000) and C3d (mol. wt 35,000).
By measuring the C3 level by usual methods, one cannot recognize if an increased synthetic rate is
masking an increased catabolism of the molecule. By selective quantitation of the small C3d fragment, a
hypercatabolism of C3 may be demonstrated, independent of the C3 synthesis rate.
MATERIALS AND METHODS
Patients studied. Thirty-nine serum samples from thirteen patients with ENL (two serum samples or more per patient,
obtained at intervals of 1 week or more); eleven sera from seven patients with uncomplicated lepromatous leprosy and twelve
sera from six patients with tuberculoid leprosy were studied. The control groups included ten patients with active pulmonary
tuberculosis and five clinically healthy individuals from Ethiopia. In addition, samples from thirty blood donors from Geneva
were studied. Leprosy and tuberculosis patients were diagnosed and treated at the Addis Ababa Leprosy Hospital and
Tuberculosis Center respectively. The age distribution of the different groups was similar, with means ranging from 23-27
years. All leprosy patients were under treatment with DDS or clofazamine. For the treatment ofENL, most patients received
in addition a combination of two or more of the following drugs: stibophen, chloroquin, acetylsalicylic acid, chlorpromazine
and prednisolone.
Collection and storage ofserum and plasma samples. For collection ofserum, blood was allowed to clot at ambient temperature
for 1-2 hr, was then centrifuged at 1500 g for 15 min and the serum was stored at — 70°C. To obtain plasma, blood was
collected in plastic tubes containing EDTA (20 mM final concentration), centrifuged at 1500 g for 15 min and the supernatant
was immediately stored at — 70°C. Serum and plasma samples were shipped to Geneva on dry ice and were kept at — 70°C for
up to 3 months.
[>25I]Cl3q binding test. The modified [l25I]Clq binding test for the detection of soluble immune complexes was used
(Zubler et al., 1976a): briefly, [125I]Clq is mixed with native test serum and then free Clq is separated from Clq bound to
complexes by a precipitation with polyethylene glycol (PEG). Results are expressed as percent [125I]Clq precipitated as
compared to the radioactivity precipitated with trichloroacetic acid (TCA) in control tubes. The mean of duplicated tests is
calculated and represents the Clq binding activity (Clq-BA) of the sample. Sucrose gradient fractions have also been tested,
and the specific Clq-BA in such gradient fractions was obtained after a correction for the non-specific Clq-BA observed in
gradient fractions obtained with NHS (Zubler et al., 1976b). In some experiments, the test was performed on sera or sucrose
gradient fractions which had been incubated in presence of mycobacterial antigens. As controls, samples were tested after
incubation in presence of 0-9% NaCl.
Complement studies. These were carried out on EDTA-plasma. Haemolytic activity (CH50) was quantitated in a continuous
flow system (Nydegger et al., 1972). Clq, C4, C3 and properdin factor B were quantitated by single radial immunodiffusion
(Perrin, Lambert & Miescher, 1974). The C3 breakdown product, C3d, was quantitated in a two-step procedure (Perrin,
Lambert & Miescher, 1975): in the first step, C3 and the high molecular weight fragment, C3c, were precipitated with PEG.
In the second step, the C3d was measured in the PEG supernatant by single radial immunodiffusion using anti-C3d antigen
antiserum. The values for CH 50, Clq, C4 and factor B were expressed in per cent of a normal plasma pool. The values
for C3 and C3d were expressed in mg%.
Density gradient studies. Ultracentrifugations were performed with a SW65-Ti rotor in a Spinco L2-65B preparative
ultracentrifuge. Samples of scrum or PEG fraction obtained from serum (0-8 ml) were layered on 4-2-ml sucrose gradients,
10-40% (w/v) in 0-1 M borate, 0-1 M EDTA, pH 8-3, and centrifuged at 34,000 rev/min for 17 hr at 7°C. In some experi¬
ments, serum (0-4 ml) was first incubated in presence of mycobacterial antigens (0-8 ml); thereafter 1-2-ml portions were
layered on 3-8-ml gradients and centrifuged at 43,000 rev/min for 13 hr at 7°C. The techniques used for the preparation of
gradients, the collection of gradient fractions and for obtaining OD patterns from gradients with a u.v. flow cell, have been
described (Zubler et al., 1976b). IgG and IgM were used as 7s and 19s sedimentation markers respectively.
In some experiments, a PEG precipitation was done in order to concentrate the Clq binding material before ultracentri¬
fugations (Zubler et al., 1976b). For the present study, 1 vol. of serum was mixed with 4 vol. of a 4% (w/v) PEG (MW 6000)
solution in borate-EDTA buffer, pH 8-3. The mixture was kept at 4°C for 1 hr, centrifuged at 2000 g for 30 min, the pre¬
cipitate was homogenized and resuspended with borate-EDTA buffer in 1/3 or 1/6 of the original volume of serum.
Experiments with mycobacterial antigens. For such experiments, an antigen preparation of M. leprae from armadillo tissue,
homogenized by sonication, was used at a protein concentration of 3 mg/ml (Kronvall et al., 1976).
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Statistical evaluation. Statistical evaluation was carried out according to Stud ent's /-test and by linear regression analysis by
the method of the least squares.
RESULTS
[125/]C7<7 binding activity in serum samples
The [125I]Clq binding activity (Clq-BA) was measured on thirty-nine serum samples from thirteen
patients with ENL, eleven sera from seven patients with uncomplicated lepromatous leprosy (L. leprosy)




















(Blood donors, Geneva) 30 7-0± 2-5 J 100± 18 100± 21 100± 14 135± 21 0-8± 0-5 100± 15
Ethiopian controls 5 9-2±4-l 107±28 119± 18 96± 22 130± 36 0-6± 0-5 101 ±23
Leprosy: ENL (total) 39 18-7± 8-7 127+29 112 ± 36 128± 39 160± 48 2-3±0-8 111 ± 27
ENL acute 12 20-6± 6-3 112± 29 115 ± 42 163± 44 188± 58 2-4± 0-4 115± 39
ENL convalescent 12 16-5±6-4 126+ 30 106± 33 107± 29 146± 41 2-0± 0-9 104± 31
Lepromatous 11 27-5± 17-7 139+28 102± 42 127± 30 140± 48 1-3 ± 0-7 104± 30
(without ENL)
Tuberculoid 12 14-5± 61 123±22 106± 41 111 ± 28 127± 23 0-8±0-4 97±29
Tuberculosis 10 12-8± 7-0 152± 21 117± 23 104± 17 157±31 0-9±0-5 122± 24
* Per cent radioactivity precipitated,
t Per cent of a normal plasma pool.
{ These are mean values± 1 s.d.
and twelve sera from six patients with tuberculoid leprosy (T. leprosy). For controls, thirty serum
samples from blood donors from Geneva, five sera from healthy Ethiopians and ten sera from ten patients
with active pulmonary tuberculosis (Tbc) who were also Ethiopian, were tested. The mean values for
Clq-BA which have been found in these patient groups are shown on Table 1. As compared to the
Clq-BA in the normal controls (blood donors), the mean Clq-BA was significantly increased in the sera
Fig. 1. [125I]Clq binding activity (Clq-BA) in the serum from patients with erythema nodosum leprosum
(ENL), uncomplicated lepromatous leprosy (L), tuberculoid leprosy (T), pulmonary tuberculosis (TBC) and
from healthy blood donors (NHS). The normal range (+2 s.d.) for the Clq-BA is indicated.
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from patients with ENL (P<0-001), L. leprosy (/><0-005) and T. leprosy (.P<0-005). The highest mean
value was found in L. leprosy. No significant difference in Clq-BA was observed between the various
leprosy patient groups. The mean Clq-BA was also increased in the The patients (P<0-005). Only in
L. leprosy was the mean Clq-BA significantly higher when leprosy was compared to The (P<0-05).
There was no significant difference between the mean Clq-BA in Ethiopian controls and that found in
blood donors from Geneva. The values for Clq-BA in individual patient's sera are shown on Fig. 1.
As compared to the normal controls, the Clq-BA w-as increased by more than 2 s.d. in 80% of ENL sera,
82% of L. leprosy sera, 58% of T. leprosy sera and 30% of The sera.
Complement levels in plasma samples
Various complement parameters were measured in plasma samples obtained from patients who had
sera tested. First, the total haemolytic complement activity (CH50) and the levels of Clq, C4, C3 and
properdin factor B were quantitated. The mean values which were observed in the various patient groups
Fig. 2. C3d levels in the plasma from patients with erythema nodosum leprosum (ENL), uncomplicated
lepromatous leprosy (L), tuberculoid leprosy (T), pulmonary tuberculosis (TBC) and from healthy blood
donors (NHS). The normal range (+ 2 s.d.) for the C3d level is indicated.
are shown on Table 1. As compared to the normal controls, all complement levels measured were in¬
creased to various extents in the leprosy and the The patients. One should mention that the mean Clq
levels were significantly increased in all these patient groups (/><0-01). In individual patients, none of the
complement values significantly correlated with the Clq-BA. Secondly, the C3d fragment of C3 was
quantitated in the plasma samples. The mean C3d levels which were observed in the various patient
groups are also shown on Table 1. The mean C3d level was significantly increased in ENL (Z3<0-001),
it was elevated at the limit of significance in J., leprosy (P = 0-05) and was not significantly different
from the normal value in T. leprosy and The. The mean C3d level was also significantly elevated in ENL
when compared to L. and T. leprosy (.P<0-001). The C3d levels in individual patient's plasma are shown
on Fig. 2. As compared to the normal control, the C3d levels were increased by more than 2 s.d. in 70%
of ENL plasma, 18% of L. leprosy plasma and in none of the T. leprosy or Tbc plasma.
Correlation between the Clq-BA and the C3d level
By linear regression analysis, a significant correlation was found between the Clq-BA and the C3d
level in patients with ENL, but the correlation coefficient was not very high (r = 0-359, /)<0-05). When
studying all the patients with leprosy, the correlation between the Clq-BA and the C3d level was not
significant (r = 0-243, P>0-05 (Fig. 3).
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more for prospective follow up study. The Clq-BA and the C3d level have been compared to the clinical
activity of the disease. From twelve ENL patients, serum samples have been obtained during both an
acute bout ofENL and a period of convalescence. The Clq-BA and/or C3d levels were found to be lower
during the convalescence in eight patients. However, the mean Clq-BA and C3d level were only in¬
significantly lower during the convalescence in comparison with the acute phase of ENL (Table 1). It
should be noted that, in fact, the Clq-BA as well as the C3d level, remained rather constant within
individual patients during the follow-up study. However, in a prolonged follow-up of one patient, the
Clq-BA and the C3d level were regularly found to be decreased during periods of convalescence, as
observed following three different bouts of ENL. All the other complement levels studied were lower
during the convalescence. No conclusions could be drawn from this study with respect to the effects of
various drug regimes.
IOOr
» 1A+A« »*• *
C3d (mg %)
Fio. 3. Correlation between the [125I]Clq binding activity (Clq-BA) and the C3d level in patients with
leprosy: (•) erythema nodosum leprosum; (a) uncomplicated lepromatous leprosy; (+) tuberculoid leprosy.
Characterization of the Chj binding material in leprosy
In order to investigate the size of the Clq binding material, the sera from two patients with ENL and
one patient with L. leprosy exhibiting an increased Clq-BA, were subjected to ultracentrifugation ana¬
lysis, using sucrose density gradients (10-40% w/v). After ultracentrifugation, the Clq-BA was measured
in each of seven serial gradient fractions. The Clq-BA was always encountered in gradient fractions 3 and
4 from the bottom of the tubes containing about 10-26s material (Fig. 4).
Some experiments were performed in order to investigate the nature of the Clq binding material in
leprosy serum. The assumption was made that the increased Clq-BA in such serum may be related to
the presence of immune complexes involving antigens from M. leprae. It is known that immune com¬
plexes in great antigen excess do not bind Clq efficiently. The Clq-BA was therefore studied to see
whether it decreased after an incubation of leprosy sera in presence of an M. leprae antigen preparation
(Ml-ag). Sera were incubated overnight at 37°C in presence of either Ml-ag or 0-9% NaCl for controls.
The Ml-ag protein concentration was 12 mg/ml serum. In experiments with three ENL and three L.
leprosy sera, the Clq-BA was found to be increased after an incubation with Ml-ag (26+ 19%, mean
Clq-BA+ 1 s.d.) as compared to controls with NaCl (17+ 18%). When T. leprosy sera, Tbc sera, normal
human sera (NHS) or NHS containing various amounts of heat-aggregated human immunoglobulins
(AHI) were used in these experiments, the Clq-BA was found to be the same (maximal difference of
2%) in samples with Ml-ag as in controls with NaCl. The serum of one patient with ENL was subjected
to ultracentrifugation analysis after an incubation with either Ml-ag or NaCl. The results are shown on
Fig. 5. When the serum was incubated with NaCl, the maximal Clq-BA was found in gradient fractions
containing about 12-20s material; but when the serum was incubated with Ml-ag, the maximal Clq-BA
was found in gradient fractions containing smaller, 8-16s material. The total Clq-BA in all the fractions
of the respective gradients was about the same after the incubation with either Ml-ag or NaCl.
Immune complexes and C3d level in leprosy
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Fig. 4. Specific [l25I]Clq binding activity (Clq-BA) measured in individual sucrose gradient fractions obtained
by separation of sera from patients with erythema nodosum leprosum (ENL) and uncomplicated lepromatous
leprosy (LL): at the top of the figure the optical density (OD) pattern obtained with a serum and the positions













Fig. 5. Specific [125I]Clq binding activity (Clq-BA) measured in individual sucrose gradient fractions
obtained by separation of the serum from a patient with erythema nodosum leprosum (ENL) after an incuba¬
tion of the serum with either an M. leprae antigen preparation or 0-9% NaCl for the control: at the top of the
figure the optical density (OD) pattern obtained with the serum and the positions of the 7s and the 19s markers
are indicated, Clq-BA is represented by the columns on the lower part of the figure.
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Since one possibility was that the increase in Clq-BA in ENL and L. leprosy sera observed in presence
ofMl-ag was the result of a reaction of Ml-ag with free anti-mycobacterial antibodies, the Clq binding
material was largely separated from free antibodies before investigating the effect of an incubation with
Ml-ag on the Clq binding activity. The Clq binding material from 2 ENL and one L. leprosy sera was
partially purified and concentrated using PEG, and then fractionated on sucrose density gradients. This
procedure led to a two to four times increased Clq-BA in 10—26s gradient fractions when compared to
the Clq-BA in respective gradient fractions obtained with the original untreated sera. When such
gradient fractions were incubated in presence ofMl-ag, the Clq-BA was found to be strongly reduced
as compared to the Clq-BA after incubation with NaCl. (Table 2).
Table 2. Effect of an incubation with M. leprae antigens on the [125I]Clq
binding activity ofpartially purified Clq binding material from leprosy sera
Specific [l25I]Clq binding activity (%)
Sera used for
purification of When incubated When incubated
Clq binding material with NaCl with Ml-ag*
S 356 ENL 41f 21
S 559 ENL 46 17
S 205 L. leprosy 49 26
NHS 0 (9-4$) 0(ll-2O
NHS+AHI (0-2 mg/ml)U 29 30
* Partially purified Clq binding material was incubated with At. leprae
antigens (Ml-ag) for 3 hr at 37°C; the Ml-ag protein concentration was
4 mg/ml sucrose gradient fraction material.
f Mean values of duplicate experiments.
% Values for 'non-specific' [125I]Clq precipitation in sucrose gradient
fraction obtained with NHS, after an incubation with NaCl or Ml-ag
respectively.
U AHI = Aggregated human immunoglobulins.
DISCUSSION
There is now good evidence that the immune reactions against M. leprae may play an important role in
the pathogenesis of leprosy, while M. leprae itself exhibits little in vivo toxicity (Godal, 1974). Lepro-
matous leprosy is characterized by the concomitant occurrence of large amounts of M. leprae and of
corresponding anti-mycobacterial antibodies (Kronvall et al., 1976). Therefore, one might expect the
formation of immune complexes as well as an activation of the complement system triggered by such
immune complexes. Deposits of immunoglobulins and C3 have been detected by immunofluorescence
in skin lesions (Wemambu et al., 1969) and renal glomeruli (Shwe, 1972) in patients with L. leprosy or
ENL. Furthermore, the existence of circulating immune complexes has been suggested by the finding of
Clq precipitins in agarose (Agnello, Winchester & Kunkel, 1970) in the sera from patients with L.
leprosy (Moran et al., 1972; Rojas-Espinosa et al., 1972; Gelber et al., 1974). Some authors found a
higher incidence of such Clq precipitins in agarose in ENL than in uncomplicated L. leprosy (Moran
et al., 1972; Gelber et al., 1974). This observation was not confirmed using a quantitative estimation of
immune complexes with the Clq binding radioassay. Indeed, in the present investigations, an increased
[125I]Clq binding activity (Clq-BA) was demonstrated frequently in the sera from patients with ENL
and with uncomplicated L. leprosy, but was also found in sera from patients with T. leprosy.
Several data support the hypothesis that the detected [125I]Clq binding material, which sedimented
in a 10—25s range, consists of immune complexes involving M. leprae antigens. The decrease of the Clq-
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BA of partially purified Clq binding material to about half of the control value after an incubation with
M. leprae antigens (Ml-ag) suggests that immune complexes involving such antigens were present in the
sera. The Ml-ag did not non-specifically interfere with the Clq binding test and the addition of Ml-ag
may lead to the formation of complexes with a higher antigen-antibody ratio, and with a lower efficiency
to bind Clq (Nydegger et al., 1974). Such experiments can only be carried out using partially purified
Clq binding fractions, since it requires a preliminary separation of free antibodies which could form new
complexes upon addition ofMl-ag. Indeed, an increased Clq-BA results from the incubation of whole
sera with Ml-ag, probably indicating its reaction with an excess of anti-mycobacterial antibodies. The
finding of a decreased sedimentation velocity of the Clq-BA after the incubation of a serum with Ml-ag
probably represents a decrease in the size of previously existing complexes upon addition of more
antigen, as well as the formation of new, small complexes. Antigen-antibody systems other than those
involving mycobacterial antigens may also be present in the leprosy sera. Bonomo & Dammacco (1970)
found, in leprosy sera, mixed cryoglobulins with IgM exhibiting anti-IgG activity. In addition, although
the interference of DNA and bacterial lipopolysaccharides is very limited in the [125I]Clq binding test
(Zubler et al., 1976a), one cannot rule out that other biological substances which bind Clq may influence
the present investigation. Moran et al. (1972) reported the possibility of a direct reaction of certain
mycobacterial antigens with Clq in agarose.
In previous studies, normal or increased levels of all of the complement components studied have
generally been observed (Saitz et al., 1968; Wemambu et al., 1969; Malaviya et al., 1972; Petchclai et al.,
1973; Gelber et al., 1974). In the present study, these findings have been generally confirmed. The
increased levels ofClq, C3 and properdin factor B during ENL probably reflect an increased synthesis of
these components in association with the inflammatory syndrome. Such modifications have been fre¬
quently observed in infectious diseases (Schur & Austen, 1968). However, the quantitation of breakdown
products of complement components such as the C3d catabolic fragment of C3 has been shown to provide
a possibility for the evaluation of complement activation independently of the synthetic rate of these
components in human disease, such as systemic lupus erythematosus (SLE) and glomerulonephritis, as
well as in in vitro complement activation studies (Perrin et al., 1975). The usual haemolytic or immuno¬
chemical methods for measuring the plasma level of complement components provide only a static
profile of the complement system and an increased synthetic rate can mask an increased catabolism. The
finding of increased C3d levels in 70% of ENL plasma probably indicates an in vivo activation of C3.
One should note that C3d levels were within the normal range in the control group of patients with
tuberculosis although C3 plasma levels were as elevated as in ENL.
The generation of C3d in plasma may result from an activation of C3, a central component of the
complement system, by the classical as well as by the alternative pathway, and either pathway may be
activated by immunological or non-immunological mechanisms (Miiller-Eberhard, 1974). In certain
clinical conditions, such as SLE or rheumatoid arthritis, increased Clq-BA values in serum were fre¬
quently observed (Nydegger et al., 1974; Zubler et al., 1976a, b) and there is a very significant correlation
between the Clq-BA and the C3d level (Lambert & Zubler 1976; Nydegger et al. 1976).
This suggests that Clq binding complexes in the serum are involved in the complement activation. In the
present study, only a poor correlation between the Clq-BA and the C3d level was found in ENL.
In addition, while C3d levels are similar to those observed in SLE by Perrin et al. (1975), Clq-BA values
are lower in ENL than in SLE. It is therefore not likely that the increased C3d levels in ENL were only
due to complement activation by immune complexes present in the circulation. One should consider the
possibility that extra-vascular immune complexes are involved in the complement activation occurring
during ENL and that the C3d catabolic fragments detected in the plasma from patients with ENL would
be diffusing from extra-vascular spaces. The results from tissue immunofluorescence studies by Wem¬
ambu et al. (1969) support such a hypothesis. In the light of the known biological effects of complement
breakdown products (Cochrane & Koffler, 1973), the demonstration of a hypercatabolism of C3 in ENL
suggests that an activation of the complement system may be involved in the pathogenesis of this clinical
condition. Furthermore, the quantitation of C3d in plasma may be of some practical interest in the early
diagnosis of ENL complications of leprosy.
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